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Abstract 
The cortex is a ~100nm thick layer of F-actin located under the cell membrane, rich 
in myosin II and actin-binding proteins. It is essential for cytokinesis, cell 
locomotion, and tissue morphogenesis. Despite its importance, our knowledge of the 
cortex is poor. Two actin nucleators, Diaph1 and the Arp2/3 complex, have been 
shown to generate actin filaments in the cortex. The actin networks generated by 
these nucleators display clear differences in their organisation and the actin-binding 
proteins they recruit. Therefore, cells may be able to rapidly control their cortical 
mechanical properties by regulating the activity of each nucleator.  
When I searched for regulators of mDia1 and Arp2/3 in a proteomic analysis of the 
cortex, I found four candidate nucleation promotion factors (NPFs): IQGAP1, 
NCKIPSD, Fli-I and the WAVE complex. Interestingly, IQGAP1 and NCKIPSD 
interact with both Diaph1 and the Arp2/3 complex, suggesting they may participate 
in crosstalk. I examined the role of each NPF in the generation and maintenance of 
cortical actin. After examining the localisation of each NPF, I determined their 
impact on cortical assembly by examining how their depletion affected bleb size. 
Indeed, reduction in Arp2/3 activity leads to smaller blebs, while large blebs result 
from a decrease in Diaph1 activity. IQGAP1 and NCKIPSD depletion yielded large 
bleb phenotypes, WAVE gave a small bleb phenotype consistent with its role in 
regulating Arp2/3, and Fli-I depletion had no phenotype. Next, I examined changes 
in F-actin network organisation after NPF depletion with scanning electron 
microscopy. The density and interconnection of the network were altered, further 
suggesting the importance of IQGAP1, NCKIPSD and WAVE in controlling the 
organisation of the actin cortex. I showed that NPF depletion significantly affected 
successful completion of mitosis in HeLa cells. Finally, in collaboration with other 
students, I examined how NPFs controlled properties of cell mechanics. 
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Impact Statement 
Formins, such as Diaph1, and the Arp2/3 complex are important for generating actin 
networks that allow for crucial cellular processes such as cytokinesis, cell 
locomotion, and tissue morphogenesis.  
Both within and outside academia, the work presented in this thesis provides a 
greater insight into the regulation of actin nucleation at the actin cortex. At present, 
knowledge regarding the control of Diaph1 and Arp2/3 is poor, thus, the elucidation 
of interactions discussed in this thesis may help in providing a basis for follow-up 
work in this field. Cancer-cell invasion into tissues requires the formation of actin-
rich structures that are found in invasive cancer cells (podosome/invadopodia). It is 
known that activation of Arp2/3 is required for podosome formation, thus, although 
not immediately, the Arp2/3 complex and its regulators could emerge as potential 
targets for therapeutic intervention. In addition to Arp2/3, formin activity is critical 
for proper cell division and thus, for the maintenance of genomic integrity during cell 
division. At present, there have been relatively few studies that directly link formins 
with disease pathogenesis; future studies are likely to link formins with cancer 
initiation, given the fundamental role of formins during cytokinesis, as discussed in 
this thesis. Overall, inappropriate control of formin or Arp2/3 function and 
expression in humans may be a critical event in cancer development. To understand 
how NPFs control these nucleators, will prove useful for use in future studies.  
In addition, the interdisciplinary nature of the research discussed in this thesis 
provides a platform for the continuation of collaborative work between biology and 
physics. The Institute for the Physics of Living Systems (IPLS) at University College 
London is an example of a cross-faculty institute promoting interdisciplinary 
approaches combining physics and biology to understand fundamental properties of 
living systems. This thesis is an example of such collaborations between theory and 
experimental groups across UCL and internationally. This allows the facilitation of 
new interactions in which quantitative approaches are combined with theory to 
provide us with a greater understanding of the fundamental processes governing 
complex behaviours of living systems, from cells to tissues and organisms. 
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Chapter 1 Introduction 
1.1 Actin 
First isolated in 1942, actin is the most abundant protein in eukaryotic cells (Straub 
1942). One of the earliest recognised functions of actin was its ability to assemble 
into linear polymers that form the thin filaments of the muscle sarcomeres 
(Dominguez & Holmes 2011). Actin is essential for many cellular processes, 
including cell division, intercellular junction formation, migration, chromatin 
remodelling, transcriptional regulation, vesicle trafficking, and cell shape regulation 
(Perrin & Ervasti 2010). The ability of this highly conserved protein to regulate such 
a wide range of cellular processes is due to the existence of many isoforms bearing 
both overlapping and unique functions. Actin is highly conserved, consisting of six 
different isoforms encoded by separate genes in mammals. Four isoforms, αcardiac, 
skeletal, smooth, and γsmooth, are expressed in muscle cells; the remaining two, βcyto 
and γcyto, are ubiquitously expressed in non-muscle cells (Perrin & Ervasti 2010). 
All of the isoforms possess very similar amino acid sequences, with no isoform 
sharing less than 93% identity with any other isoform (Perrin & Ervasti 2010).  
Higher-order actin-based networks are important for cell motility, growth and 
cytokinesis. Actin-filament networks can be categorised into two main types of 
organisation: parallel unbranched bundles of filament (bristles, microvilli, stereocilia 
and filopodia), and highly branched filament networks (lamellipodia and the actin 
cortex). The leading edge protrusions of motile cells consist of sheet-like structures 
called lamellipodia and rod-like assemblies called filopodia (Chhabra & Higgs 
2007). These two leading edge structures differ markedly in their organisation: the 
lamellipodium is a meshwork of branched actin filaments assembled by the Arp2/3 
complex whereas actin filaments in filopodia are parallel and tightly bundled (Faix & 
Rottner 2006). Yet, filopodia originate from the lamellipodial actin meshwork, 
indicating that a high degree of plasticity can be achieved locally (Small 2010). The 
driving force for the generation of both actin structures is the barbed-end elongation 
of actin filaments polymerising towards the plasma membrane. This process 
combines contractile forces and adhesion to push the cell edge forward, and is a key 
step in cell migration. Both filopodia and lamellipodia have clinical relevance in 
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cancer metastasis. Indeed, cell motility is upregulated during tumour progression and 
cancer cells crawl across surfaces via the formation of protrusions, invading 
surrounding tissues (Wang et al. 2005). Although it was long thought that cell 
movement relied solely on lamellipodia and filopodia, it was recently shown that 
membrane blebs can drive the plasma membrane forward during movement of some 
cells (Charras & Paluch 2008; Bergert et al. 2012; Ruprecht et al. 2015).  
The three-dimensional structures of actin molecules and actin filaments were 
determined in 1990 by Holmes and colleagues (Holmes et al. 1990). Individual actin 
molecules consist of 375 amino acids. Each actin monomer, globular G-actin, has 
tight binding sites that mediate head-to-tail interactions with other monomers, 
allowing them to polymerise and form filaments, known as filamentous actin or F-
actin (Dominguez & Holmes 2011). All six actin isoforms have two structural 
domains, large and small, that can be further divided into two subdomains. The small 
domain comprises subdomain 1 and 2, while the large domain comprises subdomain 
3 and 4 (Kabsch et al. 1990). The structure of the actin monomer determined by X- 
ray crystallography exists as two domains that are bridged by bonds to an adenine 
nucleotide (ATP/ADP), and a divalent cation (Mg2+/ Ca2+). In particular, the upper 
cleft is responsible for the interaction with ATP (adenosine triphosphate) or ADP 
(adenosine diphosphate) and the divalent cation magnesium, whilst the lower cleft 
binds the majority of known actin binding proteins (Schutt et al. 1993). Each domain 
is partitioned into two subdomains that allow movement between them (Page et al. 
1998).  
Crystal studies comparing the structure of actin structure bound to ATP or ADP 
show that the molecule undergoes at least two conformational changes during the 
hydrolysis of ATP and the release of Pi (inorganic phosphate) (Blanchoin & Pollard 
2002; Nolen et al. 2004; Graceffa & Dominguez 2003). Structures with bound 
nucleotide (ATP or ADP) are characterised by a closed conformation of the main 
cleft whereby the large and small domains are in close proximity, whereas 
nucleotide-free structures are distinguished by an open cleft (Figure 1-1). 
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Figure 1-1 Crystal structure of the three conformational states of actin. Domain 
I (subdomains 1 + 2), and domain II (subdomains 3 + 4) are coloured purple and red, 
respectively. The domains are connected by a linker α-helix (green). The main 
changes upon release of Pi occur in the region shown in yellow. Structures A and B 
represent nucleotide-bound open actin conformations (ATP and ADP respectively), 
whilst structure C represents the nucleotide-free open conformation (Image from 
Graceffa & Dominguez 2003).  
Actin protomers within a filament are oriented in the same direction; thus, actin 
filaments have a distinct polarity with biochemically distinguishable ends (plus or 
barbed end, and minus or pointed end) (Graceffa & Dominguez 2003). This polarity 
is important for assembly as well as for the directional movement of myosin motor 
proteins. Using electron microscopy, analyses revealed that actin filaments consist of 
two strands that twist around one another to form a right-handed helix (Carlier 1991). 
Under conditions of high protein and salt, G-actin will readily polymerise and 
assemble into F-actin polymers; this process is known as nucleation-elongation. In 
vitro, actin polymerisation can be studied using viscosity analyses, sedimentation 
assays, and fluorescence microscopy (T. Kim et al. 2014; Burlacu et al. 1992; Lim & 
Danuser 2009). The polymerisation of actin can be described as a three-step process 
consisting of a nucleation, elongation, and steady-state phase (Figure 1-2). 
ATP bound ADP bound 
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Figure 1-2 Nucleation, elongation and steady state phase of actin filament 
assembly. A, Diagram showing the three phases of actin filament assembly in vitro. 
During the nucleation phase, three actin monomers form an F-actin nucleus (pink). 
Once actin nuclei are formed, filament elongation can take place spontaneously and 
actin monomers are added to both ends of the filament, elongating it. During the 
steady state, there is no net change in polymer mass and the concentration of free 
actin monomers at the steady state is known as the critical concentration (Cc). 
Permission from MBInfo: www.mechanobio.info; Mechanobiology Institute, 
National University of Singapore. B, G-actin monomers can spontaneously self- 
assemble into polarised actin filaments with ATP-actin monomers added to the 
barbed end and ADP-actin monomers lost from the pointed end. This process known 
as treadmilling, results in a steady net flow of actin subunits through the filament. 
ATP ADP 
Barbed (+) end Pointed (-) end 
ADP 
ADP ADP 
ADP 
ADP 
ADP 
ATP 
ATP 
ATP 
ATP 
ATP 
ATP 
ATP 
ATP 
Polymerisation 
Depolymerisation 
Pi 
Treadmilling 
A 
B 
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Nucleation involves the formation of a small nucleus consisting of three actin 
monomers; this event is slow due to kinetic barriers generated by the instability of 
this aggregate (Figure 1-2A, indicated in pink). The generation of actin trimers 
represents the rate-limiting step of the actin polymerisation process (Nishida & Sakai 
1983), but once actin nuclei form, filament elongation can take place spontaneously. 
A ‘lag phase’ occurs during the initiation of polymerisation, during which no 
filaments are observed. During the elongation stage, G-actin is rapidly added at both 
ends of the growing filament and the rate of elongation is directly proportional to the 
concentration of free actin in solution (Thomas D. Pollard & Cooper 1986). As the 
actin filament grows, the system reaches a steady state and the concentration of free 
actin monomers at this state is known as the critical concentration (Cc) (Cooper et al. 
1983). Importantly, the Cc at the two ends of an actin filament is different. The Cc is 
defined as the concentration level of free ATP-G-actin where the rate of addition is 
balanced by the rate of loss and no net growth occurs at that end. Actin monomers 
are added more rapidly at the barbed end than at the pointed end (Pollard & 
Mooseker 1981). Once the steady state is reached, new ATP bound G-actin subunits 
are added at the barbed end, whereas old ADP bound G-actin subunits are lost from 
the pointed end.  
Actin monomers are bound to ATP, which is hydrolysed to ADP following their 
incorporation onto a filament. The ATP hydrolysis occurs in two main steps; first the 
phosphate bond is cleaved resulting in the generation of actin-ADP. This last step 
leads to a change in the physical properties of F-actin, which becomes less rigid and 
more prone to disassembly (Blanchoin & Pollard 2002). Although ATP is not 
required for polymerisation, ATP-actin monomers polymerise more readily than 
ADP-bound monomers. At the Cc, the length of a filament is maintained constant, as 
the newly added actin monomers treadmill along the growing filament from the 
barbed end to the pointed end, where they dissociate (Figure 1-2B).  
1.2 Actin binding proteins 
The architecture and self-assembly of actomyosin networks is governed by several 
classes of accessory proteins: nucleators, which initiate filament formation; 
nucleation promotion factors (NPFs) required for the proper spatial and temporal 
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control of actin assembly in cells (Duleh & Welch 2010); capping proteins, which 
bind to filament ends preventing further polymerisation or depolymerisation; 
depolymerisation factors and severing factors, which disassemble filaments; 
crosslinkers and stabilising proteins, which organise and stabilise higher-order 
network structures; and motor proteins, which generate movement and forces 
between filaments or between a filament and another structure (Figure 1-3). The 
collective function of these accessory proteins give rise to network properties, such 
as turnover, and are key in determining and fine-tuning the properties of actomyosin 
assemblies. In the following sections, I will describe the above proteins and their 
actions in more detail.  
 
Figure 1-3 The major classes of actin-binding proteins. These structurally diverse 
proteins direct the location, rate, and timing of actin filament assembly/disassembly, 
thus modulating the dynamics of the actin cytoskeleton. Treadmilling of actin 
filaments can be altered by sequestering proteins such as profilin; new filaments are 
nucleated by nucleators such as the Arp2/3 complex and formins; 
crosslinking/bundling proteins such as filamin/α-actinin influence the packing and 
membrane 
actin cortex 
actin crosslinking proteins 
bundling proteins 
membrane linkers 
motor proteins 
capping proteins 
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organisation of actin filaments into secondary structures; capping/severing such as 
gelsolin/cofilin proteins promote the disassembly of actin filaments. Proteins such as 
the ERM (ezrin, radixin and moesin) family bind and anchor actin to the membrane 
or other cytoskeletal networks. There are also a number of proteins that assist in the 
crosstalk between microtubules and actin, such as tau, which bind to both actin and 
microtubules simultaneously (Elie et al. 2015).  
1.2.1 Actin capping proteins 
Capping proteins control access to the free barbed ends of actin filaments and are 
therefore a major factor affecting actin filament elongation. Capping proteins have a 
high affinity for barbed ends and are tightly regulated in the cytoplasm resulting in 
the capping of most barbed ends (Schafer et al. 1996). Capping proteins, such as 
CapZ or β-actinin, help promote actin assembly by preventing the loss of actin 
subunits by blocking the exchange of subunits at the fast-growing end of actin 
filaments (Iwasa & Mullins 2007). CapZ is the most ubiquitous and abundant 
barbed-end capper, and is required for Arp2/3 complex-mediated assembly of 
dendritic actin filament networks (Edwards et al. 2014). Capping protein has also 
been shown to functionally co-regulate filament barbed-end assembly by 
simultaneously binding barbed ends with Diaph1 formin (Shekhar et al. 2015).  
Other capping proteins, such as gelsolin, increase the rate of nucleation by binding 
G-actin monomers and/or unstable oligomers (Casella et al. 1981). Gelsolin is a 
multifunctional actin regulatory protein, and the most potent actin filament severing 
protein identified to date. It initiates severing by binding to the side of an actin 
filament, resulting in slow severing of the filament regulated by Ca2+ (Sun et al. 
1999). After severing, gelsolin remains attached to the barbed end as a cap, 
preventing the reattachment of shorter actin filament and elongation at the barbed 
end, resulting in the disassembly of the actin network.  
1.2.2 Actin filament treadmilling proteins 
Many actin monomer-binding proteins maintain the G-actin pool in cells. Important 
actin monomer binding proteins include profilin, thymosin beta-4 and ADF/cofilin.  
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Profilin is an essential actin-binding protein that specifically binds G-actin at its 
barbed end, changing its conformation, stabilising ATP-actin and preventing its 
association with pointed ends whilst allowing binding to barbed ends (Bugyi & 
Carlier 2010). It has also been shown that profilin can work simultaneously with 
formins to facilitate progressive actin filament elongation following nucleation by 
the formin (Kovar et al. 2006). Profilin-actin binds to formins at the FH1 domain 
tethering multiple profilin-actin complexes near the growing end of actin filaments 
(Paul & Pollard 2008). This promotes the progressive addition of actin subunits by 
generating an artificially high concentration of actin near the barbed end, resulting in 
rapid elongation (Perelroizen et al. 1996). Profilin uses the energy from ATP 
hydrolysis generated during actin polymerisation to facilitate actin assembly (Paul & 
Pollard 2008). 
ADF/cofilin proteins remodel the actin cytoskeleton (Bamburg 1999). For example, 
during cytokinesis, the actin-rich contractile ring shrinks as it contracts through the 
interaction of ADF/cofilins with both monomeric and filamentous actin (Maciver & 
Hussey 2002). ADF/cofilin binds monomeric actin in a 1:1 stoichiometry, 
influencing rapid actin filament turnover. The depolymerising activity is twofold: 
ADF/cofilins sever actin filaments and also increase the rate at which monomers 
leave the filament's pointed end (Bamburg 1999). ADF cooperatively binds to F-
actin, increasing the treadmilling turnover rate of actin filaments, by depolymerising 
actin filaments from their pointed ends. Cooperative binding of ADF/cofilin causes 
the filament to twist and structurally weaken; this causes a modest severing effect 
that results in pointed end depolymerisation, and a 2-3-fold decrease in the average 
length (Bamburg 1999). 
There are a number of specialised actin-membrane linker proteins that allow F-actin 
to interface to the cell membrane (T D Pollard & Cooper 1986). Actin-membrane 
linking is particularly important for actin cortex stability and for enabling shape 
change to occur in response to cytoskeletal rearrangements in the cortex. There are a 
number of known actin-membrane linker proteins, including ezrin-radixin-moesin 
(ERM) proteins, annexins, (Matsui et al. 1998) and filamin.  
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The ERM proteins play a crucial role in organising membrane domains through their 
ability to interact with transmembrane proteins and the cytoskeleton. They provide 
structural links, strengthening the cell cortex and regulating the activities of signal 
transduction pathways (Fehon et al. 2010). In their inactive form, ERMs exist in a 
closed conformation with head-to-tail interactions. ERMs are activated through 
binding to membrane regions rich in phosphatidylinositol, 4,5-bisphosphate 
(PdIns(4,5)P2), allowing for phosphorylation by kinases such as Rho-associated 
protein kinase (ROCK) (Matsui et al. 1998). Following phosphorylation, ERMs 
adopt an open conformation whereby the N-terminal FERM domain binds to the 
plasma membrane and the C-terminal domain associates with F-actin (Bosk et al. 
2011). Studies have shown that ERM may also function upstream to regulate RhoA 
activity, and interact with proteins that regulate Rho GTPases, including RhoGEF 
(Rho guanine nucleotide exchange factors) and RhoGDI (Rho GDP-dissociation 
inhibitor) (D’Angelo et al. 2007). More specifically, phosphorylated ezrin is known 
to associate with protein Dbl through its NH2-terminal domain to cause Rho 
activation (Lee et al. 2004). 
The annexins are a family of Ca2+/lipid-binding proteins that have a unique 
architecture allowing them to dock onto membranes (Rescher 2004). Structurally, 
annexins are highly α-helical. They mediate regulatory interactions with protein 
ligands and regulate the annexin-membrane association (Raynal & Pollard 1994).  
Filamin family proteins bind to F-actin and a number of scaffolding proteins, 
including Rho GTPases. Filamin forms a vital scaffolding adaptor and regulatory 
component that contributes to the mechanical stability of cells by linking the internal 
F-actin network to membrane receptors and mechanosensitive components, such as 
those in muscle (Sampson et al. 2003). These include transmembrane proteins such 
as β-integrins (Sharma et al. 1995), D2 and D3 dopamine receptors (Lin et al. 2001), 
Kv4.2 potassium channels (Petrecca et al. 2000) and intracellular signalling 
molecules such as the Rho family of GTPases (Sampson et al. 2003; Ohta et al. 
1999). By establishing this critical link, the membrane is stabilised allowing for 
changes in cell shape associated with cell motility and migration. The blebbing 
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melanoma cells (M2 cells) used in my work was initially identified as a filamin 
deficient cell line (Cunningham et al. 1992).  
1.2.3 Actin filament bundling and crosslinking proteins 
Cells assemble F-actin into structures ranging from networks, where filaments 
overlap at large angles, to bundles in which parallel filaments are closely packed 
together (Figure 1-4). A variety in network conformations is important to fulfil 
differing roles in cells. Networks of cross-linked filaments constitute the cellular 
cortex, providing mechanical stability and maintaining shape, while F-actin bundles 
provide support or create membrane protrusions such as lamellipodia (Tseng et al. 
2002).   
 
Figure 1-4 Types of actin filament networks produced depend on the 
concentration of the binding proteins that cross-link filaments together. A, 
Single protein cross-linking actin filaments. Figures B-D show filament networks 
produced with increasing protein concentration, respectively: B, weakly cross-linked; 
C, composite; D, bundles; and E, bundle cluster. (Image drawn by Emily 
Harrington). 
A B C 
D E 
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F-actin bundling protein fascin and crosslinking protein α-actinin work together to 
enhance the mechanical properties of F-actin networks (Tseng et al. 2002). α-actinins 
are a protein family, which generate tight bundles of F-actin. They are a major 
component of muscle where they bundle actin filaments in the Z-disc of sarcomeres 
(Sjöblom et al. 2008). α-actinin dimerises in a head to tail manner via rod domains 
present on both ends. The dimer therefore possesses actin binding regions at each 
extremity allowing interfacing of adjacent actin filaments (Djinović-Carugo et al. 
1999). Fascin, a monomeric protein, is a major actin crosslinking protein found in 
filopodia. It binds beta-catenin and co-localises with it at the leading edges, and 
borders of epithelial and endothelial cells (Yamashiro-Matsumura & Matsumura 
1985). Fascin forms a “network of bundles” rather than a homogeneous network as 
seen in α-actinin (Courson & Rock 2010; Kureishy et al. 2002) and undergoes 
frequent cycles of association and dissociation, independent of the phosphorylation 
state (Vignjevic et al. 2006). It increases the stiffness of actin networks by reducing 
the movement of actin filaments through depolymerisation (Meyer & Aebi 1990).  
1.2.4 Motor proteins – Myosin II 
Motor proteins, such as myosin II, are the driving force behind muscle contraction 
and are responsible for the active transport of most proteins and vesicles in the 
cytoplasm (Reymann et al. 2012). Myosin II can move along the surface of a suitable 
substrate, powered by the hydrolysis of ATP by ‘walking’ along actin filaments and 
assembling into mini-filaments, allowing for crosslinking of actin filaments.  
Myosin II contains two heavy chains, each about 2000 amino acids in length, which 
constitute the head and tail domains (Reymann et al. 2012). Each of these heavy 
chains contains the N-terminal head domain, while the C-terminal tails adopt a 
coiled-coil morphology, holding the two heavy chains together (Korn 2000). The 
head of the large protein binds to actin filaments and the tail binds to cargo. In the 
myosin motor cycle, myosin moves by using the energy provided by ATP hydrolysis 
in the heads (Wilson et al. 2010). ATP nucleotide binding to the motor domain 
results in its detachment from F-actin and hydrolysis of ATP to ADP+Pi. This 
intermediate binds weakly to F-actin. When Pi is released, the motor returns to a 
nucleotide-free state (Mehta et al. 1999), allowing for the cycle to start again. 
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Myosin moves along actin filaments towards the plus end, like walking on two legs, 
by alternately changing the orientation of the head structure (Xiao et al. 2003). Thus, 
during one cycle, myosin exists in at least three conformational states: a pre-
hydrolysis ATP state unbound to actin, an ADP-Pi state bound to actin, and a state 
after the power stroke is completed (Xiao et al. 2003).  
1.2.5 Rho GTPases 
Cells receive extracellular stimuli that act to generate changes in the actin 
cytoskeleton at specific sites, primarily through Rho proteins. Once activated, Rho 
GTPases bind to a variety of effectors, including protein kinases and some actin-
binding proteins, to directly or indirectly affect the cytoskeleton (Symons 1996; Fan 
& Mellor 2012).  
Most Rho GTPases cycle between an active GTP-bound conformation and an 
inactive GDP-bound conformation, regulated by three types of protein (Rossman et 
al. 2005). Guanine nucleotide exchange factors (GEFs) catalyse the exchange of 
GDP for GTP, thereby activating the GTPase, whereas GTPase-activating proteins 
(GAPs) increase the intrinsic GTP hydrolysis rate of the GTPase, thereby 
inactivating it (Figure 1-5). Guanine nucleotide dissociation inhibitors (GDIs) 
sequester the GDP-bound form of some GTPases in the cytosol and prevent them 
from localising to membranes or being activated by GEFs (Rossman et al. 2005). In 
the GTP-bound active conformation, Rho GTPases interact with a range of effector 
proteins, including kinases, actin regulators and adaptor proteins, leading to changes 
in cell behaviour. The most important members of the Rho GTPase family, RhoA, 
Rac1, and Cdc42, regulate the formation of essential F-actin structures, such as stress 
fibers, lamellipodia, and filopodia, respectively (Hall 1998).  
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Figure 1-5 The Rho GTPase cycle. Rho GTPases (GDI, GEF and GAP) cycle 
between an active (GTP-bound) and an inactive (GDP-bound) conformation. This 
molecular switch controls a wide variety of signal transduction pathways in all 
eukaryotic cells, in particular regulating the actin cytoskeleton (Image from Etienne-
Manneville & Hall 2002). 
Formins were first recognised as Rho targets in a two-hybrid screen with yeast 
(Kohno et al. 1996). As described in more detail later (1.3.2), most formins contain a 
C-terminal inhibitory autoregulation domain (DAD) and an N-terminal Rho-binding 
domain (RBD) embedded within the larger inhibitory domain (DID). This DID 
domain enables auto-inhibition in a head to tail inactive state, and can be relieved by 
Rho binding (Nezami et al. 2006). The formin Diaph1 is activated only by the Rho 
family; whereas the related Diaph2 and Diaph3 proteins can be activated by Rac1 
and Cdc42 (Lammers et al. 2008). Another well-studied target of Rho is Rho-
associated protein kinase (ROCK). ROCK is involved in phosphorylating myosin 
phosphatase for inactivation and activates myosin light chain, promoting an increase 
in actomyosin contractility (Kimura et al. 1996). Furthermore, ROCK phosphorylates 
ERM proteins to promote their activation (Matsui et al. 1998), and is also involved in 
the inactivation of ADF/cofilin (Maekawa 1999), resulting in the stabilisation of 
actin filaments. Overall, RhoA has a central role in the cortex with the ability to 
promote contractility, actin polymerisation and membrane-cortex linking.  
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1.3 Actin nucleators  
Proteins that can stimulate de novo actin filament assembly are known as actin 
nucleators. This is because they facilitate the formation of an actin nucleus (at least a 
trimer of subunits), which is the rate-limiting step for actin-filament growth (Figure 
1-6). The best-characterised actin nucleators are: the Arp2/3 complex, formin 
proteins, and Spire proteins. Each class has a distinct mechanism of nucleation, 
suggesting that they participate in the assembly of different actin superstructures 
within distinct cellular regions or that they generate functionally different actinous 
structures (Michelot and Drubin, 2011). Despite its importance, our understanding of 
the regulatory processes involved with actin nucleators in cortical organisation 
remains poor. In the following section, I will describe the mechanisms of the Arp2/3 
and formin protein, Diaph1, as they are most relevant to my project.  
 
Figure 1-6 Actin filament nucleation mechanisms. Three main classes of protein 
have been identified that promote rapid initiation of new filament assembly: Arp2/3 
complex, spire and formin. The Arp2/3 complex functions as a template for the 
initiation of a new branched actin filament; the spire proteins form a four tandem G-
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actin-binding association to aid polymerisation; and formins promote the nucleation 
of filaments through stabilising an actin dimer or trimer (Image from Goley & Welch 
2006). 
1.3.1 The Arp2/3 complex 
The actin-related protein-2/3 (Arp2/3) complex was first purified in 1994 from 
Acanthamoeba castellanii based on its affinity for the actin binding protein profilin, 
and was shown to consist of a stable assembly of seven polypeptides (Machesky et 
al. 1994). Two of the subunits were actin-related proteins of the ACTR2 (Arp2) and 
ACTR3 (Arp3) subfamilies, giving the complex its name. The remaining five 
subunits were named actin-related protein complex, ArpC1-C5, and together formed 
a relatively stable heptameric complex. Following this identification, the Arp2/3 
complex was later identified in other organisms including humans (Winter et al. 
1997), and was shown to interact with the side of a pre-existing actin filament 
(mother filament) inducing the nucleation of a new actin filament (daughter filament) 
at a regular 70o branch angle resulting in a Y-shaped structure (Mullins et al. 1997).  
1.3.1.1 The Arp2/3 complex organisation and actin nucleation ability  
Details of the Arp2/3 complex organisation were revealed when a crystal structure of 
the bovine complex was solved at 2.0-Å resolution (Robinson et al. 2001). The 
ACTR2 and ACTR3 subunits are structurally similar to actin, as predicted from their 
sequences, sharing ~47% and ~40% of identity with β-actin, respectively (Kelleher et 
al. 1995). Of the other five subunits, ArpC2 and ArpC4 form the structural core of 
the complex, with the remaining subunits organised around them (Gournier et al. 
2001). ArpC1 is a seven-bladed β-propeller protein, whereas ArpC3 and ArpC5 are 
primarily α-helical and are the most peripheral of the subunits (Figure 1-7A). The 
Arp2/3 complex is yet to be captured in its active short-pitch conformation, whereby 
ActR2 and ActR3 undergo significant conformational changes to mimic the first two 
subunits of the nascent daughter filament. In the inactive conformation, also known 
as splayed, the ActR2 and ActR3 subunits are far away from one another and are 
thus not able to trigger nucleation of a new daughter filament (Gournier et al. 2001).  
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Upon activation by NPFs, it is thought that ACTR2 moves next to ACTR3 in a short-
pitch helix dimer. Subdomains 3 and 4 of ACTR3 and ArpC3 rotate slightly from 
their positions in the inactive crystal structure (Gournier et al. 2001; Rodnick-Smith 
et al. 2016). The rest of the subunits (ArpC1, ArpC2, ArpC4 and ArpC5) appear to 
maintain their positions, fitting into the reconstruction without modification (Rouiller 
et al. 2008). In the active configuration, the ArpC2-ArpC4 heterodimer provides the 
main surface for interaction of the complex with the mother filament and anchors 
ACTR3, the first subunit of the daughter filament (Figure 1-7B). ArpC3 and ArpC5 
contribute to branching through contact with the mother filament, whilst ArpC1 
makes only minor contact with the mother filament (Rouiller et al. 2008).  
 
Figure 1-7 Schematic representation of the Arp2/3 complex. A, Ribbon diagram 
of the crystal structure of the inactive conformation of the Arp2/3 complex. The 
Arp2/3 complex consists of Arp2 (ACTR2) and Arp3 (ACTR3), and five additional 
subunits names ArpC1-5 (Baggett et al. 2012). B, The Arp2/3 complex initiates a 
branched filament by binding to the side of a mother filament and recruiting actin 
monomers. ACTR2 and ACTR3 interact with the pointed end of the daughter 
filament, and ArpC2 and ArpC3 make substantial contact with the mother filament 
(Permission from MBInfo: www.mechanobio.info; Mechanobiology Institute, 
National University of Singapore).  
1.3.1.2 Regulation of the Arp2/3 complex 
Numerous cellular activators and inhibitors modulate the activity of the Arp2/3 
complex, providing tight control over its dynamics and the generation of branched 
actin networks in vivo. To date, NPFs known to interact with the Arp2/3 complex fall 
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into two classes depending on their activity. Class I NPFs bind directly to nucleators 
and actin monomers, initiating an activating conformational change and recruiting 
the first actin subunits for the nascent (daughter) filament, whilst class II NPFs lack 
actin monomer binding regions and instead binds actin filaments (Goley et al. 2004). 
Thus, class I NPFs activate nucleation, whilst class II NPFs maintain activation 
(Goley & Welch 2006). In addition to NPFs, ATP is also known to regulate the 
activity of the Arp2/3 complex.  
Class I NPFs 
The first class I NPF to be identified was ActA (Welch et al. 1998), a protein 
required for actin-based bacterial motility. This was then followed by the 
identification of WASp and WASp-family verprolin-homologous protein (WAVE) 
(Machesky et al. 1999). Class I NPFs are characterised by their common WCA 
domain. This domain consists of a WASp-homology-2 (WH2 or W; also called 
verprolin-homology) domain that binds to G-actin in a manner that enables 
polymerisation onto the barbed end of a growing filament. This W domain is 
essential to deliver the first actin monomer to the Arp2/3 subunits (discussed further 
in 1.3.1) ACTR2 and ACTR3 dimer to form the actin nucleus, which triggers the 
elongation of the daughter filament. The central (C, also called cofilin-homology or 
connector) and acidic (A, both regions together are known as CA) regions mediate 
binding to Arp2/3 (Egile et al. 2005).  
Scar, a WASp-related protein, enhances nucleation by the Arp2/3 complex with pre-
formed actin filaments, abolishing the spontaneous actin polymerisation lag 
(Machesky et al. 1999). Machesky et al. discussed the dendritic nucleation 
hypothesis whereby the association of Arp2/3 with Scar and the side of an actin 
filament activates nucleation of a new actin filament (Machesky et al. 1999). The 
association of the Arp2/3 complex with Scar and the side of an actin filament 
activates nucleation of a new actin filament, which is capped at its pointed end by the 
Arp2/3 complex and which grows in the barbed direction as a branch of the older 
filament (Machesky et al. 1999). These results suggested that Scar is likely an 
endogenous activator or actin polymerisation, different to the inputs of NPFs.  
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Class II NPFs 
Similar to class I NPFs, class II NPFs contain an Arp2/3 binding acidic region, 
however they lack a G-actin binding region. Instead, they contain an F-actin-binding 
region that is required to maintain the activation of Arp2/3 (Goley & Welch 2006). 
Compared to Class I NPFs, Class II NPFs are considered weak Arp2/3 activators 
(Ammer & Weed 2008; Goley & Welch 2006). It is thought that the mechanism by 
which class II NPFs activate Arp2/3 might involve a capability to promote the 
association of Arp2/3 with F-actin. Cortactin, a class II NPF, (Weaver et al. 2001) 
remains associated with the complex at the branch point (Ammer & Weed 2008), 
inhibiting branch dissociation (Weaver et al. 2001). Other class II NPFs include F-
actin-binding protein 1 (Abp1) and Pan1. Abp1 strongly accumulates at the dynamic 
leading edge of moving and spreading cells where it colocalises extensively with the 
Arp2/3 complex (Pinyol et al. 2007). This is dependent on de novo actin 
polymerisation and controlled by signalling cascades, such as activation of Rho-type 
GTPases (Pinyol et al. 2007). 
ATP/ Phosphorylation 
ACTR2 and ACTR3 have a nucleotide-binding cleft positioned between subdomain 
2 and 4, allowing for binding to ATP. Upon ATP binding, no structural changes take 
place in ACTR2, whereas subdomain 4 of ACTR3 moves closer to subdomain 2, 
causing conformational changes that propagate throughout the entire complex (Dayel 
et al. 2001). The subtle conformational rearrangement of the Arp2/3 complex upon 
interaction between ATP and ACTR3 is essential to increase the affinity of the 
complex for the WCA domain by an order of magnitude (Nolen et al. 2004). It is 
thought that hydrolysis of this ATP could be used to perform work, to provide a 
signal, or, like the guanine triphosphate (GTP) bound to the α subunit of tubulin 
heterodimers, may simply stabilise a protein fold. Conventionally, ATP hydrolysis is 
a timing mechanism that provides a timing mechanism for WASp to release the 
newly formed branch (Figure 1-8). ATP hydrolysis on the Arp2/3 complex is 
stimulated by interaction with a single actin monomer and that the interaction is 
coordinated by the VCA (the Arp2/3-activating region of WASP-family proteins). In 
this model, the Arp2/3 complex remains associated with the actin filament.  
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Figure 1-8 Model for the role of the Arp2/3 complex nucleotide binding and 
hydrolysis in the formation of new actin filaments. 1) The Arp2/3-ATP bound 
complex binds to the activator, N-WASP, with high affinity. Binding N-WASP 
brings the actin monomer attached to the WH2 domain of N-WASP in contact with 
the Arp2/3 complex and this stimulates ATP hydrolysis. 2) ATP hydrolysis to ADP-
Pi causes a conformational change on the complex forming a stable nucleus among 
Arp3, Arp2, and the conventional actin monomer. 3) Elongation of a new actin 
filament. 4) Phosphate release from the Arp2/3 complex decreases its affinity for N-
WASP and allows the Arp2/3 complex to release its membrane-associated activator 
(Image from Dayel et al. 2001). 
While binding of NPFs has long been considered essential to Arp2/3 complex 
activity, it has also been shown that phosphorylation of the ACTR2 subunit is 
necessary for Arp2/3 complex activation (Narayanan et al. 2011). Phosphorylation of 
ACTR2 induces conformational changes permitting activation, and this modification 
causes reorientation of ACTR2 relative to ACTR3 by destabilising a network of salt-
bridge interactions at the interface of the ACTR2, ACTR3, and ArpC4 subunits. 
Furthermore, recent work has shown that Nck-interacting kinase interacts with the 
Arp2/3 complex and phosphorylates it to allow activation and increased actin 
filament assembly (LeClaire et al. 2015). This possibly represents another level of 
regulation of Arp2/3 complex activity by NPFs. In this framework, Arp2/3 appears to 
function as a coincidence detector, requiring both NPF binding and phosphorylation 
of ACTR2 for increased activity (LeClaire et al. 2015). 
There are also other regulators of the Arp2/3 complex such as the glial maturation 
factor (GMF) that was recently reported to bind directly to the Arp2/3 complex to 
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inhibit nucleation and disassemble branches (Luan & Nolen 2013). Luan and Nolen 
found that GMF binds the barbed end of ACTR2, overlapping with the proposed 
binding site of WASp-family proteins.  
1.3.1.3 Cellular function of the Arp2/3 complex 
The nucleation of branched actin filaments by the Arp2/3 complex plays an 
important role in many cellular processes including lamellipodial protrusion, 
phagocytosis, endocytosis, vesicle and organelle motility, and exocytosis (Suraneni 
et al. 2012).  
At the leading edge of the lamella, two types of protrusive structures are observed; 
ruffling veil-like lamellipodia and thin, spike-like filopodia (Chhabra & Higgs 2007). 
Ultrastructural data has shown that lamellipodia are composed of orthogonal arrays 
of actin filaments with branched actin filaments near the leading edge plasma 
membrane, whereas filopodia contain parallel bundles of actin filaments (Chhabra & 
Higgs 2007). Elongation at the barbed ends of actin in lamellipodia and filopodia is 
thought to produce the protrusive force for leading edge advancement (Pollard & 
Borisy 2003; Bugyi & Carlier 2010). Protein factors regulating actin polymerisation 
at the leading edge are thus key components of the molecular machinery driving cell 
motility. The Arp2/3 localises close to the leading edge of lamellipodia (Kelleher et 
al. 1995) and organises actin into Y-branched networks (Machesky et al. 1999) 
mediated by the Scar/WAVE complex. Once the Scar/WAVE complex has been 
recruited at the leading edge, Src-mediated Abl activation results in the 
phosphorylation of WAVE, which promotes the activation of the Scar/WAVE 
complex (Sossey-Alaoui et al. 2007). Debranching and bundling of Arp2/3 complex–
nucleated actin filaments is thought to be a major pathway for filopodia formation 
(Svitkina & Borisy 1999). 
Arp2/3 complex dysfunction may also be associated with human disease, in 
particular, cancer metastasis, which relies on the capability of cancer cells to migrate 
away from primary tumours and invade healthy tissues (Wang et al. 2005; Moulding 
et al. 2007). Cancer-cell invasion into tissues also requires the formation of actin-rich 
structures such as podosomes and invadopodia that have adhesive and protrusive 
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activities and promote the degradation of the extracellular matrix. As the activation 
of the Arp2/3 complex is required for podosome formation (Linder et al. 1999) as 
well as lamellipodial formation, the Arp2/3 complex and its regulators have emerged 
as potential targets for therapeutic intervention.  
1.3.2 Formins 
Formins are large, 120-220kDa, highly conserved proteins that have essential roles in 
remodelling the actin and microtubule cytoskeletons to influence eukaryotic cell 
shape and behaviour (Hetheridge et al. 2012). There are seven known subfamilies of 
mammalian formins: DAAM, delphilin, Diaphanous related formins (DRFs), FHOD, 
FMN, FMNL, and INF. The term ‘formin’ was introduced in 1990 to describe 
protein products of the limb deformity gene in mice that were suggested to play a role 
in the formation of several organ systems (Maas et al. 1990). Shortly after this, the 
product of the Drosophila gene diaphanous, which was shown to be required for 
cytokinesis, was found to be homologous to the formin protein (Castrillon & 
Wasserman 1994). The effect of formins on actin polymerisation was first recognised 
in the yeast homologue Bni1 (Woychick et al. 1990), and GTPases of the Rho family 
were identified as activators of formin function (Watanabe et al. 1997). In this 
literature review, I will focus on the Dia subfamily of formins, in particular Diaph1, 
due to its prominence in my project. 
1.3.2.1 Diaph1 domain architecture and actin nucleation ability  
Formin polypeptides have two major functional regions: the ‘regulatory’ region, and 
the ‘active’ region. The C-terminal active region includes the formin homology 1 
(FH1) and formin homology 2 (FH2) domains, the defining element of this protein 
superfamily (Figure 1-9). Many formins (diaphanous-related formins) also have a 
Dia-autoregulatory domain (DAD).  
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Figure 1-9 Modular domain architecture of human Diaph1. A schematic view on 
the domain composition as derived from structural analysis and computational 
prediction. The structural assembly of Diaph1 includes a number of domains: formin 
homology 1 (FH1), 2 (FH2) and 3 (FH3) domains, the GTPase-binding domain 
(GBD), the Diaphanous inhibitory domain (DID), a dimerisation domain (DD) 
followed by a helical region, and the C-terminal Diaphanous autoregulatory domain 
(DAD). Interaction partners are indicated by arrows below the bar diagram. The 
intramolecular interaction between the DAD and FH3 domain leads to autoinhibition 
of the formins (Image from Schönichen & Geyer 2010). 
The FH1 domain lacks a secondary structure, and contains binding sites for profilin-
actin complexes, acting to increase the local concentration of G-actin around the 
filament barbed end (Nezami et al. 2006). All formins contain an FH2 domain, a 
~400 amino acid long structure located at the C-terminal that binds G- and F-actin 
directly to nucleate actin filaments (Zigmond 2004). The FH2 domain forms a 
doughnut-shaped dimer that encircles the F-actin barbed end and is only functional in 
a dimeric state (Romero et al. 2004). Profilin influences both FH2 mediated 
nucleation of new filaments and elongation at the barbed end. It is thought that the 
FH1 domain could provide profilin–actin complexes in a pre-oriented conformation, 
which would increase the elongation rate (Schönichen & Geyer 2010). The FH2 
domain remains bound to the barbed end of the nascent actin filament leading to 
linear actin filaments through stabilising polymerisation (Zigmond et al. 2003). Once 
a filament is nucleated, the dimeric FH2 domain moves progressively with the 
growing barded end (Shekhar et al. 2015), whilst permitting new monomer addition 
(Pruyne et al. 2002). Overall, formins govern both nucleation and elongation phases.  
dimerisation  
domain 
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Figure 1-10 Structure of the N-terminal regulation domains of Diaph1 (mDia1) 
in the dimer conformation. At the N-terminus, the GTPase-binding domain (GBD) 
is linked to the FH3 domain, while the C-terminus (consisting the DID armadillo 
repeat region) leads into a dimerisation subdomain in Diaph1. This dimerisation 
domain is formed by three α-helices, two of which from each monomer form a 
tightly intertwined four helical bundle. Adapted from (Image from Schönichen & 
Geyer 2010).  
Located at the N-terminal, the FH3 domain is the least conserved module of 
mammalian formins and is involved in formin regulation. First described by Petersen 
et al. the FH3 domain is described as the DAD recognition domain. Typically, the 
DAD-DID interaction mediates autoinhibition, strongly inhibiting actin assembly by 
the FH1 and FH2 domains (Nezami et al. 2006). Diaph1 exhibits an all-helical 
armadillo repeat fold consisting of five repeats, with the concave site of the armadillo 
repeat structure forming the recognition surface for the C-terminal DAD motif 
(Figure 1-10) (Schönichen & Geyer 2010). The C-terminal DAD domain is 
composed of two signal sequences that are recognised by the FH3 domain, leading to 
an autoinhibition of the formin. The GTPase-binding domain (GBD) precedes the 
FH3 domain at the N-terminus, with a role in interacting with GTPases of the Rho 
dimerisation domain 
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family (Watanabe et al. 1999) such as Rho, Rac and Cdc42. The central part in 
between the FH3 and FH1 domain appears helical, however its function and detailed 
structure is still unknown (Schönichen & Geyer 2010). In terms of actin nucleation, 
it has been reported that Diaph-mediated assembly of cortical actin is substantially 
faster than average, whilst Arp2/3-mediated assembly is substantially slower (Kovar 
et al. 2006; Romero et al. 2004).  
1.3.2.2 Regulation of Diaph1 
Formin activity is regulated through a succession of stages. The inactive ‘resting’ 
state is maintained through the DAD-DID autoinhibition (Chesarone et al. 2010). 
Release from this inhibitory state occurs through activation by Rho GTPases. 
Although Rho proteins help disrupt DAD-DID interactions and promote actin 
assembly, they likely do not stay associated with formins throughout their active 
period as this would require unrealistically high concentrations of Rho proteins 
compared to their measured concentrations (Seth et al. 2006). This suggests that 
RhoGTPase interaction with formins is transient and that other factors are involved 
in activating formins or maintaining them active. It has been reported that post-
translational modifications (such as phosphorylation), interactions with nucleation 
promoting factors such as Flightless-I (Higashi et al. 2010), IQGAP1 (Brandt et al. 
2007), and/or recruitment by the Abelson interactor 142 (Abl1, a component of the 
WAVE complex) may work together with Rho to activate Diaph1 and maintain it 
active by stabilising its relieved open conformation (Figure 1-11). On the other hand, 
NCKIPSD has been reported as a negative regulator of formins (Eisenmann et al. 
2007). Detailed interactions with NPFs will be discussed in 1.4. 
The opening of the DAD-DID domain leaves the DID domain bound to the plasma 
membrane, allowing the FH2 domain and adjacent DAD to initiate actin assembly. 
The conformational change induced by the DAD release is thought to provide the 
flexibility in the FH2 dimer assembly that allows actin binding and the stair-stepping 
actin polymerisation mechanism (Schönichen & Geyer 2010). The FH2 dimer 
creates an environment that favours actin monomer addition to generate actin 
filaments. It remains bound to the barbed end of the nascent actin filament whilst 
new actin subunits are rapidly added. This elongation step is further accelerated by 
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the involvement of the FH1 domain, which recruits and delivers profilin-actin 
complexes to the growing barded end. Finally, the formin and attached actin filament 
dissociate from the membrane allowing the actin filament to become incorporated 
into an actin network (Chesarone et al. 2010). 
 
Figure 1-11 Proposed mechanisms of Diaph1 interaction with NPFs. The 
structure of Diaph1 includes a GBD, DID and DD (dimerisation domain) domain at 
the N-terminal; an FH1, FH2 and DAD domain at the C-terminal. Interaction of 
Diaph1 with FliI involves the binding of FliI to the C-terminal region of Diaph1 to 
support the relief of inhibition by RhoA and enable actin filament nucleation. 
Interaction of Diaph1 with IQGAP1 involves the binding of IQGAP1 to the N-
terminus GBD domain of Diaph1. The interaction of Diaph1 and NCKIPSD is not 
well studied, however it is believed that NCKIPSD binds to the FH1 region of Dia-
related formins and acts to negatively regulate them.   
1.3.2.3 Cellular functions of formins  
Formin family proteins are well known regulators of actin cytoskeletal dynamics 
during cell division and migration, and are reported to play important roles in 
immunity and development.  
During cell division, changes in cell morphology, chromosome segregation, and 
vesicular trafficking are all fundamental events that are governed by dynamic 
cytoskeletal remodelling, with formins playing a central role in generating actin 
networks (DeWard et al. 2010). The process of cytokinesis requires the formation of 
an actin-rich contractile ring that constricts to induce plasma membrane invagination. 
Here, formins, nucleate and elongate F-actin for the cytokinetic ring (Bohnert et al. 
2013). Completion of cytokinesis is marked by abscission of the daughter cells. In 
 38 
particular, Diaph1 has been shown to localise to the spindle and midbody (Tominaga 
et al. 2000) in dividing HeLa cells. It has been shown that depletion of Diaph1 
results in cytokinetic failure due to the perturbation of actin cortex stability during 
mitosis (Bovellan et al. 2014). Furthermore, the generation of Diaph1-depleted cells 
is thought to contribute to cancer initiation and progression (Ganem et al. 2007). 
Formins control adherent cancer cell migration and invasion by assembling actin-rich 
protrusive structures and stabilising microtubules (Bartolini et al. 2008). Formins 
perform similar functions in immune cells, with studies from Diaph1 knockout mice 
showing that they also play a role in immune cell proliferation (Sakata et al. 2007). 
In prostate cancer cells, the formin Diaph3 was shown to control microvesicle 
formation, which could lead to oncogenic signal transmission to nearby cells (Di 
Vizio et al. 2009). 
Diaph1 has also been implicated in promoting the formation of actin-rich lamellipod 
protrusions by building F-actin filaments and directing signalling networks at the 
leading edge of migrating cells (Sarmiento et al. 2008). In the context of N-WASp-
depleted adenocarcinoma cells, Diaph1 drives actin-enriched cellular protrusions and 
stress fiber formation in a RhoA-dependent manner (Sarmiento et al. 2008). It was 
shown that Diaph1 knockdown inhibited formation of focal contacts, decreased 
lamellipodial thickness and impeded leading edge dynamics in migrating cells (Zaoui 
et al. 2008). Furthermore, studies have shown processive actin polymerisation of 
formins in response to physical stress applied to the cell surface (Higashida et al. 
2013). 
1.4 Nucleation promoting factors 
NPFs play a key role in controlling the assembly of actin networks nucleated by the 
Arp2/3 complex and Diaph1 (Campellone & Welch 2010). I have focused my 
literature review on four NPFs that are relevant to my project: Flightless-I, IQGAP1, 
NCKIPSD and the WAVE complex.  
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1.4.1 Flightless-I 
The flightless I (Fli-I) protein is a member of the gelsolin family (Campbell et al. 
1993). In addition to the gelsolin domain, an actin binding domain, Fli-I contains 
leucine-rich repeats (LRR) at its N-terminus, involved in protein interactions. Fli-I 
has been associated with linking the actin cytoskeleton to signal transduction 
pathways (Claudianos & Campbell 1995). In particular, Higashi et al. demonstrated 
that Fli-I positively regulates linear actin assembly mediated by Diaph1 via two 
mechanisms (Higashi et al. 2010). Firstly, Fli-I binds directly to Diaph1 and 
enhances its intrinsic actin polymerisation activity by recruiting actin monomers to 
the Diaph1 FH1-FH2 domains (Figure 1-11), elevating the F-actin assembly activity 
(Figure 1-12). Secondly, Fli-I assists RhoA in disrupting the DID-DAD interaction. 
This dual function was demonstrated for both Diaph1 and dishevelled associated 
activator of morphogenesis 1 (Daam1), both diaphanous-related formins. It is 
currently unknown how this interaction is biologically relevant.  
 
Figure 1-12 Model for the regulation of Diaphanous-related formin (DRF)-
mediated assembly by Rho and Fli-I. 1) Without GTP-Rho, DRF is kept inactive 
through the autoinhibitory DID-DAD interaction. 2) Upon GTP-Rho binding, the 
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DID-DAD interaction becomes partially perturbed. 3) Subsequent Fli-I binding to 
the DAD segment competitively accelerates the dissociation of the DID domain from 
the DAD segment. 4) The disruption of DID-DAD interaction results in the exposure 
of the FH1-FH2 domains. 5) The FH1- FH2 domains assemble the actin filaments in 
cooperation with Fli-I bound to the DAD segment. 6) Inactivation of Rho by GTP 
hydrolysis results in the dissociation of GDP-Rho from the GBD domain, and Fli-I is 
released from the DAD segment, leading to inactivation of DRF by re-association of 
the DID domain and the DAD segment (Image from Higashi et al. 2010). 
1.4.2 IQGAP1 
IQGAPs are actin-binding proteins that scaffold a plethora of molecules to modulate 
many cellular functions such as cell-cell adhesion, transcription, cytoskeletal 
architecture, and selected signalling pathways (Roy et al. 2005). IQGAP1, first 
described in 1994 (Weissbach et al. 1994), is ubiquitously expressed and is the best 
characterised isoform of the three expressed in mammals (IQGAP1, IQGAP2 and 
IQGAP3). Structurally, IQGAP1 contains isoleucine-glutamine (IQ) repeats, a 
GTPase activating protein (GAP) homology domain, a calponin homology (CH) 
domain, a coiled-coil (CC) domain, a WW domain, and a Ras GAP C-terminus 
(RGCT) domain (Figure 1-14). It is thought that the CH domain directly regulates 
actin polymerisation; the CC domain and IQ repeats facilitates the binding of 
IQGAP1 to ERM proteins, connecting components of the plasma membrane to the 
actin cytoskeleton (Liu et al. 2014; Nammalwar et al. 2014); and the GAP domain 
interacts, recruits and stabilises some Rho family GTPases (Casteel et al. 2012). 
Thus, IQGAP1 scaffolding allows regulators of actin organisation such as Cdc42 and 
Rac1 to be placed in close proximity to where actin filaments dock at the plasma 
membrane enabling tight spatial control of actin dynamics directly at the plasma 
membrane (Nammalwar et al. 2014; Jacquemet & Humphries 2013). This link to the 
Rho family proteins and the membrane supports the role of IQGAP1 as a cortical 
protein (Ramalingam et al. 2015).  
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Figure 1-13 Model of IQGAP1-dependent regulation of Diaphanous 1. GTP-
bound RhoA relieves autoinhibition of Dia1 (orange) between the diaphanous 
autoregulatory domain (DAD) and the armadillo repeat region (ARR). RhoA- GTP is 
rapidly hydrolysed. In the presence of IQGAP1 (green), the ARR of Dia1 binds to 
the diaphanous binding region (DBR) of IQGAP1 and stabilises Dia1 in its active 
conformation. CHD, calponin homology domain; FH2, formin homology 2; Dia1, 
Diaphanous 1; GBD, GTPase-binding domain; GRD, Gap related domain; IQGAPs, 
proteins containing calmodulin-binding IQ motifs and with homology to GTPase 
activating proteins (GAPs); WW, domain with two conserved Trp (W) residues 
(Image from Brandt et al. 2007). 
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Figure 1-14 Model of IQGAP1-dependent regulation of N-WASp and Arp2/3. 
N-WASp (dark blue) is shown in its autoinhibited conformation. IQGAP1 (green) 
and GTP-Cdc42 bind to N-WASp to relieve autoinhibition. The open conformation 
of N-WASp stimulates the Arp2/3 complex and promotes branched actin filament 
polymerisation. In addition, IQGAP1 might also support the open conformation of 
N-WASp through stabilisation of active Cdc42. Arp2/3, actin related protein 2/3; 
CHD, calponin homology domain; DBR, diaphanous binding region (154 amino 
acids); EVH1, Ena/VASP-homology 1; GRD, Gap related domain (408 amino 
acids); IQGAPs, proteins containing calmodulin-binding IQ motifs and with 
homology to GTPase activating proteins (GAPs); N-WASp, neural-Wiskott–Aldrich 
syndrome protein; VCA, verprolin-connecting-acidic domain; WW, domain with two 
conserved Trp (W) residues (220 amino acids) (Image from Brandt et al. 2007). 
Regulation of the cytoskeleton was one of the earliest recognised functions of 
IQGAP1. Numerous studies have suggested a role for IQGAP1 in actin dynamics, 
cell adhesion, remodelling of the actin network, and organisation of the microtubule 
network, although its specific role is not completely understood. Once activated, 
possibly through phosphorylation (Grohmanova et al. 2004), IQGAP1 acts as a 
master regulator for localised F-actin assembly through two scenarios: the N-WASp-
Arp2/3 pathway and the Diaph1 pathway (Figure 1-14). In the first case, it is 
believed that IQGAP1 and Cdc42 bind in synergy to N-WASp to relieve its 
autoinhibition (Figure 1-16A) (Le Clainche et al. 2007). The open conformation of 
N-WASp simulates the Arp2/3 complex and promotes branched actin filament 
polymerisation. In the second mechanism, IQGAP1 directly binds Diaph1 to stabilise 
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the RhoA-mediated release of autoinhibition and allow linear actin assembly (Brandt 
et al. 2007). It is currently an open question as to why IQGAP1 appears to have 
direct control of the two most potent actin nucleators that generate structurally 
different actin filament networks. Furthermore, IQGAP1 has been shown as 
necessary for Diaph1 leading edge localisation (Brandt et al. 2007), which has been 
implicated in stabilising microtubules at the cell front (Wen et al. 2004). Thus, 
IQGAP1 may also act as a facilitator of communication between the filamentous 
actin and the microtubule networks.  
It has also been shown that IQGAP1 regulates actin assembly by capping its barbed 
ends (Pelikan-Conchaudron et al. 2011). IQGAP1 can also bind directly to actin to 
promote cross-linking of actin filaments through its CHD domain, in a fashion 
similar to other actin-cross-linking proteins such as filamin and α-actinin (Kimura et 
al. 1996).  
IQGAP1 is also critical for the formation and contraction of the actomyosin ring in 
dividing yeast cells by localising to the bud neck in anaphase (Shannon & Li 1999). 
Adachi et al. reported a cytokinetic block with the knockdown of IQGAP1 (Adachi 
et al. 2014). IQGAP1 has also been shown to localise to the basolateral membrane of 
epithelial cells to correctly orient the mitotic spindle (Bañón-Rodríguez et al. 2014). 
Overall, it appears that IQGAP1 has a large inventory of binding partners and hence, 
its involvement in cellular processes is manifold. 
1.4.3 NCKIPSD 
NCK-interacting protein with SH3 domain (NCKIPSD), also known as SPIN90, 
WISH, and Dia-interacting protein (DIP), is a poorly understood actin regulator that 
is composed of a Src homology 3 (SH3) domain, proline-rich motifs, and a 
serine/threonine- rich region (LRR). Similarly to IQGAP1, NCKIPSD has been 
shown to regulate actin filament assembly through Arp2/3 (Dae et al. 2006)
 
and 
formins (Eisenmann et al. 2007). 
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Figure 1-15 NCKIPSD domain architecture. NCKIPSD interacts with the FH1 
domain of Diaphanous related formins (DRFs) via the SH3 domain (54 amino acids), 
and is also thought to interact with and inhibit Diaph3-mediated filament assembly 
via LRR domain mediated inhibition of the FH2 domain. GDB, GTPase-binding 
domain; DID, Diaphanous-inhibitory domain; FH1, formin homology 1; FH2, formin 
homology 2; DAD, Dia-autoregulatory domain; PRD, proline-rich domain (76 amino 
acids); LRR, leucine-rich domain (123 amino acids). 
Wagner et al. demonstrated that NCKIPSD directly activates the Arp2/3 complex 
without the requirement for binding to mother filaments (Wagner et al. 2013). Once 
bound, NCKIPSD stimulates steric changes to allow ACTR2 and ACTR3 to come 
into close proximity and activate filament nucleation, stimulating formation of the 
short-pitch conformation. Wagner et al. demonstrated that this distinct NCKIPSD-
activated Arp2/3 complex produced many short, linear filaments that did not branch, 
instead of the characteristic branched networks normally nucleated by the Arp2/3 
complex when it is activated by WASp or WAVE (Wagner et al. 2013). Thus, 
NCKIPSD-mediated activation of the Arp2/3 complex may not require mother 
filaments, acting as a mechanism to provide seed filaments for network assembly 
(Figure 1-16B) (Wagner et al. 2013). Intriguingly, NCKIPSD has also been shown to 
bind to N-WASp and activate Arp2/3 independently of Cdc42 (Fukuoka et al. 2001). 
In this study, NCKIPSD instead of Cdc42 also activates actin polymerisation to the 
level induced by Cdc42, through binding of WASP via its SH3 domain. This 
contradicts the direct binding to Arp2/3 as discussed above, however the interaction 
of NCKIPSD to activate nucleators isn’t well understood, and provides another 
possible interaction pathway. 
The other known NCKIPSD binding partner involves the interaction with Diaph1 
(Eisenmann et al. 2007). Eisenmann et al. revealed the two following interactions: 
Diaph1
NCKIPSD
GDB DID FH1 FH2 DAD
SH3 PRD LRR
DRF 
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Diaph1-FH1 domain binding to NCKIPSD-SH3 domain, and Diaph1-FH2 domain 
binding to NCKIPSD-LRR domain (Eisenmann et al. 2007). In this study, although 
NICKIPSD interacted with both Diaph1 and Diaph3, the FH2-LRR interaction was 
shown to inhibit only Diaph3-dependent filament assembly. This negative regulation 
suggested a novel role for the control of actin dynamics by NCKIPSD. The authors 
also studying blebbing as the actin architecture plays a fundamental role in the 
control of the blebbing and bleb initiation involves local changes in the contractility 
of the actinomyosin cytoskeleton (Eisenmann et al. 2007). They showed that 
NCKIPSD-induced blebbing is independent of Diaph1 and Arp2/3, however Diaph3 
function is required. Dynamic blebbing is indicative of the integrity of the cell 
cortex, and is an effective readout of cortical tension, further suggesting the 
importance of NCKIPSD-mediated actin cortex assembly and polymerisation. 
Interestingly, this study demonstrated a role for NCKIPSD in the control of both 
non-branched and branched actin-filament assembly that is mediated by Diaph-
related formins and activators of the Arp2/3 complex, respectively (Eisenmann et al. 
2007).  
 
Figure 1-16 Proposed mechanisms of Arp2/3 activation by NPFs. A, Activation 
of Arp2/3 by IQGAP1 requires the dual binding of cdc42 and IQGAP1 to N-WASp 
in order to relieve its autoinhibition; N-WASP then activates the Arp2/3 to nucleate 
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branched actin filaments. B, Activation of Arp2/3 by NCKIPSD involves the binding 
of NCKIPSD to Arp2/3, stimulating the generation of unbranched filaments. This 
provides seeds for N-WASp-mediated Arp2/3 complex activation. These two 
processes are independent. C, Activation of Arp2/3 by the WAVE complex involves 
the initial binding of Rac1 to the WAVE regulatory complex (WRC) for activation; 
the WAVE complex is then recruited to the membrane where it activates Arp2/3 and 
promotes the nucleation of branched actin filaments. 
1.4.4 The WAVE complex 
The WAVE complex (also called SCAR) is central to the control of cellular actin 
dynamics (Chen et al. 2010). The WAVE complex consists of five proteins: Nap1, 
Abi, Sra1, Wave1 and HSPC300 (Brick1). The WAVE complex is defined by a 
conserved C-terminal VCA motif that lies on the surface of the Sra1 subunit. It 
comprises of one or two WASP homology 2 (WH2) domains, which binds to 
monomeric actin, followed by a short central (C) region and an acidic (A) domain, 
which interacts with the Arp2/3 complex (Chen et al. 2010). WAVE typically exists 
in its inhibited state whereby a conserved surface of Sra1 and residues of Wave1 
bind the VCA and GTPase binding domain (GBD), to form a ‘meander region’. 
Rac1, a Rho GTPase family member, plays an important role in activating the 
WAVE complex (Figure 1-16C), without disrupting the integrity of the complex, 
through the binding of the VCA. Another mode of WAVE complex activation is via 
phosphorylation of the Wave protein subunit by the Abl kinase (Lebensohn & 
Kirschner 2009). Together, Rac1 activation and phosphorylation are thought to 
destabilise the meander region and its interactions with Sra1, leading to the release of 
the VCA domain of Wave1 from its interaction with Sra1 and Nap1 and subsequent 
activation of the WRC (Chen et al. 2010). Once activated, the WAVE complex is 
able to activate the Arp2/3 complex through steric conformational changes (Goley et 
al. 2004). The C-region (VCA domain) of the WAVE1 subunit subsequently orients 
the actin monomer for proper interaction with Arp2/3, leading to the nucleation of 
branched actin filaments (Kelly et al. 2006).  
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Figure 1-17 The mechanism of SCAR/WAVE mediated Arp2/3 activation. 
Activation occurs upon binding of the complex to the small GTPase Rac1, releasing 
the VCA domain of Wave1 to bind to, and activate, the Arp2/3 complex. It has been 
reported that activated Rac1 alters the conformation of the Scar/Wave complex but 
does not physically disrupt it. Once active, the Arp2/3 complex is able to initiate 
actin nucleation and generate dendritic filament networks (Adapted from Abmayr & 
Pavlath 2012).  
The interaction of the WAVE complex with Arp2/3 has been studied extensively. 
However, a less understood interaction of the Abi subunit with Diaphanous has been 
suggested as a link for the formation and stability of cell-cell junctions through actin 
polymerisation (Ryu et al. 2009); these intercellular junctions are important for tissue 
morphogenesis and signalling. In this research, Abi proteins were shown to 
colocalise with Diaphanous at cell junctions and interact in the absence of a fully 
assembled WAVE complex, highlighting their importance in regulating intercellular 
junctions.  
It is well established that GTP-loaded Rac1 induces lamellipodia and membrane 
ruffles by activating the Arp2/3 complex via WAVE proteins (Ridley 2001; Miki et 
al. 1998). In accordance, WAVE proteins have been found to accumulate at the tips 
of these projections (Hahne et al. 2001) where actin polymerisation is thought to be 
initiated and maintained, providing the propulsive force for membrane extension. 
WAVE2 has been shown to be essential for formation of lamellipodial structures at 
the cell periphery stimulated by growth factors (Yamazaki et al. 2005). WAVE has 
also been implicated in driving myosin-independent cytokinesis, through stabilising 
the furrow and allowing symmetrical division (King et al. 2010).  
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1.5 The actin cytoskeleton 
First discussed in the 1980s (Small 1988; Bray & White 1988), the actin cortex is a 
dynamic layer of actin filaments, myosin motors, and actin-binding proteins situated 
below the plasma membrane (Salbreux et al. 2012). Although an important structure 
in the cell, far less is known about the cell cortex than about lamellipodia or 
filopodia. There remains much to investigate about the structure and composition of 
the cortex, how it assembles actin filaments to allow for the various structural 
requirements, and how this assembly is regulated. Over the past decade, an 
increasing number of biological and biophysical investigations have focused on the 
actin cortex, including my work presented in this thesis.  
1.5.1 Functions of the actin cortex 
The actin cortex plays a central role in cell motility. Assembly dynamics and 
contractility of this layer are thought to generate cortical tension, drive cytokinesis, 
and play a central role in cell locomotion and tissue morphogenesis (Bray & White 
1988). On a microstructural level, contractile forces that are coordinated and 
generated from the actomyosin cortex, powered by the motor protein myosin II 
(Charras et al. 2006), push the cell edge forward to enable cell migration. Two main 
modes of force generation are incorporated; polymerisation and branching of actin 
networks, or pulling forces via the collective actin of myosin motors drawing actin 
filaments together.  
In 2D, cells often migrate by forming lamellipodia at their front. In response to 
guidance cues in the extracellular matrix (ECM), cells form lamellipodia are a classic 
example that incorporates both modes of force generation. At the leading edge in the 
direction of movement, lamellipodium protrusions are generated at the front to 
extend, and pushes the membrane forward (Tang & Gerlach 2017). As the 
lamellipodium protrudes, a contractile lamellum, situated immediately behind the 
lamellipodium is needed for translocation of the cell body and formation of new 
adhesions to the substrate (Ridley 2011). After this, the rear of the cell detaches from 
the substrate through contractions of the actomyosin cortex. In this process, the actin 
cytoskeleton, the intermediate filament network, and microtubules are involved in 
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the regulation of cell motility. It has also been suggested that crosslinking and 
bundling of cytoskeletal filaments may generate contractile forces within the cortex, 
independent of myosin activity (Sun et al. 2010). In 3D matrices, lamellipodial 
migration is rare and the cells often use either mesenchymal, amoeboid, or blebbing 
modes of migration (Friedl & Bröcker 2000). Polarised cells moving by blebbing are 
dependent on cortex formation at the leading edge of the cell (Pinner & Sahai 2008). 
Finally, it has been shown that, in extracellular matrix gels, cortical contractions help 
to push the cell nucleus through small constrictions (Lämmermann et al. 2008).  
The actin cortex is also a key determinant of cell morphology due to its dynamic 
plasticity, resulting from the continual turnover and rearrangement of its protein 
constituents and network (Salbreux et al. 2012). It has been shown that the 
actomyosin meshwork must dynamically contract, but remain attached to adherens 
junctions for cell shape change and to propagate forces across the epithelium (Jodoin 
et al. 2015). F-actin turnover is upregulated and F-actin levels are downregulated in 
ventral cells that undergo apical constriction in order to promote force balance and 
apical constriction (Jodoin et al. 2015). Changes in cell shape are necessary for 
processes such as cell migration, tissue homeostasis and cellular differentiation 
(Chalut & Paluch 2016) and shape change requires changes in the mechanical 
properties of the cortex. Mechanical properties such as stiffness and tension of a cell 
are main determinants that dictate shape change. Following a short deformation, both 
the plasma membrane and the underlying cortical actin network have been shown to 
recover their shape (Haase & Pelling 2013b); this resistance to deformation was 
found to be largely dependent upon the cytoskeleton (Haase & Pelling 2013a). 
Spatially non-uniform contractile properties in the mother cell have been shown to 
generate different-sized daughter cells following neuroblast division (Ou et al. 2010), 
emphasising the importance of the actin cortex in cellular processes.  
1.5.2 Actin cortex organisation, assembly and regulation 
The actin cortex appears as a dense meshwork of actin filaments when examined by 
scanning electron microscopy (Figure 1-18) (Charras et al. 2006). Actin filaments 
exist as bundles, and become part of a network of filaments protruding into the cell 
interior. This structural organisation provides a framework that supports the plasma 
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membrane and, therefore, determines a cell’s shape (Charras et al. 2006). In bundles, 
the actin filaments are closely packed in parallel arrays, whereas in a network the 
actin filaments crisscross, and are loosely packed. In addition to actin, the cortex 
consists of other accessory proteins, including, nucleators, nucleation promotion 
factors, actin crosslinking proteins, bundling proteins, cappers, depolymerisers and 
motor proteins (dos Remedios et al. 2003). Actin is usually attached to the plasma 
membrane indirectly via ERM proteins. They have a crucial role in organising 
membrane domains through their ability to interact with transmembrane proteins and 
the cytoskeleton (Ponuwei 2016). In doing so, they can provide structural links to 
strengthen the cell cortex and regulate the activities of signal transduction pathways 
(Fehon et al. 2010). 
 
Figure 1-18 Electron micrograph of the actin cytoskeleton of a blebbing M2 cell. 
Right: enlargement of boxed area on the left hand side. The cortex is formed by a 
meshwork of actin forming a network, regions of crosslinking and bundling are 
apparent (circled knot). Filaments can be identified (arrows). Scale: left – 2µm, right 
– 200nm. 
Bovellan et al. revealed that two proteins generated the majority of cortical actin: the 
formin Diaph1, and the Arp2/3 complex (Bovellan et al. 2014). In this study, the 
authors began by identifying proteins that were highly abundant in the cortex through 
proteomic analysis on isolated cortices. A subsequent protein knockdown screen 
revealed that Diaph1 and Arp2/3 contributed a similar amount of F-actin to the 
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cortex, but had different accumulation kinetics. Further work revealed that filaments 
with different lengths are present throughout the cortex and these are generated 
through distinct mechanisms: short-lengths for Arp2/3-nucleated filaments and long-
lengths for formin-nucleated filaments (Fritzsche et al. 2016; Bovellan et al. 2014).  
It is thought that the small GTPase, RhoA, regulates the cortex (Etienne-Manneville 
& Hall 2002). This molecular switch is the most studied cortical regulator, and has 
been reported to orchestrate the behaviour of cells through its interaction with 
proteins involved in actin polymerisation and myosin II recruitment (Charras et al. 
2006). RhoA activity has been linked to the regulation of morphogenesis, migration, 
cell division, adhesion and microtubule dynamics (Jaffe & Hall 2005). In addition to 
this, recent data has shown that RhoD, a GTPase, antagonises the function of RhoC, 
also a GTPase, which represents an example of crosstalk, whereby the action of one 
GTPase regulates the activity of another to regulate the cortex (Durkin et al. 2017).  
It has also been demonstrated that epidermal growth factor receptor kinase substrate 
8 (Eps8) and ezrin are important regulators of rapid actin reassembly for the 
initiation and retraction of protruded blebs (Aoki et al. 2016). In the expansion phase 
of membrane blebbing, Rnd3 and p190B–Rho–GAP inhibit the activation of RhoA. 
As the protruded membrane areas become enlarged, the relative concentration of 
Rnd3 decreases. Sporadic activation of RhoA leads to ROCK phosphorylation of 
Rnd3 and removal of p190B–Rho–GAP from the membrane. Thus, RhoA activation 
is amplified and sustained by the positive-feedback loop. ROCK also phosphorylates 
ezrin and activated ezrin recruits, which leads to reassembly of the actin cortex (Aoki 
et al. 2016). Here, it was found that a RhoA–ROCK–Rnd3 feedback loop determined 
the local reassembly sites of the actin cortex during membrane blebbing. 
1.5.3 The actin cortex in blebbing 
The lifecycle of a bleb can be subdivided into three steps: nucleation, expansion, and 
retraction. Bleb nucleation is initiated by an actomyosin-driven increase in 
intracellular pressure causing the formation of a membrane protrusion (Charras et al. 
2005). Two mechanisms have been put forward to explain bleb formation; 
delamination of the cell membrane from the actin cortex (Charras et al. 2005), or a 
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rupture of the cellular actin cortex (Paluch et al. 2005). In the case of delamination, it 
is thought that the initial separation of membrane and cortex is dependent upon the 
strength and/or quantity of adhesions between the membrane and the cortex via 
actin-membrane linker proteins i.e. ERM proteins, and their regulators (Charras 
2008). ERM proteins are of particular importance in the contractile cortex as they 
localise to the cell membrane and link the actin cortex to the plasma membrane 
(Charras et al. 2006).  
Once nucleated, the bleb undergoes expansion whereby the surface area and volume 
of the bleb increases rapidly. This increase in surface area may occur through a 
number of scenarios: unfolding of membrane folds, inflow of lipids through bleb 
neck, and tearing of the membrane from the cell cortex (Charras 2008). However, 
currently the exact mechanism underlying increase in surface area remains unclear. 
Blebs are devoid of an actin cortex at the beginning of expansion (Charras et al. 
2005). Once actin cortex regrowth begins, the ezrin is the first protein to be recruited 
to blebs. This is followed by the sequential recruitment of actin, actin-bundling 
proteins, and contractile proteins such as tropomyosin and myosin. Actin 
accumulation experiments show that it is likely that the formation of a sufficiently 
strong actin cortex halts bleb growth (Bovellan et al. 2014). The final stage, 
retraction, is powered by myosin II contraction (Charras et al. 2006). Myosins are 
actin-dependent motor proteins that produce movement and force through ATP 
hydrolysis. They use actin as a track along which to move, usually from the pointed- 
to barbed-end. During retraction, the bleb membrane and the newly formed actin 
cortex crumples and the membrane returns to its retracted position.  
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Figure 1-19 The lifecycle of a bleb. Membrane blebs are formed when the plasma 
membrane is detached from the actin cortex (1) by an increase in intracellular 
pressure or by a local rupture in the actin cortex. After expansion of membrane 
protrusion (2), ERM family proteins and Eps8 are recruited to the protruded bleb 
membrane to link the actin cytoskeleton to the membrane. Then, reassembly of actin 
filaments occurs rapidly by de novo polymerisation mediated by the Arp2/3 complex 
and Diaph1 (3) and covers the protruded membrane. Finally, myosin is recruited to 
actin cortex and its motor activity powers retraction (4) (Image from Ikenouchi & 
Aoki 2016). 
1.5.4 The actin cortex in cytokinesis 
Cell division in eukaryotic cells is highly complex, involving the coordination of 
multiple cellular processes and drastic remodelling of the actin cytoskeleton. Before 
a dividing cell enters mitosis, it undergoes a period of growth called interphase 
(Bertoli et al. 2013). Around 90 percent of a cell's time in the normal cellular cycle 
may be spent in interphase. Mitosis consists of four basic phases: prophase, 
metaphase, anaphase, and telophase. Cell rounding upon entry into mitosis is 
accompanied by a reduction in the focal contacts and an increase in cortical rigidity 
(Chugh et al. 2017). After cytokinesis, cells reattach to their substratum and 
reorganise their cytoskeletal networks for interphase. The concerted changes in cell 
1. Nucleation 
2. Expansion 3. Reassembly of the actin cortex 
4. Bleb retraction 
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shape and adhesion as cells prepare to enter mitosis suggest intense cross-signalling 
events between focal contacts and cell cycle signalling (Heng & Koh 2010). 
Interphase cells enter mitosis, whereby the extensive actin cytoskeleton network is 
rapidly disassembled and reorganised (prophase to metaphase), resulting in 
characteristically round cells due to the retraction of cellular protrusions (Heng & 
Koh 2010). For cells to abandon their spread interphase morphology they must first 
decrease adhesion to their substrate through the disassembly of focal adhesion 
complexes (Dao et al. 2009); this occurs in parallel to changes in intracellular 
osmotic pressure (Stewart et al. 2011). Complete reorganisation of the actin 
cytoskeleton is also required for mitotic cell rounding. Here, interphase structures, 
such as stress fibres, are disassembled upon entry to mitosis and actin filaments are 
recruited to the cortex, directly underlying the plasma membrane (Maddox & 
Burridge 2003; Kunda et al. 2008). Mitotic spindle formation requires a defined 
geometric space allowing the cell to become spherical ensuring that all chromosomes 
are captured quickly at mitosis by bringing them together with spindle microtubules 
in a small enough space (Cadart et al. 2014). This geometric requirement is a key 
process necessary for the requirements of division (Luxenburg et al. 2011). This is 
also accompanied by a reduction in the focal contacts and an increase in cortical 
rigidity. The actin network is also required in the separation of centrosomes, 
dependent upon the cortical flow of actin and the myosin network (Rosenblatt et al. 
2004; Uzbekov et al. 2002). 
 
Figure 1-20 Cell shape changes during mitosis. As the levels of CDK1–cyclin B 
activity rise (blue line), the cell begins the assembly of its cortical actomyosin 
network (red line); both of these events are accelerated by loss of the nuclear–
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cytoplasmic compartment boundary. The cortical actomyosin network that is 
assembled upon entry into mitosis is largely independent of the activity of the actin 
nucleator ARP2/3 complex (purple line), which is inhibited at the onset of prophase. 
At anaphase, this mitotic actomyosin network is remodelled to generate a contractile 
actomyosin ring at the cell centre. The ARP2/3 complex is then reactivated as cells 
re-enter interphase. (Image from Ramkumar & Baum 2016). 
At the onset of anaphase, the cells elongate, round and rapidly pinch into two by the 
formation of an equatorial furrow, producing two independent daughter cells (Zhang 
& Robinson 2005). Actin rearranges and localised to the cleavage furrow, forming 
part of the contractile ring (Figure 1-21) central to the overall process of cell 
division, known as cytokinesis. Animal cell cytokinesis is initiated during anaphase, 
when the decline of cyclin-dependent kinase 1 (CDK1) activity leads to a 
stabilisation of microtubules and reorganisation of the mitotic spindle (Figure 1-20) 
(Fededa & Gerlich 2012). Another essential factor in central spindle assembly, 
Aurora B, ensures tight temporal coordination between chromosome segregation and 
cytokinesis and is kept active by unsegregated chromatin at the division plane to 
inhibit abscission until the division plane is cleared of chromatin (Steigemann et al. 
2009). It is known that F-actin and the microtubule cytoskeleton coordinate and 
remodel throughout cell division to allow for changes in cell shape, orientation and 
positioning (Lancaster & Baum 2014; Evangelista et al. 2002). These successive cell 
shape modifications require myosin II contraction and exocytosis (Lecuit & 
Wieschaus 2000).  
 
Figure 1-21 Mouse fibroblast cell expressing LifeAct-GFP (F-actin marker) in 
the process of cell division; images showing anaphase, telophase, and 
cytokinesis. During anaphase, there is an enrichment of actin prior to furrow 
formation. At telophase, actin is strongly localised at the cortex forming a contractile 
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ring (asterisk) at the cleavage furrow. Lastly, in cytokinesis, actin undergoes 
dynamic rearrangement in all regions of the dividing cell and is strongly localised at 
the boundary of daughter cell division where actomyosin contraction occurs (Image 
courtesy of Dr. Priyamvada Chugh and Prof. Ewa Paluch).  
During mitosis, the rearrangement of actin is crucial and reliant upon the activity of 
nucleators and actin-binding proteins. There is a shift in the dominance of different 
cortical actin nucleators at the onset of mitosis, from the Arp2/3 complex to formins 
(Bovellan et al. 2014). This is apparent in cells entering mitosis in culture through 
the loss of Arp2/3-generated actin-based membrane protrusions, lamellipodia (Ibarra 
et al. 2005). This loss of lamellipodial actin is accompanied by the activation of the 
formin-based actin nucleator Diaphanous (Rosa et al. 2015), and drives the assembly 
of a cortical network of actin filaments. Importantly, once activated, through physical 
association with Rho-family GTPases, Diaphanous generates non-branched actin 
filaments, suitable for the generation of cortical tension by myosin II minifilaments 
(Skau et al. 2009). 
An intact actin cytoskeleton is important during cell cycle progression. The 
importance of the cortex in the cell cycle has been extensively studied through the 
use of drugs that interfere with actin filament turnover in cells. Depolymerisation of 
actin filaments by toxins such as cytochalasin D and latrunculin B has been reported 
to delay progression of mitosis in primary cells and fission yeast, suggesting that an 
intact actin cytoskeleton is required for the efficient onset of mitosis (Lee & Song 
2007). In addition, the actin cytoskeleton has been shown to be required for correct 
biogenesis of the mitotic spindle, a role traditionally reserved for the microtubules. 
Indeed, studies have shown that spindle assembly is disrupted when actin is 
depolymerised (Uzbekov et al. 2002) and myosin II is inhibited (Rosenblatt et al. 
2004). Some recent observations have suggested that actin and microtubule 
structures may act synergistically in the assembly and positioning of the mitotic 
apparatus (Woolner et al. 2008). 
The small GTPases belonging to the Rho family are well-known players involved in 
the regulation and remodelling of the actin cytoskeleton and are crucial for cell 
motility and morphogenesis (Etienne-Manneville & Hall 2002). Rho GTPases have 
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been found to regulate cell cycle progression acting at many stages, with two main 
sites of action: one at the G1/S transition and the other during cytokinesis. RhoA 
organises the assembly of the contractile ring and induces the actomyosin-driven 
constriction of the cleavage furrow (Barr & Gruneberg 2007). The activities of RhoA 
effectors have also been implicated in spindle formation during early mitosis and 
completion of cytokinesis, participating in the abscission process where daughter 
cells completely separate (Schmidt et al. 2007). There are a number of other proteins, 
CDK1, Plk1 and Aurora kinases, which are also actin cytoskeleton regulators, 
providing further insight into how cell cycle progression can regulate the actin 
cytoskeleton, and vice versa. 
Overall, it appears that the regulation of the actin cytoskeleton and cell cycle are 
functionally connected. The nature of this functional integration is not well 
understood, in particular, whether proteins known to regulate the actin cytoskeleton 
are implicated in cell cycle control. 
1.6 Aims 
The cortex is a 0.1 to 1 µm thick layer of actin and associated proteins that underlies 
the cell membrane and determines the shape of animal cells. Whereas the biology of 
some actin structures (lamellipodia, filopodia) is well understood, the events leading 
to the formation and subsequent regulation of a submembranous actin cortex are not 
due to the lack of a good model system. It is essential for cytokinesis, cell 
locomotion, and tissue morphogenesis, making it an important physical component 
of the cell.  
Prior work in the laboratory has shown that two actin nucleators, Diaph1 and the 
Arp2/3 complex, generate actin filaments in the cortex. To study actin assembly in 
the cortex, I aim to use blebs as a model system. I aim to search for regulators, 
nucleator promoting factors (NPFs), of Diaph1 and Arp2/3 through depletion studies 
in M2 and HeLa cells. I will examine the role of each NPF identified through 
localisation studies and impact of depletion upon various markers. The first marker 
will be bleb size, a reporter of cortical actin assembly. Following this, I will examine 
changes in F-actin network organisation using scanning electron microscopy (SEM). 
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SEM will allow for the identification of alterations of the interconnection and density 
of the network, further suggesting an important role of the particular NPF.  
It has also been previously shown that Arp2/3 and Diaph1 depletion has a serious 
impact upon progression through mitosis and on cell survival. Thus, I will deplete 
HeLa cells of selected NPFs and study the impact of depletion upon the cell cycle. 
As an addition, in collaboration with other students, I will also examine how NPFs 
control properties of cell mechanics. 
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Chapter 2 Materials & Methods 
2.1 Cell Culture   
For the initial screen to determine the role of proteins on cortical actin nucleation, I 
imaged the impact of protein depletion on blebbing. I reasoned that changes in 
cortical actin nucleation and actin accumulation rate due to nucleator and NPF 
depletion should be most obvious in blebs because they are initially devoid of F-
actin. For this, I used M2 melanoma cells that bleb continuously and have a well-
defined cortex. Thus, they are a good model system to study cortex composition and 
assembly. HeLa cells were subsequently used to investigate the role of regulators of 
actin nucleator activity during the cell cycle. 
2.1.1 M2 cells 
M2 cells are derived from a primary human melanoma, lacking in the actin 
crosslinker filamin A (Cunningham et al. 1992). They were cultured in Minimal 
Essential Medium growth medium with Earle’s salts (MEM, Gibco), supplemented 
with penicillin/streptomycin antibiotics (Gibco), and 10% of a mix of fetal bovine 
serum (FBS) (Sigma) and newborn calf serum (Sigma) (20:80). For subculture, cells 
were washed with phosphate-buffered saline (PBS, Invitrogen), detached from the 
flask surface using 0.05% trypsin-EDTA (Gibco), centrifuged at 1500rpm for 3min 
and resuspended into fresh growth medium, split in a 1:5 ratio. Optimal growth 
conditions were maintained with cells cultivated in a humidified 5% CO2 incubator 
at 37oC.  
M2 cell lines  
A previously established M2 LifeAct-Ruby cell line was used to study the effect of 
various protein knockdowns and F-actin dynamics (previously established by Dr. 
Miia Bovellan). LifeAct is a small 17 amino acid peptide that binds exclusively to F-
actin, allowing the visualisation and imaging of actin dynamics in cells. It was 
originally extracted from the Abp140 protein in yeast (Riedl et al. 2008). The M2 
LifeAct-Ruby cell line was grown in the presence of 500µg/mL G418 (Calbiochem). 
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For this project, a number of derivatives of the M2 LifeAct-Ruby cell lines were 
generated. These stably expressed GFP or BFP and an shRNA targeting ACTR2, 
ARPC2, Diaph1, Flightless-I, IQGAP1, NCKIPSD, Sra1 and Nap1. For generation 
of stable knockdown lines, shRNA plasmids were linearised with Ssp1 restriction 
enzyme (New England Biolabs) and transfected into M2 LifeAct-Ruby cells with 
Lipofectamine 2000 (see 2.2.1). Transfected cells were selected with 1µg/mL 
puromycin (Calbiochem) for several weeks while maintaining selection with 
500µg/mL G418.      
2.1.2 HeLa cells 
HeLa cells are immortal human cells derived from a tissue sample taken in 1951 
from Henrietta Lacks, a patient with cervical cancer (Syverton & Scherer 1952). 
HeLa cells were cultured in DMEM (Gibco) supplemented with 
penicillin/streptomycin and 10% FBS. Cells were subcultured at a ratio of 1:5 and 
cultivated similarly to M2 cells.   
HeLa cell lines  
For this project, a number of derivatives of the HeLa cell lines were generated. These 
stably expressed GFP or BFP and an shRNA targeting ACTR2, ARPC2, IQGAP1, 
NCKIPSD, Sra1, Nap1, BAIAP2, VANGL1 and MARK2. For generation of stable 
knockdown lines, shRNA plasmids were linearised with Ssp1 restriction enzyme 
(New England Biolabs) and transfected into HeLa cells with Lipofectamine 2000 
(see 2.2.1). Transfected cells were selected with 1µg/mL puromycin (Calbiochem) 
for several weeks. 
2.1.3 HEK293T cells 
Human embryonic kidney cells 293 (HEK293) are a cell line originally derived from 
the kidney cells of a human embryo (Graham et al. 1977). For my project, HEK293T 
cells were used for generation of lentiviruses encoding shRNA constructs. HEK293T 
cells are particularly useful for generation of adenoviruses, retroviruses, and 
lentiviruses as they are quick and easy to reproduce and maintain, have a high 
 61 
efficiency of transfection and protein production, and can faithfully translate and 
process proteins (Stepanenko & Dmitrenko 2015). 
HEK293T cells are derived from HEK293 cells but stably express the SV40 large T 
antigen, which can bind to SV40 enhancers of expression vectors to increase protein 
production (Yao-Cheng et al. 2014). HEK293T cells were cultured in DMEM 
(Gibco) supplemented with penicillin/streptomycin and 10% FBS. Cells were 
subcultured at a ratio of 1:5 and cultivated similar to HeLa cells.   
2.1.4 Freezing cells for long-term storage 
For long-term storage, cells were frozen and kept in liquid nitrogen. To do this, 75-
90% confluent cells were washed once in PBS and trypsinised. Once detached, cells 
were centrifuged as described above, the supernatant was aspirated and the pellet 
was resuspended in ‘freezing media’ (DMEM/MEM + 10% DMSO + 20% FBS). 
Resuspended cells were aliquoted into 1.5mL cryogenic vials, put into a cell freezer, 
and stored at -80oC for 24 hours before transferring into liquid nitrogen.  
Frozen cells were recovered by thawing at room temperature, diluting in 10mL of 
fresh medium in a falcon tube before centrifuging for 5 minutes at 1500rpm to 
remove DMSO. Cells were then resuspended in fresh culture medium and transferred 
to a flask.  
2.2 Transfection  
2.2.1 Lipofectamine 2000 (shRNA studies) 
Transfections were performed using a liposome-mediated method. Lipid-mediated 
gene delivery uses lipids to allow a cell to absorb exogenous DNA. Transfer of 
genetic material into the cell takes place via liposomes, vesicles that can fuse with 
the cell membrane.  
The day before transfection, cells were plated on 6-well plates (35mm well diameter, 
Corning) and incubated in growth medium. For transfection, two preparatory 
mixtures were made; (1) cDNA from a miniprep was diluted in 100µL Opti-MEM 
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(Gibco) and (2) 3µl Lipofectamine 2000 (Invitrogen) was diluted in 100µL Opti-
MEM. Miniprep cDNA purification was done according to manufacturer’s 
instructions using QIAprep miniprep kit (Qiagen). Mixtures 1 and 2 were combined 
and incubated at room temperature for 20-30 minutes. Growth medium was removed 
from each well and the cells were washed with PBS.  Wells were then replenished 
with 800µl Opti-MEM supplemented with the Lipofectamine-cDNA mixture. Cells 
were incubated for four hours, after which the transfection mixture was aspirated and 
replaced with normal culture medium.  
To generate cell lines with stable gene knock down, pGIPZ shRNA (Open 
Biosystems, Table 2-1) constructs expressing the shRNA together with BFP/GFP 
fluorophores were used. Fluorescent protein expression allowed identification of 
transfected cells. To obtain viable cell lines with a high level of protein depletion, 
both 250ng and 500ng of purified and linearised shRNA were initially transfected 
into cells. The shRNA vector encoded a puromycin resistance gene therefore cells 
were selected with 1µg/mL puromycin.  
Table 2-1 pGIPZ shRNA constructs (Human). The columns of the table contain 
the name of the construct, accession number of the targeted gene, manufacturer’s 
oligo ID, and the mature sense sequence of each construct used in the shRNA. 
Construct Accession Oligo ID Sequence 
Non-silencing - RHS4346 - 
Diaph1_22 NM_001079812 V3LHS_392378 CAGATAGTTCTGCACAAGA 
ACTR2/Arp2_63 NM_005722 V3LHS_341063 TTCTTGGTACTCTTGTCGG 
ACTR3/Arp3_82 NP_005712.1 V3LHS_382341 TCGCTTCAACATGCCAGCT 
ArpC2_25 NM_005731 V2LHS_199425 ATTTCAAAGAAATACTGAC 
IQGAP1_07 NM_003870 V3LHS_334306 AGGTTGACTTCACAGAAGA 
NCKIPSD_95 NM_016453 V3LHS_341595 TTCTCTTGCACATTTTCTT 
NCKIPSD_98 NM_184231 V3LHS_341598 TCAGGAGCAACAACAGCTT 
Flightless-I_22 NM_002018 V3LHS_386022 ACTGTGGAAGACACACACT 
CYFP1/Sra1_63 NM_001324125 V2THS_258463 TTAATAATCTCATCTTTGC 
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NCKAP1/Nap1_66 NM_205842 V3LHS_347966 TATAGAGAAGCATAACTCA 
Wave2_14 NM_006990 V2LHS_95114 TATCCTTGGTGTCCTGCAG 
 
2.2.2 Lipofectamine RNAi max (siRNA studies) 
The Lipofectamine RNAi max reagent (Invitrogen) was used to transfect cells with 
siRNA (Table 2-2). siRNA stocks were made by resuspending siRNA in RNase-free 
buffer at a final concentration of 20µM. Stocks were aliquoted into smaller volumes 
to limit freeze-thaw cycles, and stored at -20oC. 
The day prior to siRNA transfection, cells were plated onto a 6-well plate. To 
transfect siRNA, a reaction mix was prepared. Tube 1 contained 200µl Opti-MEM 
and 2µl of siRNA (20µM), whilst tube 2 contained 200µl Opti-MEM and 4µl 
Lipofectamine RNAi max. Tube 1 and 2 were then combined and incubated at room 
temperature for 20 minutes. Plated cells were washed with PBS, and the medium was 
replaced with 1.6mL of growth medium without FBS. Finally, the transfection mix 
was added to cells and incubated at 37oC. After 24 hours, the transfection medium 
was replaced with fresh growth medium. Cells were generally used for experiments 
72 hours after transfection. To test siRNA efficiency, a western blot and/or qPCR 
was run. 
Note: Diaph1 siRNA and Nap1 siRNA were used at half concentration (10µM) due to 
the strength of their phenotype. Protein depletion was verified using Western 
blotting.  
Table 2-2 siRNA ON-TARGETplus pool sequences (Human, GE Dharmacon), 
Diaph1 Stealth siRNA (Human, Thermo Fisher). The name of the construct, the 
four target sequences contained in the pool, and manufacturer’s oligo ID for each 
siRNA pool. 
Construct Target sequence Oligo ID 
Non-silencing UGGUUUACAUGUCGACUAA 
UGGUUUACAUGUUGUGUGA 
D-001810-10-05 
 64 
UGGUUUACAUGUUUUCUGA 
UGGUUUACAUGUUUUCCUA 
ACTR2/ARP2 GAAAGAGCAUUUAUCGUUU 
GAACAUGGAUCUUAGAGUC 
AGAAUGGAAUGGACUCUUA 
UGGUGUGACUGUUCGAUAA 
L-012076-02-0005 
Diaph1 GGCUUCAAUAUCAGCUUCCUCUGUA HSS102771 
IQGAP1 GAACGUGGCUUAUGAGUAC 
GCAGGUGGAUUACUAUAAA 
CGAACCAUCUUACUGAAUA 
CAAUUGAGCAGUUCAGUUA 
L-004694-00-0005 
NCKIPSD GAGAAACGAGUUCGAGUCU 
GCACGCCUUUCGCCCAGUU 
CCGAGAAGCUGUUGUUGCU 
CGAGAGAUGUGCAAGGAAU 
L-021376-00-0005 
Flightless-I UUAACAAGAAUGAGCGGAA 
ACGAAGACCUAGACGGCAU 
CCGGGAAGGUGAAACGCGA 
CAACCAGGGCAUCGUGUAU 
L-017506-01-0005 
Nap1/NCKAP1 CAUCCUAUCUUAUCGACAA 
GCAGACGACUUUAUAGAUA 
GGAGAAUGUUGAUGUGUUA 
GGUCGUAGCUCUUUCUUCA 
L-010640-00-0005 
Sra1/CYFIP1 GCACAAUCCUGCAGUACGU 
GGAGAGAAUUCGCAAGUUC 
GAUAAACGGUUACGAUCAG 
GAGUACGGCUCUCCUGGUA 
L-014185-00-0005 
 
2.2.3 Transient Transfections for localisation studies 
For the study of protein localisation, 1µg of purified cDNA of the GFP tagged 
protein of interest was transfected into cells plated onto 25mm coverslips. 
Lipofectamine 2000 was used as the transfection agent (see 2.2.1). Cells were 
imaged after overnight incubation and discarded after use.   
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2.2.4 Fluorescence Activated Cell Sorting (FACS) 
The Flow Cytometry Core Facility at UCL Great Ormond Street Institute of Child 
Health carried out FACS using a FACSAria III. All sorting experiments were run 
alongside Stephanie Canning and Dr Ayad Eddaoudi.  
Flow cytometer was used to generate a population of cells that expressed a 
homogenous level of GFP/BFP-tagged construct of interest. Cells to be FACSed 
were grown to full confluence in a T75 dish (10 million cells). Negative wild-type 
control cells, without GFP/BFP expression were also grown in a T75 dish prior to 
sorting. On the day of sorting, cells were trypsinised and centrifuged at 1500rpm for 
3 minutes. Cells were resuspended with 5mL FACS medium (for 100mL: 5mL 
EGTA K/Na (final concentration, 1mM), 2mL HEPES (Thermo Fisher, final 
concentration, 25mM), 93mL Gey’s Balanced Salt Solution (Sigma-Aldrich) and 1g 
BSA (Sigma-Aldrich, 1%)) then filtered through a cell strainer (100µm pore size, 
Fisher Scientific) to remove clumps. The high pressure during sorting can cause the 
sort buffer to become basic. Thus, the added HEPES buffer maintains the pH at 7.0 - 
8.0. The use of EGTA prevents the formation of aggregates. Gey’s Balanced Salt 
Solution contains phosphate bicarbonate buffered cell suspension and washing 
solution. During FACS, the positive cells (top 5% of those expressing the desired 
fluorophore) were collected in a 15 mL falcon tube containing fresh Gey’s medium. 
After sorting, sorted cells were centrifuged for 5 min at 1500rpm and plated into on 
well of a 6/12-well plate, and amplified.  
2.3 Transduction  
2.3.1 Viral Transfection (shRNA studies) 
In addition to the liposome-mediated method described above, some stable lines 
were generated using the following lentiviral method learnt from Dr. Geneviève 
Lavoie during a 3-month internship in the laboratory of Prof. Philippe Roux at the 
University of Montréal, Institute of Immunology and Cancer (IRIC).  
Lentiviral vectors are advantageous as they can stably and rapidly integrate a 
transgene or shRNA into the genome of most cell types (Sakuma et al. 2012). For 
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this project, lentiviral vectors derived from the human immunodeficiency virus 
(HIV-I) were used. Essential lentiviral (HIV-1) genes must be expressed in these 
cells to allow the generation of lentiviral particles. These genes are usually expressed 
by several plasmids: (i) a lentiviral expression plasmid, such as pLV-Green, 
containing the psi (Ψ) packaging sequence and the transgene gene of interest inserted 
between the lentiviral LTRs allow target cell integration, (ii) a packaging plasmid, 
such as pLV-HELP, encoding the pol, gag, rev and tat viral genes and containing the 
rev-response element (RRE); and (iii) a pseudotyping plasmid, such as pLV-iVSV-
G, encoding the G protein of the Vesicular Stomatitis Virus (VSV-G) envelope gene. 
 
Figure 2-1 Lentiviral vector production in HEK293T cells and target cell 
transduction.  Essential lentiviral (HIV-1) genes must be expressed in HEK293 cells 
to allow the generation of lentiviral particles. HIV-1 genes are expressed by several 
plasmids: (i) a lentiviral expression plasmid, such as pLV-Green, containing the psi 
(Y) packaging sequence and the transgene gene inserted between the lentiviral LTRs 
allow target cell integration, (ii) a packaging plasmid, such as pLV-HELP, encoding 
the pol, gag, rev and tat viral genes and containing the rev-response element (RRE); 
and (iii) a pseudotyping plasmid, such as pLV-iVSV-G, encoding the G protein of 
the Vesicular Stomatitis Virus (VSV-G) envelope gene. Cells are transfected, and the 
supernatant is used to transduce the target cells. Once in the target cells, the viral 
RNA is reverse-transcribed, imported into the nucleus and stably integrated into the 
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host genome (Figure from InvivoGen Insight, Innovation within reach – Spring 
2010).  
To transfect HEK293T cells with the necessary cassette of plasmids, the calcium 
phosphate transfection method was used. In the morning of the transfection day, 2 
million HEK293T cells were seeded in a 75cm2 flask. 4 hours later, the transfection 
mix was prepared. Tube 1 contained HBS (NaCl (280mM), Na2HPO4 (1.5mM) and 
HEPES (50mM) in water at pH 7). Tube 2 contained water, CaCl2 (2M), viral 
plasmids (1.5µg pMDLg/pREE, 1.5µg pRSV-Rev and 3µg pMD2-VSVG) and 6µg 
of the shRNA plasmid (Table 2-3).  
Medium was removed from the HEK293T flask and fresh medium was added to the 
flask. The contents of tube 2 was added to tube1 drop by drop, and mixed gently. 
This transfection mix was then added to cells and incubated. From then on, biosafety 
level 2 precautions were taken when handling. This transfection method generates a 
precipitate that is dispersed onto the cultured HEK293T cells. Cells take up the 
precipitate via endocytosis or phagocytosis. 
The day after transfection, culture medium was replaced with warm growth medium. 
Cells that were to be infected were seeded at 0.25 million (HeLa cells) and 0.5 
million (M2 cells) in 10 cm dishes. On the third day, the virus supernatant was 
collected from the HEK293T flasks and filtered through 0.45µm filters to remove all 
cell debris. Hexametrine dibromide (Sigma) was added to a final concentration of 
5µg/mL to aid viral entry. The filtered virus supernatant was added onto the host 
cells, and the transduction process began. Host cells were left to grow for 3 days 
after infection and HEK293T cells were discarded safely. Three days after infection, 
cells were washed at least twice with PBS and fresh medium containing puromycin 
(1µg/mL) was added to begin selection. Over the next couple of days, cells were split 
at least once or twice to ensure all virus particles have been removed from the 
medium. To confirm mRNA transcript and protein depletion, I used western blotting 
and/or qPCR. 
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Table 2-3 PLKO shRNA constructs (Human). The columns of the table contain 
the name of the construct, accession number of the targeted gene, manufacturer’s 
oligo ID, and the mature sense sequence of each construct used in the shRNA. 
Construct Accessi
on 
Oligo ID Sequence 
PLKO 
(Empty) 
- SHC001 - 
Flightless-
I_63 
NM_00
2018 
TRCN0000
152063  
CCGGCCATTTCAAGAGGAAGTTCATCTCGAGATGAA
CTTCCTCTTGAAATGGTTTTTTG 
Flightless-
I_51 
NM_00
2018 
TRCN0000
157051  
CCGGGCTGCCACAGATCAACTACAACTCGAGTTGTA
GTTGATCTGTGGCAGCTTTTTTG 
IQGAP1_8
5 
NM_00
3870 
TRCN0000
047485 
CCGGCCAGTAATCTACATTTCCATTCTCGAGAATGG
AAATGTAGATTACTGGTTTTTG 
IQGAP1_8
7 
NM_00
3870 
TRCN0000
047487  
CCGGGCATCCACTTACCAGGATATACTCGAGTATAT
CCTGGTAAGTGGATGCTTTTTG 
Nap1/NCK
AP1_41 
NM_01
3436 
TRCN0000
151941  
CCGGCCTCTCAATCAAGATACTCAACTCGAGTTGAG
TATCTTGATTGAGAGGTTTTTTG 
NCKIPSD_
43 
NM_01
6453 
TRCN0000
278443  
CCGGCTAGAGGAGCTGCTGCATATTCTCGAGAATAT
GCAGCAGCTCCTCTAGTTTTTG 
NCKIPSD_
72 
NM_01
6453 
TRCN0000
141072  
CCGGCTAGAGGAGCTGCTGCATATTCTCGAGAATAT
GCAGCAGCTCCTCTAGTTTTTTG 
BAIAP2_4
8 
NM_00
6340 
TRCN0000
060948 
CCGGGCGCTGAAGAAATACCAGACTCT 
CGAGAGTCTGGTATTTCTTCAGCGCTTTTTG 
VANGL1_
91 
NM_13
8959 
TRCN0000
062091 
CCGGCTACAAAGATTTCACCATCTACT 
CGAGTAGATGGTGAAATCTTTGTAGTTTTTG 
MARK2_8
4 
NM_00
4954 
TRCN0000
001584 
CCGGAGATGATGAACTAAAGCCTTACTCGAGTAAGG
C TTTAGTTCATCATCTTTTTT 
Kirrel3_79 NM_03
2531 
TRCN0000
005579 
CCGGCCGTTCCCAGAGAAATCTCAACTCGA 
GTTGAGATTTCTCTGGGAACGGTTTTT 
 
2.4 Imaging 
2.4.1 Confocal Microscopy (Spinning Disk) 
Live-cell imaging and immunofluorescence experiments were performed on an 
inverted confocal microscope (IX81, Olympus) with a spinning disk head 
(Yokogawa, CSU22). Cells plated on 25mm glass coverslips were mounted in a 
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sample holder, and imaged in Leibovitz L-15 (Gibco) medium supplemented with 
10% FBS. L-15 lacks phenol red and is CO2 independent, allowing experimentation 
without environmental control. Images were acquired with an Andor iXon camera 
using 100x oil-immersion objective and analysed using Image J 
(http://rsbweb.nih.gov/ij/) and Microsoft Excel software. Images were acquired using 
488nm excitation light and collecting emission at 525nm for GFP-tagged constructs, 
561nm excitation light and collecting emission at 617nm for Lifeact Ruby, and 
405nm excitation light and collecting emission at 447nm for BFP-tagged constructs.  
To evaluate bleb size in live M2 cells, cells needed to be detached and replated on 
the day of the experiment to obtain a high proportion (>90%) of blebbing cells, as 
the cells spread and stop blebbing 24-48 hours after plating. Time-lapse movies of 
the cells were then acquired at 20s intervals for 5 minutes. 
2.4.2 Permeabilisation-fixation 
In some cases when examining protein localisation to the cortex, we used 
permeabilisation-fixation to decrease cytoplasmic background. Prior to the 
permeabilisation-fixation, cells were imaged as described above (see 2.4.1). At a 
chosen time point, L-15 imaging media was quickly replaced with a 
permeabilisation-fixation solution composed of 0.5% Triton-X (Thermo Scientific) 
and 0.25% glutaraldehyde (Sigma) diluted into cytoskeleton buffer (CSB). The 10x 
stock of CSB consists of 500mM Imidazole, 500mM KCL, 5mM MgCl2, 1mM K-
EDTA, 10mM K-EGTA. The Triton-X detergent removed the membrane and 
membrane-bound proteins, allowing the escape of unbound cytoplasmic proteins. 
This allowed for clear visualisation of proteins bound to the cytoskeleton.    
2.4.3 Long term Time-Lapse Microscopy 
Multi-position long-term time-lapse microscopy was performed on a Zeiss Axiovert 
200M time-lapse microscope at the LMCB – MRC Laboratory for Molecular Cell 
Biology UCL. Training and support for this light microscope facility was provided 
by Dr Andrew Vaughan.   
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To assess the impact of protein depletion on cell morphogenesis during the cell 
cycle, HeLa cells were examined using long-term time-lapse imaging. To increase 
the proportion of mitotic cells, cells were arrested in S-phase with a single thymidine 
block by treatment with 2mM thymidine (Sigma-Aldrich) for 16-24 hours. The block 
was released by replacing thymidine containing medium with normal DMEM 
medium ~7-8 hours before the start of imaging.  
During imaging, cells were maintained at 37 °C and supplied with 5% CO2 on the 
microscope stage. Multi-position long-term time-lapse microscopy was performed 
using a 20X air objective. All experiments were repeated at least 3 times with at least 
10-15 positions imaged per well. Experiments examining cell lines with stable 
shRNA depletion were plated the day before imaging. Experiments examining single 
and combination transient siRNA knockdowns were imaged beginning 48 hours after 
transfection. Time-lapse data was analysed with FIJI using the Bio-Importer plugin 
and progression outcomes were tabulated (Table 2-4).  
Table 2-4 Classification of progression through the cell cycle or failure for HeLa 
cells during long term time-lapse imaging experiments. 
  Position 1 Position 2 Position 3 
Normal     
Death in interphase     
Death after interphase with rounding Prophase    
 Metaphase    
 Anaphase    
 Telophase    
Death after interphase without rounding     
Oscillation and fail     
Oscillation and divide     
Death after dividing (couldn’t spread)     
Divide and regress     
Bleb size     
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2.4.4 Scanning Electron Microscopy  
To examine the molecular scale organisation of the actin cortex, I performed 
Scanning Electron microscopy using a JEOL7401 Field Emission Scanning Electron 
Microscope (JEOL, Tokyo, Japan) at the Anatomy Building, UCL. Training, support 
and coating of coverslips was provided by Dr Mark Turmaine. Critical point drying 
of the samples was carried out at the LMCB – MRC Laboratory for Molecular Cell 
Biology UCL, and all training was provided by Dr Jemima Burden. The protocol for 
scanning electron microscopy of the actin cortex was adapted from that of Tatyana 
Svitkina for examining the lamellipodium (Svitkina 2009). 
Cells were plated onto 13mm glass coverslips and allowed to attach (three hours for 
M2 cells, overnight for HeLa cells). After an initial wash with L-15, the membrane 
was quickly removed using CSB containing 0.5% Triton-X and 0.25% 
glutaraldehyde. This was followed by a second extraction with 2% Triton-X and 1% 
CHAPS in CSB. Cells went through a second fix with 2% glutaraldehyde in a 0.1M 
cacodylate buffer at pH 7.4. A final tannic acid (LabGuard) and 2% uranyl acetate 
fix were carried out before dehydration of cells with a series of ethanol dilutions 
(starting at 10% and proceeding stepwise to 100%). Cells were dried using a critical 
point dryer (Leica EM, CPD 300) and coverslips were mounted onto 12mm cylinder 
stubs (Agar Scientific) using 12mm carbon adhesive discs (Agar Scientific). Finally, 
coverslips were coated with platinum-palladium.  
Cells were imaged using the JEOL7401 Field Emission Scanning Electron 
Microscope (JEOL, Tokyo, Japan). For consistency, images of each M2 bleb were 
taken at 30kx, 50kx, 70kx, and 90kx magnifications. The results presented are 
representative of imaging of 8-10 cells, and at least two blebs per cell. Similarly, 
HeLa cells were imaged at two distinct positions: above the nucleus, and around the 
cell’s periphery. 
2.4.5 Drug Treatments 
Latrunculin B (Merck Biosciences), an actin-sequestering drug (Coué et al. 1987), 
was used at a concentration of 750nM to depolymerise F-actin in HeLa cells. CK666 
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(Tocris), a small molecule inhibitor against the Arp2/3 complex (Nolen et al. 2009) 
was used to study the role of the Arp2/3 complex in the cortex.  
Cells were first imaged for 10 time points at 10s intervals to provide baseline 
behaviour for comparison, then 100µM CK666 was added and the cells were 
incubated for 3min at room temperature. During this time, the microscope was 
refocused choosing a plane that cut through the centre of the nucleus. This was 
necessary because CK666 caused increased rounding of the cells. After a 3-minute 
incubation, cells were imaged for an additional 20 time points. For all drugs, an 
amount of DMSO corresponding to the volume that the drug was diluted in was used 
as a vehicle control.  
2.4.6 Immunofluorescence sample preparation 
For immunofluorescence, cells were fixed for 10 minutes with 2% formaldehyde, 
0.1% glutaraldehyde and 0.2% Triton X (Sigma) in CSB. After fixing, 1% Triton X 
was added for 5 minutes and then cells were washed three times with PBS and 
finally, they were blocked with PBS containing 10% horse serum (HS) for 3x5 
minutes at room temperature. During the last wash, Hoechst 33342 was added for 5 
minutes to allow nuclear staining. To allow examination of the F-actin cytoskeleton, 
cells were incubated with phalloidin-567 (1:200 in PBS/HS, Life Technologies) in a 
moist, dark chamber for 60 minutes at room temperature. The cells were then washed 
three times with PBS/HS and mounted with FluorSave reagent (Calbiochem).  
2.5 Molecular biology  
2.5.1 RNA extraction 
qPCR analysis was carried out by Prof. Phillippe Roux and Dr. Geneviève Lavoie at 
the University of Montréal, Institute of Immunology and Cancer (IRIC).  
Confirmation of knockdown efficiency by shRNA or siRNA was verified by qPCR. 
mRNA was extracted from cells harvested from a T25/T75 flask using the RNAeasy 
mini-kit (Qiagen). Before mRNA isolation, cells were resuspended, lysed and 
homogenised with the provided lysis buffer (RLT supplemented with β-
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mercaptoethanol). Resuspended cells were further disrupted by quickly passing 
through a small gauge needle twice. Cells were transferred to a QIA spin column and 
centrifuged at 14,000 RPM for 2 minutes at room temperature. The spin column was 
subsequently washed with 70% ethanol before RNA elution with 30µl of nuclease-
free water. RNA was stored at -80oC before being sent on dry ice to Montréal for 
qPCR analysis. 
2.5.2 Western blotting 
Western blotting was performed with an SDS-PAGE electrophoresis system (XCell 
SureLock Mini-Cell, Invitrogen) to assess the level of protein expression in control 
and knockdown cells.  
Cells were cultured in T25 flasks prior to whole cell lysate production. Cells were 
trypsinised and gently washed with PBS to remove all residual growth medium. The 
pellet was resuspended with RIPA lysis buffer supplemented with sodium 
orthovanadate, PMSF in DMSO and a protease inhibitor cocktail (Santa Cruz 
Biotechnology). After resuspension, the lysate was centrifuged at 4C for 4 minutes. 
The supernatant was transferred to a clean 1.5mL eppendorf tube and an equal 
volume of LaemmLi SDS-Sample Buffer (2x, Sigma) was added. The sample was 
then denatured at 95C for 5 minutes. The lysate was stored at -80C for long-term 
storage. For use, the lysate was thawed at room temperature and re-boiled for 5 
minutes before loading (10-15µl) onto the gel.   
For running the gel, 4-12% gradient precast gels (Invitrogen) were used and run at 
200V and 50mA for 45-60 minutes at room temperature. 5µl of prestained protein 
ladder plus (10-250 kDa, Sigma Aldrich) was loaded to monitor protein separation. 
Once running was complete, samples were transferred to a polyvinylidene difluoride 
(PVDF) membrane (Immobilion P-transfer membrane, Millipore) for 2 hours at 
200V and 220mA at 4C. Prior to antibody probing, the membrane was blocked with 
5% milk with continuous agitation for 1 hour at room temperature. The membrane 
was cut as appropriate and probed with appropriate primary antibodies overnight (see 
Error! Reference source not found.) at 4C with continuous shaking. GAPDH 
Novus Biological) was used as a protein loading control for all protein runs.  
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Table 2-5 List of primary antibodies used in Western blotting. Suppliers, 
dilution, and host species are also indicated. 
Protein Product No & Vendor Dilution Species 
GAPDH (control) NB300-221, Novus Biological 1:10,000 Mouse 
Diaph1 ab96784, Sigma/AbCAM 1:200 Rabbit 
Arp2 sc-10125, Santa Cruz  1:100 Goat 
Arp3 #4738, Cell Signalling 1:200 Rabbit 
IQGAP1 WH0008826M1, Sigma-Aldrich 1:200 Mouse 
NCKIPSD ab88467, AbCAM 1:500 Mouse 
Nap1/NCKAP1 ab96715, AbCAM 1:500 Rabbit 
Sra1/CYFP1 ab156016, AbCAM 1:1000 Rabbit 
Flightless-I ab108594, AbCAM 1:1000 Rabbit 
 
The following day, the membrane was washed 5 times and stained with horseradish 
peroxidase-conjugated secondary antibody (anti-mouse IgG, GE healthcare; anti-
rabbit IgG, GE healthcare; anti-goat IgG, abCAM) diluted at 1:100,000 in 5% milk 
for 1 hour at room temperature. The membrane was washed again, and an enhanced 
chemiluminescence (ECL, GE Healthcare) mixture was pipetted onto the membrane.  
Protein levels were detected with the CCD-based imaging ImageQuant LAS 4000 
system. An image was taken in continuous intervals of 1 minute. A single image of 
the ladder was also taken as a reference. Images were analysed with Image J to 
determine relative protein concentration.  
2.5.3 Transformation and plasmid replication 
DNA transformation was performed to amplify plasmids and generate stocks of 
bacteria expressing the plasmids of interest. The plasmid was introduced into 
chemically competent Escherichia coli DH5α bacterial cells (Life Technologies). 
For transformation, 2µl of miniprep DNA was added to 50µl of thawed bacteria. The 
cells were tapped gently to ensure mixing of DNA, and then incubated on ice for 30 
minutes. Each transformation tube was heat-shocked by placing into a 42C water 
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bath for 30 seconds, after which the tube was placed on ice for 2 minutes. Lastly, 
250µl of warm Luria-Bertani broth (LB, Life Technologies) was added to the 
bacteria and they were incubated with shaking at 37C for 1 hour. 
After incubation, 100µl of bacteria was plated onto LB-agar plates (25g/l of 
bactoagar in LB media) containing kanamycin or ampicillin at the appropriate 
concentrations for selection. Bacteria were evenly distributed on the plate using an 
L-shaped glass pasteur pipette (Fisher Scientific). Plates were incubated at 37C 
overnight. After incubation, a well-grown isolated colony was selected and 
inoculated into a tube containing 3mL LB-medium and the appropriate antibiotic. 
The bacteria were cultured with vigorous shaking at 37C overnight. Approximately 
18 hours later, the bacteria were collected by centrifugation (1min, 14,000 RPM) and 
plasmid DNA was isolated using QIAprep Miniprep Kit (Qiagen) and eluted in 30µl 
of milli-Q water.  
To make a bacterial stock, a mix of 750µl bacteria and 250µl glycerol was 
transferred to a cryogenic vial and kept at -80oC. 
2.6 Image processing and analysis 
2.6.1 M2 blebbing phenotype quantification 
In order to identify the phenotype generated as a result of knockdown by shRNA, 
M2 cells were imaged with optical microscopy (see 2.4.1) and bleb size was 
evaluated. Cells containing the shRNA construct were identified based upon 
appropriate FP expression. In order to quantify different phenotypes, cells were 
categorised by their bleb size: no blebs, small blebs, normal blebs or large blebs. 
Bleb size distribution for each cell was assessed from videos, and not the stills shown 
in this thesis. Statistical comparisons between non-silencing control cells and 
shRNA-targeted cells were carried out using chi-squared tests.  Results were deemed 
significant for p<0.01. 
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2.6.2 Estimation of cortical mesh size from Scanning Electron Microscopy 
images 
The JAVA programme used to recognise, segment and calculate the size of the 
cortical mesh was developed with Dr Matthew Smith (Prof. Ewa Paluch group, 
MRC-UCL). Matthew provided continuous support and guidance for this 
quantification.  
To quantitatively assess changes in mesh size induced by protein depletion, I 
collaborated with Matthew Smith to develop a quantitative method. Images of the 
actin cortex at 70k magnification were selected because single filaments could easily 
be identified and because they possessed a relatively large field of view. Using FIJI, 
a plugin (Trainable WEKA segmentation), was ‘trained’ to recognise and 
differentiate between filaments and gaps in the cortical mesh visible in SEM images 
(Figure 2-2), thus identifying and highlighting the upper most cortical mesh level. 
The areas of these gaps were tabulated and converted to nm2 through the use of a 
Matlab programme.    
Data was collected and analysed by arranging into frequency tables using different 
bin sizes (nm) for analysis of small holes and large holes, and cumulative graphs 
were drawn. For each condition, I analysed 2-3 blebs on 6-7 representative cells and 
the data presented represents the common trend. 
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Figure 2-2 Estimation of cortical mesh size from SEM images. The WEKA 
segmentation plugin is trained to segment filaments (red) and mesh ‘gaps’ (green) 
from acquired electron micrographs. Following this, each gap is highlighted 
individually (lower right panel), and its area is measured for analysis. All 
micrographs used are at 70x magnification.   
2.7 BioID 
In July 2015, I was awarded a three-month Bogue Fellowship by the Department of 
Cell and Developmental Biology, funding a visit to the laboratory of Prof. Phillippe 
Roux at the IRIC of the University of Montréal. During my time in Montréal, biotin 
identification (BioID), a new and powerful proximity-dependent labelling approach 
was used to map novel interactions. Dr. Geneviève Lavoie carried out cloning of all 
BirA constructs. Antoine Meant generated all stable cell HeLa lines prior to the start 
of the project, and analysed the mass spectrometry data with SAINTexpress as 
detailed below. 
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2.7.1 BioID stable cell lines 
The first step in the BioID approach is constructing an expression plasmid in which 
the gene of interest is fused with BirA* (see appendix 11.1 for full sequence). The 
fusion constructs also included an epitope tag (i.e. myc, FLAG) that allows both 
optical and biochemical detection of the fusion protein. BirA* is a 33.5 kDa protein, 
and the BirA*-fusion is usually made at either the N or C terminus of the target 
protein. This fusion is thought not to impair localisation, stability, or function of the 
target protein. The biotinylation activity of the BirA*-fusion protein, which is 
essential to the success of the method, was assessed by blotting cell lysates with 
streptavidin-HRP. 
The following HeLa cell lines were used for the BioID experiments: FLAG (no 
BirA*) control, BirA* control, BirA*-GFP control, Diaph1-BirA*, Diaph1ΔDAD-
BirA*, Arp3-BirA* and ArpC4-BirA*. Lines were constructed by viral transduction 
and cultured in 15cm dishes, in HeLa growth medium (DMEM, FBS and 
penicillin/streptomycin) supplemented with 200µg/mL hygromycin (Sigma) for 
selection.  
2.7.2 Cell line characterisation  
First, we verified expression of the BioID constructs and searched for the optimal 
duration for biotin treatment. This consists of two steps requiring optimisation: firstly 
to check protein induction with tetracycline to ensure sufficient BirA protein 
expression, and secondly to establish the time of biotinylation incubation for a 
sufficient signal. 
To characterise the most effective tetracycline induction time, 100,000 cells were 
plated onto 6-well plates in growth media without hygromycin antibiotic. The day 
after plating, cells were induced by adding 1µg/mL tetracycline (Sigma) for the 
following durations: 24 hours, 12 hours, 8 hours, 4 hours and 0 hour (control). Cells 
were then washed with cold PBS, scraped with the addition of 150µl of Laemmli 
SDS-sample buffer, and collected into an Eppendorf. This whole-cell lysate was 
stored at -20oC. 
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To characterise the best duration for biotinylation, cells were plated as above and 
induced for 24 hours. Biotin (50µM, BioBasic) was added for the following 
durations: 24 hours (added at the same time as tetracycline), 12 hours, 8 hours, 4 
hours, 2 hours, and 0 hour (control). Cells were then washed with cold PBS, scraped 
with the addition of 150µl of Laemmli SDS-sample buffer, and collected into an 
Eppendorf. This whole cell lysate was stored at -20°C. Characterisation of 
biotinylation durations reduced non-specific binding between biotin and other non-
proximal proteins.  
2.7.3 Western blotting 
Probing induced proteins 
Prepared lysate samples were separated by SDS-PAGE (60V, overnight) and 
transferred to a PVDF membrane (see 2.5.2). The membrane was probed with FLAG 
primary antibodies overnight at 4°C with continuous shaking. Tubulin (Novus 
Biological) was used as a protein loading control for all protein runs. Protein levels 
were detected by developing blots on x-ray films with 15 seconds exposure. 
Table 2-6 List of primary antibodies used to probe induction and biotinylation. 
Protein Product No & Vendor Dilution Species 
Tubulin (control) ab6046, abCAM 1:5000 rabbit 
FLAG  F1804, Sigma-Aldrich 1:2000 mouse 
HRP-Streptavadin RPN123IV, GE Healthcare 1:5000 - 
 
Probing biotinylated proteins 
Prepared lysate samples were separated by SDS-PAGE (200V, 2 hours) and 
transferred to a PVDF membrane (see 2.5.2). Prior to antibody probing, the 
membrane was blocked with 5% BSA for 1 hour at room temperature, followed by a 
1 hour incubation with HRP-conjugated streptavidin. The membrane was washed 
three times, and developed on x-ray films for 10 minutes.  
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2.7.4 Affinity capture of biotinylated proteins 
On the first day, BirA* stable cell lines were grown on two 15 cm plates (5 million 
cells per plate). The next day, cells were treated with 1µg/mL tetracycline and 
medium supplemented with 50µM biotin for 24 hours (Figure 2-3). Cells were 
collected on the third day by scraping with 2mL cold PBS into falcon tubes. At this 
stage, the two plates for each cell line were pooled. Cells were pelleted at 500g for 5 
minutes at 4°C, and stored at -80°C until ready for cell lysis and affinity purification.  
The collected cell pellet was resuspended in 1.5mL cold RIPA lysis buffer, before 
adding 1µl (250 units) of Benzonase (Sigma-Aldrich) to degrade DNA/RNA. 
Lysates were sonicated on ice at 20% amplitude (3 x 10 second bursts with 2 seconds 
rest intervals). Sonicated samples were then centrifuged for 20 minutes at 13,000rpm 
at 4°C and the supernatant were collected in a clean Eppendorf. Prior to affinity 
capture, streptavidin-sepharose beads (GE Healthcare) were washed 3 times with 
1mL RIPA buffer. Beads were spun for 2 minutes at 3000rpm, and the supernatant 
was discarded between each wash. The lysate was added to the washed beads and 
incubated at 4°C for 3 hours.  
After incubation, the beads were spun for 2 minutes at 3000rpm and the supernatant 
was discarded. 1mL of RIPA lysis buffer was added to the beads and spun for 2 
minutes at 3000rpm. This wash-spin was repeated three times. Beads were then 
washed with 1mL of 50mM Ammonium Bicarbonate (ABC, pH 8.5) and the 
supernatant was discarded. This wash was repeated three times. Lastly, beads were 
resuspended in 100µl of 50mM ABC and supplemented with 10µl (1µg) of trypsin. 
Beads were incubated overnight at 37oC with continuous rotation.  
The next day, another 1µg of trypsin was added to beads and incubated for a further 
4 hours. Beads were then pelleted at 3000rpm for 2 minutes. The supernatant 
(containing the peptides) were transferred to a new Eppendorf. The remaining beads 
were rinsed twice in 100µl of chromatography-grade water (Sigma-Aldrich) and 
pooled with the collected supernatant, to ensure the complete collection of bound 
peptides. Between each wash, beads were vortexed and spun for 2 minutes at 
3000rpm.  
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Formic acid was added (final concentration of 2%) to the collected peptides to end 
digestion, and the sample was spun for 10 minutes at 10,000 rpm. The supernatant 
was transferred to a new tube (ensuring not to collect any beads) and the sample was 
dried using SpeedVac (Thermo Scientific). Before sending for mass spectrometry, 
dry peptides were resuspended in 13µl of a 5% formic acid aqueous solution.  
 
Figure 2-3 The protein of interest is tagged with a mutant form of E. coli biotin 
ligase BirA (R118G), denoted as BirA*. Following incubation of cells with biotin, 
BirA* biotinylates proteins that are in the proximity of the BirA*-fusion protein and 
these are referred to as “proximity interactors.” The labelling radius of BirA* is 
estimated to be around 10 nm; proteins outside this radius are denoted as 
“nonproximal proteins”. Following biotinylation, proteins are solubilised and 
biotinylated proteins are precipitated by streptavidin beads for mass spectrometry 
analysis (Adapted from Firat-Karalar & Stearnsx 2015). 
2.7.5 Mass spectrometry and data analysis 
Affinity captured peptides were sent to the proteomics core facility at the IRIC to be 
identified by mass spectrometry.   
For each prey the results consists of 4 biological replicates giving the total numbers 
of spectral counts identified and the total number of spectral counts obtained for the 
12 biological control replicates. For example, for the protein BSG, using 
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Diaph1DAD as a bait, we identified 5,6,3,6 peptides in the replicates and 0 in the 
controls. To determine if the number of spectral counts identified with the bait differs 
significantly from those identified in a non-specific interaction, we use the 
SAINTexpress software (specific analysis of interactome, http://saint-
apms.sourceforge.net/Main.html), which allows us to compare and determine the 
potential for a real interaction between bait and a specific prey. This potential will 
depend on: 1) the reproducibility of the spectral counts identified for a prey among 
bait biological replicates, 2) the abundance of spectral counts for this same prey 
identified for control baits: FLAG (no BirA*) control, BirA* control, BirA*-GFP 
control). 
For each prey, the two biological replicates of the bait with the highest scores are 
involved in the computation of the scores by SAINTexpress analysis (e.g. 5|6|3|6 -> 
6 and 6 for BSG). After that, the software compared the two replicates to four 
hypothetical controls. For each prey, the 12 biological control replicates are 
compressed in four new controls. The compression of the biological replicates is 
done randomly to give this hypothetical new control. Using this method allows to 
obtain a more stringent and robust analysis of the results. 
Finally, the software presents a range of scores but two used as determinants: the 
Avg(P) also called SAINT score and the Bayesian false discovery rate (FDR). The 
aim of SAINT is to convert the label-free quantification (spectral count) for a prey 
protein identified in a purification of the bait into the probability of a true interaction 
between the two proteins (Choi et al. 2011). The FDR represents the ordering of 
interactions in decreasing order of probability, Avg(P), allowing the selection of a 
threshold that considers the average of the complement probabilities as the Bayesian 
FDR. Preys with an Avg(P) >0.85 are conserved and considered as good potential 
interactors. Prey with a BFDR<0.05 are also kept to give at least 95% chance of 
identifying something real. The other prey is discarded, as they are likely the result 
of non-specific interactions.  
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Chapter 3 The actin cortex contains several NPFs 
The foundation of my PhD, which I have developed to produce this thesis, is a study 
by Dr. Miia Bovellan and colleagues, led by my supervisor, Dr. Guillaume Charras 
(Bovellan et al. 2014). This chapter summarises the published research by Dr. Miia 
Bovellan and introduces some data that I produced during the first few months of my 
PhD. Section 3.1 details the previous work completed by Dr. Miia Bovellan; section 
3.2 details the repeat experiments carried out by myself of the work in 3.1; section 
3.3 details new follow-on experiments that I carried out; and section 3.4 details 
previous work that formed the basis of my project. 
3.1 Previous research contributions 
The contractile actin cortex is recognised as the main determinant of cell shape and is 
crucial for many important physiological processes. However, little was known about 
the proteins that participate in nucleating the cortex and the regulation of cortex 
assembly. Using proteomics based on isolated blebs, consisting mostly of actin 
cortex and membrane, Bovellan et al. detected the presence of the formin Diaph1 
and all seven subunits of the Arp2/3 complex in the cortex (Bovellan et al. 2014). 
Imaging studies revealed their localisation at the cell periphery, consistent with the 
reasoning that a nucleator with a role in nucleating the cortex would be found in the 
cortex or the membrane. Overall, Bovellan et al. introduced the concept of a 
differential contribution of the Arp2/3 complex and Diaph1 in nucleating and 
assembling the cell cortex (Bovellan et al. 2014).  
When I joined the laboratory, Bovellan et al. had initially used a chemical inhibitor, 
CK666, to reduce the activity of the Arp2/3 complex. CK666 is a small-molecule 
inhibitor that exerts its inhibitory function by stabilising the inactive state of the 
Arp2/3 complex through the steric block of the movement of ACTR2 and ACTR3 
subunits into their activated conformation (Gournier et al. 2001; Nolen et al. 2004). 
Although its use is widespread, there is some evidence to suggest that results are not 
consistent with gene-silencing techniques. Thus, my initial aim was to deplete 
Arp2/3 subunits using shRNA interference to validate the results obtained with the 
use of CK666.  
 84 
3.2 The Arp2/3 complex and Diaph1 generate the majority of cortical actin 
One limitation of CK666 is that the inactive Arp2/3 complex is still present, allowing 
it to interact with binding partners or assemble into a complex, albeit lacking 
activity. To achieve a high degree of confidence and validate the results obtained 
from chemical inhibition, I depleted subunits of the Arp2/3 complex using an 
shRNA-silencing interference-mediated approach. In this approach, target mRNA is 
destabilised by the expression of a short hairpin RNA; this is processed into siRNA 
and binds to target mRNA leading to target-specific stable mRNA depletion. I 
established stable cell lines of blebbing M2-Lifeact cells with knockdowns for 
ACTR2 and ACTR3 subunits, and Diaph1. Non-silencing shRNA constructs were 
used to control for non-specific effects of silencing via the shRNA vector. Gene 
knockdown efficiency by the targeting shRNA was assessed with quantitative real-
time PCR (qPCR) and western blotting (Figure 3-1).  
 
Figure 3-1 Validation of nucleator depletion in M2 cells. A, mRNA transcript 
abundance of ACTR2 (Arp2), ACTR3 (Arp3), and Diaph1 using qPCR; this revealed 
high knockdown in ACTR2 (90% knockdown), ACTR3 (78% knockdown) and 
Diaph1 (70% knockdown) in stable knockdown M2 cell lines. B, Western blot 
showing protein levels in stable knockdown M2 cells expressing NS, ACTR2, 
ACTR3, and Diaph1 shRNA, probed with anti-ACTR2, anti-ACTR3, anti-mDia1 
and anti-GAPDH.  
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Both protein and RNA analysis confirmed significant depletion of ACTR2, ACTR3 
and Diaph1 in the M2 lines generated. Following this, stably depleted cells were 
imaged by confocal microscopy to investigate the effect of nucleator depletion on 
bleb size. Changes in bleb size reflect changes in the rate of actin regrowth under the 
bleb membrane, with increases in growth rate associated with small blebs and 
decreases associated with large blebs. Bovellan et al. found that the rate of de novo 
actin assembly in Diaph1-depleted cells was 2-fold slower than in controls. In 
contrast, perturbation of Arp2/3 activity by CK666 or ArpC2 shRNA both led to an 
approximately 2-fold increase in actin assembly rate (Bovellan et al. 2014). 
Regrowth rate could affect bleb size because of percolation effects. Percolation 
theory describes the behaviour and formation of a connected network. For example, 
during the cortical actin network under the bleb membrane, the expansion of a bleb 
would continue until a few continuous chains of actin filaments span the whole 
perimeter of the bleb. To explain the change in regrowth rate observed upon 
nucleator depletion, it was reasoned that if a slower-than-average nucleator is 
depleted, assembly speed would increase. Conversely, if a faster-than-average 
nucleator is depleted, assembly speed will decrease. Depleting Diaph1, a fast actin 
nucleator (Romero et al. 2004), would result in slower actin regrowth, explaining the 
formation of a larger bleb. This is the opposite for depleting Arp2/3, a slower actin 
nucleator.  
 
Figure 3-2 shRNA depletion of the Arp2/3 complex or Diaph1 leads to changes 
in bleb size. Live confocal microscopy image of M2 melanoma cells stably 
expressing GFP-actin and stably transfected with non-silencing shRNA, cells stably 
expressing Lifeact-Ruby and stably transfected with ACTR2, ACTR3 or Diaph1 
shRNA. Depletion of Arp2/3 subunits results in small blebs, and depletion of Diaph1 
results in large blebs, (scale bars: 5µm). Still images taken from live movies. 
Non-silencing Diaph1 shRNAC ActR2 shRNAActR3 shRNA Diaph1 shNon-silencing shRNA
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Figure 3-3 Distribution of blebbing phenotypes in M2 cells. M2 cells were 
depleted of Diaph1, ACTR3 or ACTR2 by shRNA interference. Cells depleted of 
Diaph1 produced a high proportion of large blebs, whilst Arp2/3 depleted cells 
generated mostly small blebs. When compared to cells stably expressing non-
silencing shRNA, cells expressing Diaph1 shRNA, ACTR3 shRNA and ACTR2 
shRNA all showed significantly altered bleb distributions (**p<0.01, chi-squared 
test). (Non-silencing shRNA n=211 cells, Diaph1 shRNA n=155 cells, ACTR3 
shRNA n=101 cells and ACTR2 shRNA n=120 cells). Experiments were repeated 
four times.  
Using cells with Lifeact-Ruby expression, we can image the regrowth of cortex and 
measure bleb size in M2 cells. Stable depletion of Arp2/3 complex subunits (ACTR3 
and ACTR2) led to significant decreases in bleb size (Figure 3-2). On the other hand, 
stable depletion of Diaph1 resulted in 88% of cells producing large blebs (Figure 
3-3). Although explainable through actin regrowth speed differences as described 
above, it is also possible that other factors participate in controlling bleb size. For 
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example, depletion of an important actin nucleator, such as Diaph1, could weaken 
the cortex due to lower F-actin polymerisation, resulting in larger expansion of the 
bleb. The influence of contractility cannot be ruled out in this instance, as 
contractility generates the pressure that drives bleb growth. The actin cortex is a 
network composed predominantly of actin and myosin. These two proteins work 
together to regulate mechanics, dynamics and the organisation of the actin cortex. 
Thus, the reduction or loss of actin will have an impact upon actomyosin 
organisation, potentially resulting in a change of bleb size.   
The actin cytoskeleton plays a key role by providing a scaffold contributing to the 
definition of cell shape, force for driving cell motility and cytokinesis, amongst other 
processes. A thorough understanding of these processes requires insight into the 
spatial and temporal organisation of actin filaments into diverse higher-order 
structures, such as networks, parallel bundles, and contractile arrays. To further 
examine the impact of nucleator depletion on cortex organisation, scanning electron 
microscopy (SEM) was used to provide such high-resolution images of the actin 
filaments constituting the actin cortex. It was reasoned that the effect of depletion 
should be most apparent in blebs because generation of their cortex necessitates de 
novo cortical actin polymerisation.  
In the control conditions, the actin cortex mesh appears homogenous, with the 
appearance of single filaments (Figure 3-4A/B, arrow). Depletion of Arp2/3 complex 
subunits (ACTR2 and ACTR3) led to visibly longer actin filaments (Figure 3-4C/D, 
arrows). This was consistent with results obtained by inhibition of Arp2/3 complex 
activity using CK6666. Depletion of Diaph1 led to an increase in areas devoid of 
actin filaments and the overall organisation was potently affected (Figure 3-4E/F). 
Furthermore, a combined depletion of Diaph1 with CK666 resulted in an overall loss 
of actin density and further disorganisation of the actin cortex (Figure 3-4G/H). This 
data demonstrates that in M2 cells, Arp2/3 and Diaph1 have an important role in 
controlling bleb size and filament organisation, supporting their involvement in actin 
cortex nucleation.  
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Figure 3-4 shRNA depletion of the actin nucleators leads to cortex architecture 
changes. Representative scanning electron micrographs of the actin cortex at the 
surface of a bleb in detergent-extracted M2 cell stably expressing non-silencing 
shRNA (A/B), ACTR2 shRNA (C/D), Diaph1 shRNA (E/F), or stably expressing 
Diaph1 shRNA cells and treated with the Arp2/3 complex inhibitor CK666 (G/H). B, 
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D, F and H are magnifications of the boxed zones in A, C and E respectively. A/B, 
The cortex is composed of a dense mesh of overlapping filaments primarily oriented 
tangential to the bleb surface. The actin filament density within the mesh appears 
approximately uniform. Individual filaments can clearly be distinguished (white 
arrow). C/D, The cortex appears less uniform than in control cells with areas of high 
filament density (white arrow) alternating with large gaps devoid of filaments 
(arrowhead). E/F, Filaments appear generally longer than in control cells and can be 
traced over several hundred nanometers (white arrows). G/H, The actin cortex is 
visibly less dense than in control cells. Only few actin filaments (white arrow) 
subsist with gaps of several hundred nanometers in between. 
3.3 Diaph1 and Arp2/3 depletion significantly increased cell cycle failure 
Eukaryotic cell division, in particular, requires a contractile ring of actin and myosin 
that cleaves the cell in two. This ring remains dynamic with F-actin continually 
turning over. Thus, actin polymerisation driven by nucleator activity is a central 
process in cytokinesis, and an important process that warrants further understanding. 
To this aim, I generated individual stable HeLa cells depleted for ACTR2 and ArpC2 
by shRNA (Figure 3-5). The stable depletion of Diaph1 led to an unviable cell 
population, so instead I used siRNA to allow for temporary silencing. 
Figure 3-5 Validation of protein depletion in HeLa cells. A, mRNA transcript 
abundance of ArpC2, ACTR2 (Arp2), and Diaph1 using qPCR; this revealed high 
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knockdown in ArpC2 (73% knockdown) and ACTR2 (70% knockdown) in stable 
knockdown HeLa cell lines, and Diaph1 (94% knockdown) using siRNA depletion. 
B, Western blot showing protein levels in stable knockdown HeLa cells expressing 
NS and Diaph1 siRNA, probed with anti-mDia1 and anti-GAPDH as a loading 
control. 
To reflect the succession of morphological changes leading up to, and following the 
division of cells, I categorised each cell as either ‘normal’ or having ‘failed to 
progress’ normally through the cell cycle. The ‘failure to progress’ group had 
numerous subdivisions, including those that died at the various stages in mitosis, and 
those that presented an abnormal event during the division, such as oscillations. This 
fine categorisation allowed for the pinpointing of the stage of cell division that was 
disrupted by the knockdown, reflecting the importance of the regulator at that 
particular stage of the cell cycle. The results observed are graphically represented as 
displayed in Figure 3-6.  
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Figure 3-6 Nucleator depletion affects progression through the cell cycle and 
interrupts it at different stages. HeLa cells were imaged for 19 hours (overnight) 
in temperature-controlled conditions, data was analysed and presented 
graphically. A, When compared to cells transfected with non-silencing 
shRNA/siRNA, cells depleted in ACTR2 and Diaph1 showed significantly reduced 
rates of successful cell cycle progression (**p<0.01). When compared to single 
transfections of ACTR2 (**p<0.01) and Diaph (*p<0.05), cells depleted of both 
ACTR2 and Diaph1 showed a significant increase in total cell death. In contrast, 
cells depleted for ArpC2 did not display a significant difference (p=0.42). Results 
were gathered from 4 independent experiments examining: Non-silencing shRNA 
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(n=936 cells), non-silencing siRNA (n=178 cells), ArpC2 shRNA (n=423 cells), 
ACTR2 shRNA (n=611 cells), Diaph1 siRNA (n=200 cells), ACTR2 shRNA + 
Diaph1 siRNA  (n=219 cells). Data was analysed with a Chi-squared statistical test. 
B, Distribution of cell deaths as a function of cell cycle stage. Cells that died during 
interphase are represented in grey, cells that died in prophase in green, metaphase in 
blue, anaphase in purple, telophase in yellow and after dividing in orange, are shown. 
Cells that died after dividing includes those that divide and regress, those that divide 
and could not spread, and cells that oscillated. All knockdown lines show a high 
proportion of cell death occurring in mitosis, however, cells depleted of Diaph1 
typically die during interphase. 
Depletion of ArpC2 did not significantly affect progression through cytokinesis, 
consistent with previous results obtained from siRNA depletion (Bovellan et al. 
2014). However, ArpC2 depletion gave rise to increased cell blebbing in interphase, 
also consistent with a previous study (Derivery et al. 2008). Here, it was surprising to 
see that ACTR2 and ACTR3 had different impacts on successful progression through 
the cell cycle. Interestingly, depletion of ACTR2 displayed a significant effect on the 
progression of division past mitosis (Figure 3-6A).  
Bovellan et al. demonstrated the perturbation of actin cortex stability during mitosis 
as a result of Diaph1 siRNA depletion (Bovellan et al. 2014). This was confirmed by 
my results (Figure 3-6A) where total cell death exceeded 50%, a figure much higher 
than the controls. Although the death rate is similar to ACTR2 depletion, I did notice 
a difference in the specific cell cycle stage at which death occurred. Cells depleted of 
Diaph1 predominately tended to fail in interphase (Figure 3-6B, Figure 3-7D). On 
the contrary, cells depleted of ACTR2 instead failed during early mitosis (Figure 
3-7B). This suggests a differing role for both actin nucleators in reorganising the 
actin cortex during the cell cycle. Failure during interphase may indicate failure to 
remodel the cytoskeleton prior to mitosis, where the cells abandon the spread 
morphology characteristic of interphase and adopt a round shape. Conditions that 
disturb mitotic cell rounding have been observed to be detrimental to spindle 
morphogenesis (Kunda et al. 2008) and orientation (Théry et al. 2007), suggesting 
interdependence between mitotic cell rounding and other aspects of mitosis. 
Moreover, it has been shown that a uniform Diaph1-dependent F-actin cortex 
coincides with initial rounding during mitosis (Ramanathan et al. 2015).    
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Figure 3-7 Live cell imaging of shRNA silenced HeLa cells using phase contrast 
microscopy. HeLa cells were imaged for 19 hours (overnight) in temperature-
controlled conditions, and stills were taken from the live movies. A, Control cells 
progress through mitosis abandoning the flat morphology of interphase, then advance 
through the stages of mitosis before cell cleavage and abscission where the daughter 
cells separate. B, ArpC2 shRNA cells appear normal with the presentation of small 
blebs during mitosis (arrowhead). C, ACTR2 shRNA cells were very blebby during 
mitosis, with many cells dying at this stage. D, Diaph1 siRNA cells appear more 
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elongated in interphase and frequently die during interphase. E, Combined depletion 
of ActR2 (with shRNA) and Diaph1 (with siRNA) resulted in a decrease in cell 
survival, with the majority of cells dying in interphase. Scale: 20µm. 
Finally, the double depletion of Diaph1 and ACTR2 led to a substantial increase in 
overall cell death in HeLa cells (Figure 3-6A, Figure 3-7E) when compared to single 
depletion, adding up to a total of 70% failure. This further supports the importance of 
both Diaph1 and the Arp2/3 complex as major contributors to nucleation of the actin 
cortex.  
3.4 Cortical nucleation promoting factors identified through proteomics 
The identification of the Arp2/3 complex and Diaph1 as major contributors to the 
nucleation of the actin cortex led to an important follow up question: how is the 
activity of actin nucleators regulated in the cell cortex following activation by 
RhoGTPases? In addition to the detection of the Arp2/3 complex and Diaph1, 
proteomic analysis of the cortical fraction identified a number of actin-regulating 
proteins (Table 3-1). These proteins are thought to interact with Arp2/3 and/or 
Diaph1 to regulate actin polymerisation via distinct mechanisms and are called 
nucleation-promoting factors (NPFs). NPFs maintain nucleator activity or directly 
activate nucleators downstream of RhoGTPases.  
The motivation for this investigation is that understanding how NPFs control actin 
assembly is critical to determine how cells control their mechanical properties 
through changing the organisation of cortical actomyosin. Thus, for a holistic 
appreciation of F-actin nucleation by Arp2/3 and Diaph1, it becomes important to 
focus upon the upstream signalling mechanisms that maintain or relay activation 
downstream of RhoGTPases.  
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Table 3-1 Nucleation-promoting factors detected by proteomics in the 
detergent-insoluble fraction of separated blebs. Analysis of three independent 
biological replicates revealed ~170 actin-binding proteins, actin regulatory proteins, 
and proteins known to interact with actin binding proteins. Detected peptide numbers 
were averaged over three experiments. The following proteins: Flightless-I, 
NCKIPSD, IQGAP1 and three subunits of the WAVE complex were detected at a 
high degree of confidence and reproducibility (more than 3 peptides detected in at 
least two separate experiments). Protein abundance index (PAI) was calculated based 
on spectral counts. Prof. Philippe Roux carried out proteomic analysis.  
 
Examination of the proteomic results revealed the presence of several NPFs in the 
actin cortex of blebs: WAVE complex subunits (Sra1/Nap1) (Bovellan et al. 2014), 
IQGAP1 (Biro et al. 2013), Flightless-I, and NCKIPSD (also known as 
DIP/WISH/Spin90). All of these proteins have additionally been identified as 
substrates modulated by phosphorylation during the cell cycle in HeLa cells (Olson 
& Nordheim 2010; Dephoure et al. 2008). The WAVE complex is activated by Rac 
and activates nucleation via the Arp2/3 complex (Steffen et al. 2004). NCKIPSD has 
been shown to interact with both Diaph1 (Eisenmann et al. 2007) and Arp2/3 (Dae et 
al. 2006). Flightless-I is a RhoA effector that binds to the DAD domain of formins to 
prevent autoinhibition (Higashi et al. 2010), suggesting it also acts as a class II NPF. 
IQGAP1 is a large scaffolding protein activated by Cdc42 and Rac1, and shown to 
interact with WAVE, WASp and Diaph1 through its different domains (Brandt et al. 
2007; Foroutannejad et al. 2014; Gorman et al. 2012). In both cases, it prevents 
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inactivation of its interactor, suggesting it acts as a class II NPF. Thus, these NPFs 
appear promising candidates for controlling the length and organisation of actin 
filament networks, as well as coordinating the activity of cortical nucleators.  
 
Figure 3-8 Schematic of potential interactions between NPFs and cortical 
nucleators. Based on the literature, the following interactions are grouped into those 
that activate nucleation via the Arp2/3 complex, and those that activate nucleation 
via Diaph1. There is evidence for NCKIPSD and IQGAP1 interacting with both 
Arp2/3 and Diaph1, although the interaction between NCKIPSD and Diaph1 is 
thought to be inhibitory.   
3.5 Conclusion 
Overall, my initial data confirms the concept of a differential contribution of the 
Arp2/3 complex and Diaph1 in nucleating and assembling the cell cortex introduced 
in Bovellan et al. The perturbation of both Arp2/3 and Diaph1 led to profound 
changes in actin cortex organisation, indicating that they play a crucial role in 
generating cortical actin in the submembraneous F-actin cortex in M2 and HeLa 
cells. Recent work has shown that formin-nucleated filaments are, on average, ten 
times longer than Arp2/3-nucleated filaments, however formin-generated filaments 
represent less than 10% of all actin filaments (Fritzsche et al. 2016). Kinetically, both 
nucleators appear to have distinct roles in cortical actin nucleation, suggesting 
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differential contribution towards F-actin assembly, dependent upon the physiological 
needs.   
Furthermore, NPFs that modulate nucleator activity were identified and subdivided 
into two categories based on their proposed role in literature: those that interact with 
the Arp2/3 complex and those that interact with Diaph1. Many actinous structures 
require formins and the Arp2/3 complex for their formation. It is possible that both 
nucleators cooperate to generate the actin network (Bovellan et al. 2014). 
Alternatively, it has been proposed that the difference in structure induced by each 
nucleator could dictate specific filament function (Michelot & Drubin 2011). Both 
cases underline the importance of coordinating the activity of each nucleator for the 
generation of actinous structure and for dictating its mechanical properties. As a 
consequence, the control of crosstalk between nucleators is a subject of great interest. 
Here, I investigate the role of the identified proteins: IQGAP1, NCKIPSD, 
Flightless-I and the WAVE complex, as potential NPFs interacting with Diaph1 or 
Arp2/3. I also investigate their role in supporting and maintaining activation through 
stabilisation of active nucleator conformations, and interacting with other small 
molecules.  
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Chapter 4 Candidate NPFs localise to the actin cortex 
Cortex reassembly was investigated in two cell lines; M2 cells, because they display 
a visible cortex throughout the cell cycle, bleb, and thus need to reassemble cortex 
continuously, and HeLa cells, because they have a well-defined cortex during 
metaphase. I performed an imaging screen to check for cortical localisation of 
candidate NPFs, reasoning that NPFs that localised to the cortex were good 
candidates for regulating cortical actin nucleators. 
4.1 Localisation in M2 cells 
To determine nucleator localisation, I transfected GFP tagged full length IQGAP1, 
NCKIPSD, Flightless-I and the WAVE complex subunits Sra1 and Nap1 in M2 cells 
stably expressing the F-actin reporter LifeAct-Ruby. As shown in Figure 4.1, 
IQGAP1 displayed a clear cortical localisation and formed a well-defined rim under 
bleb membranes. When I imaged the bleb life cycle, I found that blebs were initially 
devoid of IQGAP1 and that IQGAP1 was recruited after bleb growth had ceased. 
The other proteins I examined displayed a strong cytoplasmic signal, perhaps 
because of a high bound/unbound ratio. Indeed, if most of the proteins of interest are 
not bound to the actin cytoskeleton, this will result in high cytoplasmic fluorescence, 
obscuring the lower amount of cortical bound protein and making it difficult to 
distinguish above background. Another potential issue is that the GFP tag might 
interfere with protein function.  
To overcome issues due to high cytoplasmic background, I decided to attempt 
permeabilisation-fixation experiments after initial baseline imaging. In this approach, 
the unbound fraction is removed by permeabilisation, allowing the bound fraction to 
be visualised through stabilisation by fixation. I observed that Flightless-I localised 
strongly to the cortex but was less apparent in blebs (Figure 4-1, arrow). This could 
suggest that it may not be important for recruitment and reassembly of the actin 
cortex but rather gets recruited once a mature cortex has been re-established. Both 
NCKIPSD and IQGAP1 clearly localised to the cortex (Figure 4-1, arrow), and were 
also visible underneath the membrane of blebs (Figure 4-1, asterisk). Sra1 and Nap1 
did not display strong cortical localisation and remained predominantly cytoplasmic 
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after permeabilisation. Similar results were obtained with other subunits of the 
WAVE complex. However, as the WAVE complex is a well-established Arp2/3 
interactor and it was identified with high certainty in the cortex we decided not to 
rule it out for further study. Interestingly, cells transfected with Sra1 and Nap1 had 
markedly less blebs than untransfected cells, perhaps signifying that overexpression 
of WAVE complex subunits leads to changes in cytoskeletal organisation. This issue 
made it difficult to analyse the patterns of expression during blebbing. Similar 
localisation were also obtained by Dr Guillaume Charras using immunostaining in 
M2 cells, except for the WAVE complex that showed a clear enrichment in blebs. 
Together these results support Flightless-I, IQGAP1 and NCKIPSD as good 
candidates for regulating cortical actin nucleation.  
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Figure 4-1 Localisation of candidate NPFs in M2 cells. Full-length proteins with 
GFP tags were transfected into cells. Transfected cells were imaged for a few frames 
to provide a baseline, after which the imaging medium was replaced by medium 
containing detergent and fixative. During this time, I continued imaging, allowing for 
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the cortical localisation to be visualised. Arrows point to regions of localisation at the 
cortex; asterisks point to regions of localisation at the cell blebs. Scale bar: 5µm. 
4.2 Localisation in HeLa cells 
I then proceeded to examine localisation in HeLa cells in interphase using the same 
permeabilisation fixation strategy. For all proteins, localisation appeared more 
cytoplasmic before permeabilisation (Figure 4-2). Similar to localisation in M2 cells, 
IQGAP1 had the strongest cortical expression at the actin cortex, supporting a 
possible role in regulating actin nucleation at the cortex. Flightless appeared to show 
a weak cortical expression at the actin cortex, also supporting its potential role in 
regulating actin nucleation at the cortex. Localisation of NCKIPSD was not as 
apparent as Flightless and IQGAP1, even with removal of the membrane. WAVE2, a 
WAVE subunit detected in the earlier proteomics, displayed some cortical 
localisation, albeit not uniform across the cell.  
As overexpression may lead to mislocalisation of proteins, we also carried out 
immunostaining experiments to confirm localisation of endogenous proteins in 
interphase and metaphase. In mitotic cells, IQGAP1 revealed a clear cortical 
localisation (Figure 4-3), however immunostainings for other proteins showed 
higher cytoplasmic background (Flightless-I, NCKIPSD, WAVE2 and Sra1). Despite 
this, Flightless-I. Wave2 and NCKIPSD did show some enrichment at the cortex 
(arrows). These data could either reflect a low proportion of active protein bound to 
the cortex or be due to poor quality antibodies. 
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Figure 4-2 Localisation of candidate NPFs in interphase HeLa cells. Full-length 
proteins with GFP tags were transfected into cells. Transfected cells were imaged for 
a few frames to provide a baseline, after which the imaging medium was replaced by 
medium containing detergent and fixative. During this time, I continued imaging, 
allowing for the cortical localisation to be visualised. Arrows point to regions of 
localisation at the cortex; asterisks point to regions of localisation at the cell blebs. 
Scale bar: 5µm. 
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Figure 4-3 Immunostaining localisation of NPFs in mitotic HeLa cells. Arrows 
point to regions of localisation at the cortex. Scale bar: 5µm. Images taken by Dr 
Guillaume Charras. 
4.3 Conclusion  
Overall, IQGAP1, NCKIPSD and Fli-I appear to localise to the cortex, with IQGAP1 
most strongly localised. This makes these NPFs good candidates for regulation of 
cortical actin nucleators. Localisation of the WAVE complex subunits was more 
challenging to obtain, however as previously mentioned, the WAVE complex is a 
well-established Arp2/3 interactor and has been identified with high certainty in the 
cortex. Never the less, it is important to note that WAVE2 and Sra1 were not seen at 
the cortex, possibly due to the GFP tag affecting its localisation or incorporation into 
the complex. 
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Chapter 5 NPF depletion affects bleb size  
To investigate the role of NPFs in modulating nucleator activity, I examined how 
their depletion affected bleb size. There are many candidate actin-binding proteins 
that have been identified in the literature, however little is known about their 
mechanism of action and relative contribution to the assembly of actin, especially 
within the actin cortex. Bleb size is a good reporter of the effect of perturbing an 
important actin nucleator, or in this case NPF, because generation of their cortex 
necessitates de novo cortical actin polymerisation. Based on previous work, depletion 
of Arp2/3 or Diaph1 yields a small or large blebbing phenotype, respectively 
(Bovellan et al. 2014). I hypothesised that the depletion of an NPF important for 
regulation of a nucleator would result in phenocopying of the bleb size. I directed my 
initial focus towards the proteins detected by mass spectrometry of the cortex in 
isolated blebs: Flightless-I, IQGAP1, NCKIPSD and the WAVE complex (Table 
3-1).  
To this aim, I generated stable M2 cell lines depleted for each of the NPFs identified. 
These cells also stably expressed Lifeact-Ruby to allow for imaging of F-actin. 
Depletions were verified with qPCR to quantify mRNA transcript levels (Figure 
5-1A), and western blotting to quantify protein levels (Figure 5-1B).  
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Figure 5-1 Validation of protein depletion in M2 cells. A, mRNA transcript 
abundance of IQGAP1, NCKIPSD, Flightless-I, Nap1 and Sra1 using qPCR; this 
revealed high knockdown in IQGAP1 (90% knockdown), NCKIPSD (70% 
knockdown), Flightless-I (83% knockdown), Nap1 (70% knockdown) and Sra1 
(67% knockdown) in stable knockdown M2 cell lines using shRNA depletion. B, 
Western blot showing protein levels in stable knockdown M2 cells expressing NS, 
NCKIPSD (shRNA1, 72% protein depletion; shRNA2, 63% protein depletion) and 
IQGAP1 shRNA (85% protein depletion), probed with anti-NCKIPSD, anti-IQGAP1 
and anti-GAPDH as a loading control. 
5.1 Depletion of Flightless-I has no effect on bleb size in M2 cells 
The first actin-binding protein that I studied was Flightless-I (FliI). I reasoned that if 
FliI was needed for Diaph1 activation as suggested in the literature (Higashi et al. 
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2010), its depletion would lead to the observation of large blebs, comparable to what 
is observed for Diaph1 depletion (Bovellan et al. 2014).  
To confirm FliI knockdown, I performed qPCR to quantify mRNA. Results obtained 
from qPCR experiments revealed a knockdown of 83% (Figure 5-1). I observed no 
significant phenotype accompanying FliI depletion in M2 cells (Figure 5-2), with the 
majority of blebs categorised as ‘normal’ sized (Table 5-1, Figure 5-6).  
 
Figure 5-2 Representative images of M2 cells expressing Lifeact-Ruby and different 
shRNA constructs, scale - 5µm. FliI shRNA bleb size was not significantly different 
compared to non-silencing shRNA cells.    
Overall, FliI revealed no significant phenotype in M2 cells, suggesting that it may 
not play an important role in the control of actin regrowth in blebs. Actin nucleation 
by Diaph1 is important for the normal progression of the cell cycle; thus, it is 
possible that the depletion of FliI may produce more profound effects when 
examining progression through the cell cycle. Therefore, I did not rule out a role for 
FliI and continued to study it in further experiments in HeLa cells.  
Non-silencing shRNA Diaph1 shRNA
Flightless-I shRNA
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5.2 IQGAP1 depletion phenocopies Diaph1 knockdown  
I next investigated IQGAP1 as a potential NPF. As previously mentioned, it is 
thought that IQGAP1 has a dual role in regulating Diaph1-mediated nucleation and 
the activity of the Arp2/3 complex; thus, the expected depletion phenotype could not 
be readily hypothesised. To detect and validate IGQAP1 knockdown, I performed 
qPCR and western blotting to quantify mRNA and protein levels, respectively. 
Results obtained from qPCR experiments revealed a 90% knock down in mRNA 
transcripts and high protein depletion (85% protein depletion) (Figure 5-1). 
A clear and significant phenotype of large blebs was observed with the depletion of 
IQGAP1 in M2 cells, with almost 60% of cells displaying large blebs compared to 
25% of large blebs in the control cells (Table 5-1, Figure 5-6). This is similar to the 
large bleb phenotype observed with the knockdown of Diaph1, but not consistent 
with the small bleb phenotype observed upon Arp2/3 complex subunit depletion 
(Figure 5-3). The observed phenotype suggests that the removal of IQGAP1 affects 
Diaph1 activity. Although the phenotypic analysis suggests that IQGAP1 controls 
actin nucleation via regulation of Diaph1, the results do not exclude the existence of 
other Diaph1 activators.  
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Figure 5-3 Representative images of M2 cells expressing Lifeact-Ruby and different 
shRNA constructs, scale - 5µm. IQGAP1 shRNA bleb size was significantly larger 
compared to non-silencing shRNA cells.  
5.3 NCKIPSD depletion phenocopies Diaph1 knockdown  
Similar to IQGAP1, NCKIPSD appears to be an important protein, which may act to 
coordinate the activity of both cortical nucleators. To evaluate the effect on bleb size, 
a stable cell line with NCKIPSD depletion was generated in M2 cells. Results 
obtained from qPCR experiments revealed a 70% knockdown, and western blotting 
revealed a protein knockdown of shRNA 1 and 2 of 72% and 63% protein depletion, 
respectively. It has been reported that NCKIPSD negatively regulates Diaph3 and 
interacts with Diaph1 (Eisenmann et al. 2007); and for this reason I decided to 
examine if Diaph1 may also be negatively regulated. If this were the case, I would 
expect to see smaller blebs, as the removal of an inhibitor would allow increased 
Diaph1 activity. Furthermore, if NCKIPSD was important for regulation of Arp2/3, I 
would expect to also see small blebs, similar to the Arp2/3 depleted small bleb 
phenotype previously reported. Contrary to both predictions, the NCKIPSD 
depletion had a phenotype associated with large blebs (Figure 5-4). 45% of cells 
depleted of NCKIPSD displayed large blebs, significantly more than displayed in 
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control cells (Figure 5-6, Table 5-1). This suggests that NCKIPSD is acting through 
the Diaph1 nucleation pathway as an activator. This is contrary to its perceived role 
as a negative regulator of Diaph1 or as a positive regulator of Arp2/3 due to the lack 
of a phenocopy in bleb size. Here, it is important to remember that NCKIPSD has 
been reported to nucleate small linear filaments via Arp2/3, and these may have a 
different function to the usual dendritic arrays present when WASp or the WAVE 
complex activates Arp2/3.  
 
Figure 5-4 Representative images of M2 cells expressing Lifeact-Ruby and different 
shRNA constructs, scale - 5µm. NCKIPSD shRNA bleb size was significantly larger 
compared to non-silencing shRNA cells.  
5.3.1 WAVE complex depletion phenocopies Arp2/3 complex depletion 
The WAVE complex is a well-studied and well-characterised NPF, known to control 
actin cytoskeletal dynamics through activity of the Arp2/3 complex (Semba et al. 
2006). I began my investigation by generating stable M2 cell lines depleted for the 
three detected subunits: Nap1, Sra1 and WAVE2. After qPCR analysis, I decided not 
to continue investigating WAVE2 due to weak mRNA depletion. On the other hand, 
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shRNA depletion of Sra1 and Nap1 resulted in a 57% and 70% knockdown of 
mRNA, respectively (Figure 5-1). In M2 cells, Cells with Sra1 and Nap1 knockdown 
displayed a very strong phenotype of small blebs similar to that seen with a depletion 
of the Arp2/3 complex (Figure 5-5). Nap1 depleted cells presented an overwhelming 
small bleb phenotype, with 90% of cells displaying either small blebs or no blebs. 
Similarly, 80% Sra1 depleted cells displayed either small blebs or no blebs. This is a 
significant shift in phenotype compared to only 30% of cells in the control group that 
display small or no blebs (Figure 5-6, Table 3-1). This result is consistent with the 
role of the WAVE complex as a potent Arp2/3 activator, and in particular, Sra1 and 
Nap1 being the binding interface for activation of the Arp2/3 complex (Chen et al. 
2010).  
 
Figure 5-5 Live confocal imaging of M2 cells stably expressing LifeAct-Ruby. Cells 
depleted for Nap1 or Sra1 presented very small blebs, similar to Arp2/3 knockdown. 
A large number of cells also presented no blebs at all, scale - 5µm.  
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Table 5-1 Raw data and statistical analysis of the phenotypes observed in the 
shRNA screen with M2 blebbing cells. Cells were counted and categorised into 
groups according to bleb size: no blebs, small blebs, normal blebs, and large blebs. 
For each shRNA construct, observed distributions were compared to expected 
numbers based on the categorisation observed in non-silencing shRNA control using 
a chi-squared test. Differences were considered significant for **p<0.01.   
		 Phenotype	
Observed	
number	of	cells	
in	each	category	
Expected	number	
of	cells	in	each	
category	based	
on	control	
P-Value	
(CHITEST)	
CONTROL	(non-
silencing	shRNA)	 No	blebs	 15	 		 		
		 Small	blebs	 54	 		 		
		 Normal	blebs	 79	 		 		
		 Large	blebs	 63	 		 		
Flightless-I	shRNA	 No	blebs	 12	 13	 <0.01	
		 Small	blebs	 22	 48	 		
		 Normal	blebs	 114	 70	 		
		 Large	blebs	 39	 56	 		
IQGAP1	shRNA	 No	blebs	 20	 13	 <0.01	
		 Small	blebs	 15	 48	 		
		 Normal	blebs	 45	 71	 		
		 Large	blebs	 109	 56	 		
NCKIPSD	shRNA	 No	blebs	 7	 9	 <0.01	
		 Small	blebs	 17	 32	 		
		 Normal	blebs	 45	 47	 		
		 Large	blebs	 56	 37	 		
Sra1	shRNA	 No	blebs	 8	 2	 <0.01	
		 Small	blebs	 24	 10	 		
		 Normal	blebs	 7	 15	 		
		 Large	blebs	 0	 12	 		
Nap1	shRNA	 No	blebs	 15	 3	 <0.01	
		 Small	blebs	 22	 10	 		
		 Normal	blebs	 3	 15	 		
		 Large	blebs	 0	 12	 		
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Figure 5-6 Distribution of blebbing phenotypes observed in M2 knockdown 
cells. IQGAP1 and NCKIPSD shRNA depleted cells mostly displayed large blebs. 
Sra1 and Nap1 shRNA depleted cells displayed a prominent small bleb phenotype, 
with no large blebs observed. FliI depleted cells displayed mostly normal sized blebs. 
When compared to cells stably expressing non-silencing shRNA, cells expressing 
Flightless-I shRNA, IQGAP1 shRNA, NCKIPSD shRNA, Sra1 shRNA and Nap1 
shRNA showed significantly different bleb distributions (**, p<0.01). Five 
independent experiments per cell line examining: 211 cells for non-silencing, 187 for 
Flightless-I, 189 for IQGAP1, 125 for NCKIPSD, 39 for Sra1 and 40 for Nap1.  
5.4 Potentiation of the WAVE small bleb phenotype with drug treatments 
To further assess the impact of drug treatments on bleb size and to determine which 
pathway each NPF regulates, I attempted to potentiate the M2 Nap1 shRNA small 
bleb phenotype with drugs. For this, I combined Nap1 stable cell line depletion with 
treatment of CK666 (an Arp2/3 inhibitor), or with SMIFH2 (a formin inhibitor). I 
reasoned that if there was no noticeable change in bleb size with treatment, this 
suggests that the drug is acting in the same pathway as the inhibitor. Whereas, if 
there was a clear change in phenotype, this may suggest that the drug is acting in a 
distinct complementary pathway. As Nap1 is likely to activate Arp2/3, I reasoned 
that the addition of CK666 to Nap1 depleted cells should not exhibit a change in the 
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proportion of the small bleb phenotype. I reasoned that the addition of SMIFH2 
would possibly result in the weakening of the small bleb phenotype due to the 
inhibition of formins, thus balancing out the remaining nucleator.  
To compare Nap1 potentiation under the different conditions, counts for the small 
bleb phenotype were collected; these included those cells categorised as having ‘no 
blebs’ or ‘small blebs’. M2 cells treated with CK666 presented an overall majority of 
small blebs, whilst those treated with SMIFH2 presented a minority of cells with the 
small bleb phenotype (Figure 5-7). This is consistent with results of blebbing 
phenotypes observed in Arp2/3 and Diaph1 shRNA depleted cells (Bovellan et al. 
2014). For use, the chemical inhibitors CK666 and SMIFH2 are dissolved in DMSO, 
and as a control Nap1 shRNA and DMSO were also combined. The addition of 
DMSO did not have a significant effect on bleb size compared to Nap1 depleted cells 
alone (p=0.83). The potentiation of Nap1 with CK666 resulted in no significant 
change of the small bleb with the addition of CK666 (p=0.91) (Figure 5-7), 
providing further evidence supporting the Nap1 and Arp2/3 interacting pathway.  
When treating to control cells, SMIFH2, a general formin inhibitor, resulted in cells 
with the large bleb phenotype, consistent with Diaph1 depletion results. SMIFH2 
treatment to Nap1 depleted cells did not change the overwhelming small phenotype 
of Nap1 depleted cells, however there was a significant decrease in the percent of 
cells classified as presenting small blebs (**p<0.01). I expected to see a change of 
overall bleb size towards the more normal sized phenotype due to the balancing out 
of remaining nucleators. SMIFH2 is known to have a short longevity of activity, 
meaning that after a few weeks, it no longer inhibits formins. This may have had an 
impact on the results observed. Furthermore, this combination was only 
experimented once, and requires repeating to validate these results.  
It would be interesting to carry out similar potentiation experiments with the other 
NPFs, IQGAP1 and NCKIPSD to further study their interactive pathways. In fact, 
with regards in particular to NCKIPSD, potentiation with chemical inhibitors may 
give a better understanding of the interplay and dual role of interacting with both 
Diaph1 and the Arp2/3 complex. This approach, similar to that carried out with Nap1 
depletion, will reveal any differences in phenotype, reflected by the degree of 
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nucleator inhibition. This will also reveal which of its effects on Arp2/3 or Diaph1 
dominates the phenotype observed in live cell imaging experiments.  
 
Figure 5-7 Potentiation of M2 Nap1 shRNA phenotype with CK666 and 
SMIFH2. CK666 100µM treated cells mostly displayed small blebs, and SMIFH2 
10µM treated cells displayed mostly larger blebs. Similar to CK666 treatment, Nap1 
knockdown cells displayed a prominent small bleb phenotype. The comparison 
between controls Nap1 shRNA and Nap1 shRNA + DMSO did not show significant 
deviations in the quantity of small bleb phenotype (p=0.83). The comparison 
between Nap1 shRNA + DMSO and Nap1 shRNA + CK666 did not show significant 
deviations in the quantity of small bleb phenotype (p=0.91). The comparison 
between Nap1 shRNA + DMSO and Nap1 shRNA + SMIFH2 did show significant 
deviations in the quantity of small bleb phenotype (**p<0.01, chi-squared test). One 
independent experiment per condition examining: 211 cells for non-silencing, 22 for 
CK666, 69 for SMIFH2, 40 for Nap1 shRNA, 168 for Nap1 shRNA + DMSO, 72 for 
Nap1 shRNA + CK666, and 67 for Nap1 shRNA + SMIFH2.  
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5.5 Conclusion 
The main goal is to understand how NPFs function in modifying the cortex 
organisation, thickness, dynamics and mechanical properties. As a first step, I began 
by investigating the effect that depletion of candidate NPFs had upon bleb size. This 
initial screen served to provide an assessment of the involvement of each NPF in 
generation of cortical actin, determined by the impact on bleb size.   
In these experiments, I found that IQGAP1 depletion and NCKIPSD depletion both 
had phenotypes associated with large blebs, suggesting that they primarily affect 
Diaph1 activity. Depletion of the WAVE regulatory complex subunits Nap1 and 
Sra1 both gave rise to a small bleb phenotype, consistent with their known role in 
regulating Arp2/3 complex activity and suggesting that the WAVE complex controls 
Arp2/3 activity in blebs. Flightless-I depletion had no consistent effect on bleb size, 
suggesting that it may not play an important role in the control of cortical actin 
regrowth in blebs (Table 5-2). Together, these experiments suggest that IQGAP1, 
NCKIPSD and the WAVE complex play a role in controlling cortex regrowth under 
the membrane of blebs. 
Table 5-2 Summary of blebbing phenotypes observed in M2 cells with depletion 
of nucleator or NPF. Diaph1 and Arp2/3 depletion results in large and small blebs, 
respectively. Depletion of Flightless-I had no effect on bleb size. IQGAP1 and 
NCKIPSD depletion resulted in large blebs. Sra1 and Nap1 depletion resulted in 
small blebs. 
Normal size blebs Large bleb phenotype Small bleb phenotype 
Non-silencing control Diaph1 depletion Arp2/3 depletion 
Flightless-I depletion IQGAP1 depletion Sra1 depletion 
 NCKIPSD depletion Nap1 depletion 
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As a complement to shRNA depletion, it would be interesting to carry out some 
rescue experiments. RNAi rescue experiments are performed to confirm target RNAi 
specificity because the exogenously expressed protein should rescue the loss-of-
function phenotype. Here, constructs are designed to reintroduce the knocked down 
recombinant protein. To rescue the blebbing phenotype, I would reintroduce the full-
length protein from a species that is not targeted by the shRNA. Other experiments 
could also attempt to rescue the phenotype with specific domains of the protein to 
determine which mediate its function. For example, for IQGAP1, I would rescue 
with the full-length protein but also with the Diaph1-binding region (DBR), which I 
would expect to rescue my protein given my experiments.  
There is also the possibility of rescuing with an agonist of Diaph1-related formins, 
IMM01. This chemical inhibitor disrupts the autoinhibitory interaction between 
diaphanous inhibitory domain (DID) and diaphanous autoregulatory domain (DAD) 
interaction. With this, it would be possible to treat lines depleted for activators of 
Diaph1.  
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Chapter 6 Cortex molecular organisation is regulated by NPFs 
To link cellular scale observations to molecular level mechanism, I examined how 
NPFs controlled cortical organisation using scanning electron microscopy (SEM). 
Electron microscopy allows for a higher-level understanding of the cortical 
organisation, and allows for the link between physical structure and mechanical 
function to be considered. Mesh size is an important determinant of cortical 
mechanics because the organisation of the actin cortex controls the rigidity and 
mechanical stability of the cell surface and drives shape changes by acting as a 
scaffold for myosin motor contractility. The organisational features of the actin 
cortex, such as bundling, cross-linking, density and filament length, contribute to the 
physical and mechanical properties of the actin cortex. Here, the effect of depleting a 
protein important for the promotion of actin assembly should be most apparent in 
blebs that necessitate de novo actin nucleation for cortex formation. As in previous 
work (Bovellan et al. 2014), we found that depletion of Diaph1 led to large gaps 
within the cortex, while Arp2/3 depletion led to the appearance of longer filaments 
but no clear change in actin density.  
6.1 IQGAP1 depletion phenocopies Diaph1 depletion  
I have shown that IQGAP1 depletion phenocopies Diaph1 depletion in the bleb size 
assay. Therefore, I studied the effect that loss of IQGAP1 has on the cortical 
organisation, and compared this to what has been observed in Diaph1 depleted cells. 
As previously described, depletion of Diaph1 led to extensive changes in cortical 
actin organisation, with large gaps in the cortex devoid of actin filaments (Figure 
6-1B, asterisk). This is very different from the homogeneous mesh observed in 
control conditions, with a gap size of approximately 30 nm (Figure 6-1A). Consistent 
with a role in controlling Diaph1, IQGAP1 depletion led to cortices with large gaps. 
There were also areas of high filament density (Figure 6-1C, circled). The cortex 
appears less dense, particularly in areas devoid of actin filaments. Mechanistically, 
RhoA binds to the autoinhibited conformation of Diaph1, to open and activate it, 
allowing subsequent actin nucleation. It has been shown that RhoA only partially 
(15%) activates Diaph1 (Li & Higgs 2003; Li & Higgs 2005; Maiti et al. 2012). This 
suggests that further binding partners, such as IQGAP1, are required to amplify the 
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effect of RhoA to efficiently activate Diaph1 in vivo. With this in mind, and 
comparing with my data, it is possible that Diaph1 retains some nucleating activity 
without the requirement of further stabilising activity by IQGAP1.  
The comparison of cortical organisation between Diaph1 and IQGAP1 knockdown 
cells further supports a role for IQGAP1 as an important player controlling Diaph1-
mediated actin nucleation. Although a significant organisational disruption is evident 
in IQGAP1 depleted cells, there remain regions of uniform filaments and the 
phenotype is less pronounced than in Diaph1 depleted cells. This is consistent with 
the phenotypic observation of blebs discussed above; it can be seen that the blebs are 
not as large and uniform around the cell as with Diaph1 depletion (Figure 5-3).  
 119 
 
Figure 6-1 Scanning electron micrographs of membrane extracted M2 cells. 
Right hand side panels are magnifications of boxed areas from left hand side panels. 
A, Non-silencing shRNA M2 cells display a homogenous mesh with single filaments 
visible (arrows). B, Diaph1 shRNA knockdown cells have large blebs with regions 
devoid of actin filaments (asterisk). The mesh appears generally disorganised. C, 
IQGAP1 shRNA depleted cells present some disorder and areas devoid of actin 
filaments (asterisk) are visible. Some areas of cortex homogeneity are visible 
(circled) Scale; left panels 2µm, right panels 100nm.  
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6.2 NCKIPSD depletion leads to denser cortical actin  
In the case of NCKIPSD knockdown, electron microscopy was deemed especially 
advantageous to visualise the overall structure of cortical actin filaments, as the 
blebbing phenotype was unexpected. One hypothesis was that a reduction in the 
number of unbranched actin filaments nucleated by NCKIPSD activation of Arp2/3 
would result in increased formation of branched filaments, changing the overall 
architecture of the cortex. In this case, I would expect filaments with more 
interconnections, and regions devoid of filaments as a result of the inhibition of 
NCKIPSD. On the contrary, the depletion of NCKIPSD caused a tightening of the 
overall actin cortex mesh (Figure 6-2). This cortical organisation is different from 
that seen in Diaph1 depleted cells, and also very different from that of Arp2/3 
depleted cells.  
 
Figure 6-2 Scanning electron micrographs of membrane extracted M2 cells. The 
actin cortex of NCKIPSD shRNA depleted cells features a very tight mesh with 
regions where single actin filaments appear stumpy, highly bundled and 
indistinguishable (circle). There was also an increase in unknown aggregates at the 
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surface, possibly a feature of the sample preparation. Scale; left panels 2µm, right 
panels 100nm. 
The increase in filament density may stem from generation of unbranched actin 
networks via WAVE activation of Arp2/3 in the absence of NCKIPSD, which 
generates unbranched filaments with Arp2/3. Thus, WAVE and NCKIPSD may 
compete for Arp2/3. Furthermore, NCKIPSD has been shown to bind to Diaph1 but 
not inhibit its elongation activity. Therefore, NCKIPSD may serve as a scaffolding 
protein in addition to being an NPF. In this hypothesis, NCKIPSD would generate an 
actin seed via Arp2/3 nucleation and bring a Diaph1 dimer into contact with the 
newly created barbed end. In this hypothesis, we should find that co-depletion of 
NCKIPSD and WAVE leads to large blebs with low actin density. Another 
hypothesis is that the high density comes from release of Diaph1 inhibition due to 
depletion of NCKIPSD. In this case, we should see that co-depletion of Diaph1 and 
NCKIPSD should lead to large blebs with low actin density.  
To visually represent the relative production of linear vs. branched actin filaments by 
Diaph1 and Arp2/3, I have drawn a schematic as shown below. Diaph1 always 
generates linear filaments, and Arp2/3 generates branched filaments except when 
activated through NCKIPSD (Figure 6-3A). When NCKIPSD is depleted (Figure 
6-3B), there are a greater proportion of branched filaments being nucleated, which 
could explain the increase in cortical density. It has recently been shown that formin-
nucleated filaments make up only 10% of the total number of cortical filaments, and 
are, on average, 10 times longer than Arp2/3-nucleated filaments (Fritzsche et al. 
2016). The proportion of Arp2/3 nucleated filaments has been heavily skewed 
towards branched filament topologies, explaining the apparent increase in density. It 
should be noted, however, that this explanation does not take into account other 
activators of Diaph1 or Arp2/3, and only considers the contributions by IQGAP1, 
NCKIPSD and WAVE.  
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Figure 6-3 Generation of linear vs. branched actin filaments may be modulated 
by the identity of NPFs interacting with the Arp2/3 complex and Diaph1. A, 
Diaph1 exclusively generates linear actin filaments, whilst the Arp2/3 complex 
generates branched actin filaments except when activated through NCKIPSD. B, 
Depletion of NCKIPSD results in the removal of pathways resulting in linear actin 
filament nucleation via Diaph1 and Arp2/3. 
6.3 WAVE subunit depletion leads to a cortex with longer filaments 
Depletion of the WAVE regulatory complex subunits Nap1 and Sra1 both gave rise 
to a small bleb phenotype, consistent with their known role in regulating Arp2/3 
complex activity. I further expected to see a similar cortical organisation in WAVE 
depletion as in Arp2/3 depleted cells. Previous work showed that Arp2/3 depletion 
led to longer filaments that could be traced over several hundred nanometres (Figure 
6-4A). Depletion of the Arp2/3 complex would reduce the generation of branched 
filaments. Using electron microscopy, I observed long actin filaments in the actin 
cortex of cells depleted for Nap1 and Sra1 (Figure 6-4B/C) WAVE complex 
subunits. The small size of blebs made imaging a single bleb difficult, as even the 
most expanded bleb was sometimes very small. This further supports the role of the 
WAVE complex acting as an NPF for the Arp2/3 complex in the cortex.  
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It has also been demonstrated that the WAVE complex can drive myosin-
independent cytokinesis through a spindle-directed signalling pathway (King et al. 
2010). Thus, it would also be interesting to observe the effect that depletion of 
WAVE has upon the progression through the cell cycle in HeLa cells. Because of 
this, I would expect the depletion of WAVE subunits to have a significant impact on 
cell division.  
 
Figure 6-4 Scanning electron micrographs of membrane extracted M2 cells. A, 
The actin cortex of ACTR2 shRNA depleted cells features long actin filaments 
traced up to several hundred nanometres (arrows). B/C, Nap1 and Sra1 shRNA 
(WAVE complex subunits) actin cortex features similar long actin filaments. These 
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filaments also appear bundled at times. The arrows follow the length along a single 
filament. Scale; left panels 2µm, right panels 100nm. 
6.4 Quantitative analysis of changes in actin cortex mesh induced by NPF and 
nucleator depletion 
To quantify the actin cortex mesh, a method for segmenting and recognising the 
‘gaps’ of the cortex was developed in collaboration with Dr. Matt Smith, LMCB. 
Initially, SEM micrographs were input into a trainable FIJI plugin (WEKA 
segmentation) to differentiate between the actin filaments and gaps in the cortex. For 
this, a few actin filaments were manually selected and a few gaps were manually 
identified. The plugin was then able to use this limited information to automatically 
distinguish between the two categories: filaments and gaps for the whole image. The 
plugin then output the location and area of all of the identified gaps. Using the data 
collected, I was able to determine the mesh sizes from cells depleted of the different 
NPFs.  
 
Figure 6-5 Quantitative segmentation analysis of SEM micrographs. The actin 
mesh of membrane extracted M2 cells was analysed to determine the proportion of 
holes that are a certain size (indicated by their size in nm). As qualitatively 
determined previously, the non-silencing control, ACTR2 shRNA and Nap1 shRNA 
mesh size did not differ much (average size is around 30nm). The mesh size of 
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NCKIPSD shRNA cells appears tight, with the holes also revealed as smaller than 
the controls (mostly less than 25nm), in agreement with the image data. 
Each condition represents seven micrograph images that were analysed individually, 
before pooling. To generate the quantitative segmentation analysis of SEM 
micrographs as shown in the graphs, data was binned into bins of 5 nm for Figure 
6-5 and binned into 20 nm for Figure 6-6. This allowed for proper representation of 
the different sized holes that are reflected by the depletion of Diaph1 and its 
proposed NPFs, or Arp2/3 and its proposed NPFs.  
 
Figure 6-6 Quantitative segmentation analysis of SEM micrographs. The actin 
mesh of membrane extracted M2 cells was analysed to determine the proportion of 
holes that are a certain size (indicated by their size in nm). IQGAP1 and Diaph1 
depleted cells displayed the largest holes (size of up to 250nm). 
Previous work has reported a 30 nm mesh size in the cortex of M2 cells (Bovellan et 
al. 2014), corresponding well to the expected size of actin-dependent membrane 
protein confinement zones (Kusumi et al. 2011). In agreement with this, the mesh in 
the non-silencing control cells displayed a peak at 28nm with 100% of the actin 
cortex mesh gaps falling between 20 and 60nm (Figure 6-5, blue). ACTR2 and Nap1 
depleted cells also featured a similar mesh size range, with 2-3% of holes above 75 
nm (Figure 6-5, purple/green). As expected, Diaph1 depleted cells had a greater 
spread of mesh sizes, with 75% of holes greater than 75 nm (Figure 6-6, red). 
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IQGAP1 depleted cells replicated this mesh size pattern, however, there was a 
greater proportion of holes falling below the 75 nm range (Figure 6-6, green). 
Interestingly, NCKIPSD depleted cells had a very narrow range of mesh size, with 
almost all the holes at less than 25 nm (Figure 6-5, orange). It is important to 
comment on the variation in the non-silencing shRNA trace, suggesting that the 
numbers may not be repeatable.  
This quantification strongly supported the judgements made from visually analysing 
the electron micrographs. In terms of mesh size, Arp2/3 and Nap1 can be grouped; 
Diaph1 and IQGAP1 appear to yield similar results; and NCKIPSD may be involved 
in a role different to that observed with other NPFs. We know that depleting both 
Arp2/3 and Diaph1 leads to substantial detriment in actin cortex organisation, 
affecting actin localisation and cortex stability. It would have been interesting to 
measure the size of the cortex in M2 cells with a dual depletion for both Arp2/3 and 
Diaph1 to further confirm potentiation as seen in other experiments. It should be 
noted, however, that measurements on fixed cells may suffer from artefacts such as 
cell shrinkage and altered architecture of the plasma membrane and actin networks. 
Therefore, the determination of actin cortex density and membrane-cortex distance 
measurements might best be performed on living cells.  
6.5 Conclusion 
Consistent with a role in controlling Diaph1 suggested by the blebbing phenotype, 
IQGAP1 depletion led to cortices with large gaps although the effect was less 
pronounced than Diaph1 shRNA. WAVE subunit depletion led to a cortex with 
longer filaments, consistent with its role in controlling Arp2/3 activity and the small 
bleb phenotype obtained upon depletion. NCKIPSD depletion led to a clear increase 
in cortical density, which was surprising given the large bleb phenotype that 
observed in live imaging that is consistent with a reduction in Diaph1 activity.  
Based on these results, it appeared that depletion of NCKIPSD disrupted Diaph1 
activity but increased density. NCKIPSD has been shown to contribute to the 
nucleation of unbranched actin filaments via Arp2/3 (Wagner et al. 2013). This 
unbranched organisation is more advantageous for myosin-mediated contractions 
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than the branched topologies obtained through WAVE-mediated Arp2/3 activation. 
A reduction in Diaph1 actin polymerisation and cortex weakening could explain the 
large bleb phenotype observed with NCKIPSD depletion. NCKIPSD depletion 
would also limit the formation of unbranched actin filaments; thus, I would expect 
this to be demonstrated through an observed modification of cortical contractility. 
Cortical contractility is especially crucial in the formation of the furrow during cell 
division. With this in mind, I predicted that there would be a perturbation of cell 
division observed with the depletion of NCKIPSD.  
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Chapter 7 NPF depletion perturbs the cell cycle  
The actin filament network is crucial for dictating cell shape, and participates in the 
dynamic regulation of cellular functions. In HeLa cells, cells adhere to the 
substratum during interphase and spread to assume their characteristic shape 
supported by the actin cytoskeleton. This actin cytoskeleton is reorganised during 
mitosis to form rounded cells with increased cortical rigidity. The most dramatic 
changes in eukaryotic cytoskeletal organisation and dynamics occur during passage 
through mitosis. Here, the actin cytoskeleton is reorganised after mitosis, allowing 
cells to regain their spread shape and attachment to the substratum. The modulation 
of such drastic changes in cell shape in coordination with cell cycle progression 
suggests a tight regulatory interaction between cytoskeleton signalling, cell-cell/cell-
matrix adhesions and mitotic events. 
Given the importance of the actin cortex in numerous stages of the cell cycle and that 
NPFs appeared to control the activity of actin nucleators, I reasoned that depletion of 
NPFs may perturb normal progression through the cell cycle. For example, IQGAP1 
depletion phenocopies Diaph1 depletion, suggesting that it activates and works via 
Diaph1. Thus, I would expect a similar outcome while following progression cells 
depleted of IQGAP1 through the cell cycle.  
7.1 Generation of NPF depleted stable lines in HeLa cells 
To this aim, I generated stable HeLa cell lines depleted for each of the NPFs 
identified using shRNA. Protein depletions were verified with qPCR to quantify 
mRNA (Figure 7-1A) and western blotting to quantify protein levels (Figure 7-1B). 
Certain shRNA knockdowns (Diaph1, Nap1, Sra1) were lethal and for those, stable 
cell lines were not made but instead siRNA was used. siRNA depletion was also 
verified by qPCR and western blotting. All shRNA knockdown lines had a strong 
depletion; similarly, siRNA depletions were also high.  
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Figure 7-1 A, mRNA transcript abundance of ACTR2 (Arp2) shRNA, ACTR2 
(Arp2) siRNA, ArpC2 shRNA, Diaph1 siRNA, IQGAP1 shRNA, IQGAP1 siRNA, 
NCKIPSD shRNA, NCKIPSD siRNA, Nap1 siRNA and Sra1 siRNA using qPCR; 
this revealed high knockdown in ACTR2 (Arp2) shRNA (70% knockdown), ArpC2 
shRNA (73% knockdown), IQGAP1 shRNA (80% knockdown), and NCKIPSD 
shRNA (50% knockdown) in stable knockdown HeLa cell lines. qPCR revealed high 
knockdown in ACTR2 siRNA (98% knockdown), Diaph1 siRNA (94% knockdown), 
IQGAP1 siRNA (98% knockdown), NCKIPSD siRNA (80% knockdown), Nap1 
siRNA (97% knockdown) and Sra1 siRNA (91% knockdown). B, Western blot 
showing protein levels in stable knockdown HeLa cells expressing NS and IQGAP1 
shRNA, probed with anti-IQGAP1 and anti-GAPDH as a loading control. Western 
blot showing protein levels in knockdown HeLa cells expressing NS, Nap1, and 
Diaph1 siRNA, probed with anti-Nap1 and anti-Diaph1 as a loading control.  
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7.2 NPF depletion has an impact on normal cell cycle progression 
To assess the impact on cell cycle progression upon depletion, NPF knockdown lines 
were imaged and classified into the following categories: those that progressed 
normally through the cell cycle (Table 7-1A), those that died in interphase (Table 
7-1B) and those that died in mitosis (Table 7-1C). A further categorisation of those 
that died in mitosis was made into groups that died during prophase, metaphase, 
anaphase, telophase or other. Cells in the ‘other’ group included cells that oscillated 
before death, cells that divided and regressed, and cells that divided but failed to 
spread.  
Table 7-1 Categories of HeLa cell cycle progression A, Cells that progressed 
through the cell cycle normally B, Cells that died in interphase C, Cells that died 
during the various stages of mitosis – prophase, metaphase, anaphase, telophase, and 
other. 
 
In the live imaging of non-silencing shRNA HeLa cells, most cells progressed 
through the cell cycle normally. They were able to round, divide and spread robustly 
(Figure 7-2, see Vid1, USB). Even in control conditions, a small number of cells die, 
mostly due to failures in mitosis. In the NPF depleted lines, shown later, some 
knockdowns result in a higher number of cells dividing into three, or even four, 
daughter cells. In the control condition, cells that progress normally through the cell 
cycle complete cytokinesis in an average of just over two hours (130 minutes, 60 
control cells analysed). This timing is taken from the moment rounding is first 
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detected, until the daughter cells have divided. Certain malfunctions can result in a 
delay during mitotic cell rounding or during abscission where the daughter cells 
separate after cytokinesis.  
 
Figure 7-2 Live cell phase imaging of non-silencing shRNA HeLa cells. Control 
cells progress through the cell cycle in an average of 130 min (time from the 
beginning of mitotic rounding until daughter cells have divided). Here, cells round 
up abandoning the flat morphology of interphase, then advance through the stages of 
mitosis before cell cleavage and abscission where the daughter cells separate. Scale 
bar: 20µm (see Vid1, USB). 
Firstly, the overall impact on cell progression was studied in cells depleted of a 
single NPF. I looked for similarities between depletion of NPF and depletion of 
nucleator. In previous work, Diaph1 depletion led to a significant increase in cell 
death during the cell cycle (Bovellan et al. 2014). The situation is more complex with 
the Arp2/3 complex as ArpC2 depletion does not affect progression through the cell 
cycle but ACTR2 depletion does. Diaph1 depletion was further accompanied by an 
increase in the incidence and size of blebs during anaphase and cytokinesis (Bovellan 
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et al. 2014). Thus, I examined how depletion of each NPF in turn affected cell cycle 
progression and actin cortex morphology.  
In the previous bleb size studies, Flightless-I had no phenotype when depleted and I 
hypothesised that it might play a role in cell cycle progression. However, depletion 
of Fli-I showed no increase in cell death in HeLa cells, and surprisingly, significantly 
decreased the incidence of cell death (Figure 7-3). This indicates a function of Fli-I 
separate from a cortical NPF function in the cell cycle. As discussed before, Fli-I 
may have a role in other actin related processes in the cortex.  
 
Figure 7-3 Flightless-I depletion affects cell survival. When compared to cells 
transfected with non-silencing shRNA, cells depleted in Fli-I showed significantly 
different rates of successful cell cycle progression (**p<0.01). Results were gathered 
from 3 independent experiments examining: non-silencing shRNA (n=399 cells), Fli-
I shRNA (n=178 cells). Data was analysed with a chi-squared test.  
Next, I investigated the effect on cell cycle progression of depleting IQGAP1 or 
NCKIPSD. Both IQGAP1 and NCKIPSD depletion led to cells with a significantly 
higher total cell death compared to the non-silencing controls (Figure 7-4). 50% of 
cells with a Diaph1 knockdown do not progress through the cell cycle as normal, but 
0	
10	
20	
30	
40	
50	
60	
70	
80	
90	
100	
NS	shRNA	 Fli-I	shRNA	
%
	to
ta
l	c
el
l	d
ea
th
	
Total cell death 
** 
 133 
this value is significantly lower for both IQGAP1 and NCKIPSD knockdown, albeit 
staying significantly higher than for controls.  
 
Figure 7-4 Progression through mitosis categorised by total cell death when 
depleted with NPFs thought to modulate Diaph1 activity. When compared to cells 
transfected with non-silencing shRNA, cells depleted in IQGAP1 displayed 
significantly increased rates of total cell death (**p<0.01). There is no significant 
difference between NCKIPSD shRNA/siRNA depletion (p=0.19). Compared to 
Diaph1 depletion, both IQGAP1 (**p<0.01) and NCKIPSD (*p<0.05) depletion 
resulted in a significantly lower percent of total death. Results were gathered from 3 
independent experiments examining: non-silencing shRNA (n=399 cells), non-
silencing siRNA (n=178 cells), Diaph1 siRNA (n=185 cells), IQGAP1 shRNA 
(n=528 cells), NCKIPSD shRNA (n=462 cells), NCKIPSD siRNA (n=515 cells). 
Data was analysed with a chi-squared test.  
The data shows that IQGAP1 and NCKIPSD play an important role in allowing 
normal cell cycle progression. Similar to previous experiments, the phenotype seen 
in IQGAP1 knockdown is not as intense as with Diaph1 knockdown, supporting the 
existence of other Diaph1 activators. Morphologically, Diaph1 cells are 
characteristically quite thin and elongated in interphase (see Vid2, USB) with most 
abruptly dying in interphase (Figure 7-5B). IQGAP1 depleted cells were extremely 
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blebby throughout mitosis (see Vid3, USB), with very large blebs seen especially at 
the poles, suggesting cortical instability. These cells typically divide asymmetrically, 
and take an increased time during all stages of the cell cycle (Figure 7-5C). The 
delay in IQGAP1 depleted cells appears to be most pronounced from the start of 
rounding to anaphase. IQGAP1 knockdown cells that progress past interphase take 
114 minutes on average, compared to 50 minutes in control cells. As Figure 7-5C 
shows, after cytokinesis, there is a delay in abscission of the daughter cells, with a 
visible connection of the intercellular bridge connecting the two daughter cells. This 
delay in severing will be discussed in 7.3. Similarly, cells depleted of NCKIPSD 
were also very blebby during mitosis (see Vid4, USB), with a high number failing to 
progress past mitosis. NCKIPSD knockdown cells were less spread in interphase 
compared to the controls, and those cells that did survive went through multiple 
rounding attempts before the final rounding allowing the cell to enter mitosis. In 
addition, cells often underwent several cycles of rounding and spreading before 
finally rounding for mitosis. Alteration in cell shape poses difficulties in critical 
mitotic processes such as spindle assembly, signalling, and targeting processes 
during check point regulation and may be responsible for the increase in abnormal 
mitosis behaviour (Lancaster & Baum 2014). 
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Figure 7-5 Live cell imaging of shRNA silenced HeLa cells using phase contrast 
microscopy. A, Control cells progress through the cell cycle abandoning the flat 
morphology of interphase, then advance through the stages of mitosis before cell 
cleavage and abscission where the daughter cells separate. B, Diaph1 siRNA cells 
appear more elongated in interphase and frequently die during interphase. C, 
IQGAP1 shRNA cells are very blebby during mitosis (arrowhead), and those that 
survived were unable to sever the intracellular connection between the daughter 
cells. D, NCKIPSD siRNA cells were less spread in interphase, very blebby during 
mitosis (arrowhead) and many depleted cells failed to progress through mitosis. 
Scale: 20µm. 
Depletion of subunits of the WAVE regulatory complex, Nap1 and Sra1, has 
consistently been shown to phenocopy Arp2/3 knockdown in our assays. Thus, I 
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expected to see a large impact on total cell death, similar to that I see with ACTR2 
depletion. Surprisingly, Sra1 and Nap1 depletion had no significant effect on total 
cell death (Figure 7-6), similar to ArpC2 depletion. This is also consistent with 
observations using the Arp2/3 inhibitor CK666 (Bovellan et al. 2014). 
 
Figure 7-6 Progression through mitosis categorised by total cell death when 
depleted with NPFs thought to modulate Arp2/3 activity. When compared to cells 
transfected with non-silencing shRNA, cells depleted in ACTR2 shRNA/siRNA 
displayed significantly increased rates of total cell death. There is no significant 
difference between ACTR2 shRNA/siRNA depletion (p=0.07). ArpC2 depletion 
does not significantly increase cell death (p=0.42). Depletion of both WAVE 
complex subunits, Nap1 (p=0.44) and Sra1 (p=0.29), did not significantly affect cell 
death. Results were gathered from 3 independent experiments examining: non-
silencing shRNA (n=399 cells), non-silencing siRNA (n=178 cells), ArpC2 shRNA 
(n=443 cells), ACTR2 shRNA (n=382 cells), ACTR2 siRNA (n=594 cells), Sra1 
siRNA (n=629 cells), Nap1 siRNA (n=542 cells). Data was analysed with a chi-
squared test.  
In addition to the cell death phenotypes induced by siRNA, I also generated cell lines 
depleted in Sra1 and Nap1 with shRNA. Depletion of Sra1 and Nap1 with shRNA 
led to extensive changes in the morphology of the cell. Knockdown cells were 
generally very rounded and grew in clumps, failing to spread as expected (see Vid8 
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and Vid10, USB). There appeared to be a loss of attachment between the cell and the 
substrate, making them less adherent and extremely easy to detach. This is consistent 
with previous work that highlighted the Arp2/3 complex’s importance for cell 
spreading. Arp2/3 complex inhibition has been shown to greatly alter the structural 
organisation of actin in spreading cells (Henson et al. 2015). In my experiments, this 
characteristic made it very difficult to count the cells and analyse the acquired data, 
as it sometimes appeared like the cell survived even though it may have died (Figure 
7-7F). Thus, instead of using shRNA-depleted cells, I used siRNA-depleted cells that 
did not exhibit clumping to such extent (see Vid7 and Vid9, USB). Both Nap1 and 
Sra1 siRNA depleted cells were less spread than controls and all cells displayed 
small sized blebs during mitosis (Figure 7-7D, E). Cells depleted for WAVE 
complex subunits were able to go through cytokinesis, albeit at a much slower rate. 
Similar to NCKIPSD depleted cells, WAVE knockdown cells often underwent 
several cycles of rounding and spreading before finally rounding for mitosis.  
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Figure 7-7 Live cell imaging of silenced HeLa cells using phase contrast 
microscopy. A, Control cells progress through the cell cycle as normal, abandoning 
the flat morphology of interphase, then advance through the stages of mitosis before 
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cell cleavage and abscission where the daughter cells separate. B, ArpC2 shRNA 
cells appear normal with the presentation of small blebs during mitosis (arrowhead). 
C, ACTR2 shRNA cells were very blebby during mitosis, with many cells dying at 
this stage. D, Sra1 siRNA cells were less spread in interphase and progressed 
through mitosis significantly more slowly. E, Nap1 siRNA cells were less spread in 
interphase with the presentation of small blebs during mitosis (arrowhead). F, Nap1 
and Sra1 shRNA cells have a very strong phenotype, promoting growth in colonies 
making it difficult to analyse or study. These shRNA cells were not used further in 
this investigation. Scale: 20µM. 
7.3 NPF depletion induces changes in the duration of mitotic stages  
When analysing long-term movies of cells depleted in NPFs, I noticed that some 
depletions appeared to perturb the duration of various mitotic stages. To this aim, I 
analysed the captured videos to determine the duration of each mitotic stage in NPF 
depleted cells and compared these to control cells.  
I quantified two events: rounding timing and abscission timing (Figure 7-8). 
Rounding timing represents the time from the first sign of rounding to a completely 
rounded cell. In terms of the cell cycle, rounding is concurrent with nuclear envelope 
breakdown at the onset of mitosis and is completed before anaphase. The abscission 
timing represents the time required to progress from anaphase to the end of 
cytokinesis. Cytokinesis, initiated at anaphase onset, cleaves the cytoplasm until only 
a small bridge termed the midbody remains between the two daughter cells. With 
time, the midbody is severed in a process called abscission, resulting in complete 
separation of the two daughter cells. During analysis, I noticed that pinpointing the 
exact timing of abscission timing is challenging because it is difficult to tell if the 
daughter cells have completely separated. Thus, for ease of analysis in this section 
and for consistency, I measured the time when the daughter cells have completely 
cleaved but not completely separated.  
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Figure 7-8 Quantification of rounding time and abscission time in HeLa cells. 
Rounding timing represents the time from the first sign of rounding (interphase exit) 
to a completely rounded cell in metaphase. Abscission time represents the duration 
between anaphase to the end of cytokinesis where the daughter cells are held 
together only by a small bridge.  
7.3.1 NPFs significantly perturb rounding duration 
Mitotic cell rounding is likely important for chromosome segregation and the 
positioning of the cytokinetic furrow, making it an important process to study and to 
understand the role of the actin cortex during this stage (Maddox & Burridge 2003). 
It has been shown that F-actin is required for coordinated retraction of the cell 
margin at the onset of mitosis, demonstrating that the actin cytoskeleton plays an 
active role in mitotic cell rounding (Cramer & Mitchison 1997). Conditions that 
disturb mitotic cell rounding have been observed to be detrimental to spindle 
morphogenesis and orientation (Kunda et al. 2008), suggesting that mitotic cell 
rounding is a key stage for successful completion of mitosis. Many studies have 
observed a role for actin and associated proteins in cortical retraction and rigidity 
(Maddox & Burridge 2003). It is known that cortical stiffness increases at mitotic 
entry (Kunda et al. 2008; Maddox & Burridge 2003) participating to the 
immobilisation of specific proteins in the actin network (Théry & Bornens 2008). At 
mitotic onset, the assembly of a linear uniform Diaph1-dependent F-actin cortex 
coincides with initial rounding, promoting cortical rigidity (Ramanathan et al. 2015).  
In cells transfected with NS shRNA, I measured a mean rounding duration of 19 (±6) 
minutes, consistent with previous work (Sivakumar et al. 2014). Mitotic rounding 
time was calculated by determining the duration between when the cell began 
rounding and when rounding was complete. Diaph1 and IQGAP1 depleted cells had 
First sign of rounding 
(Interphase exit) Metaphase Cytokinesis Anaphase 
Rounding time Abscission time 
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a significantly quicker rounding time with a mean of 6 (±6) minutes and 9 (±6) 
minutes, respectively, half the time of control cells (Figure 7-9). The similarity in 
effect of IQGAP1 and Diaph1 rounding is consistent with our other observations that 
suggest IQGAP1 plays a role in maintaining Diaph1 activity.  
ACTR2 and NCKIPSD depletion had an effect opposite to Diaph1 and IQGAP1 
depletion. ACTR2 and NCKIPSD depleted cells appeared take significantly longer in 
rounding when compared to the controls, with a mean of 30 (±20) minutes and 29 
(±12) minutes, respectively. Sra1 and Nap1 depleted cells displayed quicker 
rounding time, with a mean of 8 (±5) minutes and 13 (±20) minutes, respectively. 
This was unexpected because in most of my experiments, Sra1 and Nap1 depletion 
phenocopies ACTR2 depletion. Examination of the videos of Sra1 and Nap1 
depleted cells showed that these cells spread very little. Therefore, the limited 
spreading of Nap1 and Sra1 depleted cells may contribute to shortening their 
rounding time.  
It has been shown that formin-nucleated bundled F-actin networks tend to a better 
substrate for myosin II contractility than networks nucleated by Arp2/3 (Ramanathan 
et al. 2015). Stewart et al. showed that mitotic rounding depends both on the 
actomyosin cytoskeleton and the cells’ ability to regulate osmotic swelling (Stewart 
et al. 2011). The cortex resists the swelling forces coming from osmotic effects. 
Thus, if a cell is less contractile, it can round faster. Depletion of IQGAP1 or Diaph1 
would make less contractile filaments, and hence increase rounding speed, as the cell 
is able to resist the osmotic forces better. This could be one explanation for the fast 
rounding times recorded with IQGAP1 and Diaph1 depletion. It is also possible that 
there may also be a weakening of cell–substrate adhesion that leads to the rapid 
detachment and subsequent rounding. Depletion of the WAVE subunits also resulted 
in a quicker rounding time, contrary to expectation based on slower Arp2/3 depletion 
rounding time. As mentioned above, these cells were already much more 
morphologically round compared to the controls. This could mean that the time 
recorded in this case may not be accurate to represent the total rounding time from 
the spread morphology. On the other hand, ACTR2 and NCKIPSD depletions led to 
significantly slower rounding times. It has been shown that depletion of the Arp2/3 
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complex has no effect on either cortical tension or cortical F-actin enrichment 
(Ramanathan et al. 2015), however other studies have shown that Arp2/3 does have a 
role in potentiating actin cortex stability (Watanabe et al. 1997). In this case, it is 
possible that depletion of Arp2/3 perturbs the turnover of actin at the cortex needed 
for proper cell rounding, meaning that the cell takes longer to acquire its round 
morphology. Such as in the case of NCKIPSD, multiple rounding attempts are seen, 
which could show that the depletion of these nucleators affects the signalling 
pathways required for the initiation and completion of rounding. 
 
Figure 7-9 Duration of mitotic cell rounding is perturbed by nucleator and NPF 
silencing. The duration of mitotic rounding was plotted for each nucleator and NPF 
knockdown. ACTR2 shRNA and NCKIPSD siRNA depletion significantly slowed 
rounding, whilst Diaph1 siRNA, IQGAP1 shRNA, Sra1 siRNA and Nap1 siRNA 
depletion significantly decreased rounding time (**p<0.01). Whiskers indicate 
minimum and maximum actin rounding times. 30 cells were analysed for each 
siRNA/shRNA HeLa depletion. Data was analysed with a Mann-Whitney U-Test.  
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7.3.2 Abscission time durations 
In my experiments, abscission time is measured from anaphase to the end of 
cytokinesis, where the daughter cells are held together only by a small bridge (Figure 
7-8). In the final step of cytokinesis, the mother cell cleaves into two until the 
daughter cells are connected only by the midbody (Weiss 2012). This sequence of 
events makes it interesting to study in more detail. The contractile actin cortex, in 
particular, is crucial for the cleavage of the furrow, allowing the consequential 
separation of the daughter cells. Separation of mother and daughter cells involves 
coordinated actomyosin ring contraction (Kunda et al. 2008; Carreno et al. 2008; 
Kunda et al. 2012) and septum synthesis, followed by septum destruction. Diaph1 
has been reported as localised to the mitotic spindle from anaphase to telophase, 
suggesting a role of Diaph1 in the spindle-cleavage furrow interaction during cell 
division (Kato et al. 2001). These events occur in precise and rapid sequence once 
chromosomes are segregated and are linked with spindle organisation and mitotic 
progress by intricate cell cycle control machinery (Weiss 2012). This mitotic exit is 
important to allow daughter cells to re-enter G1 to allow for the next division, and 
this tight regulation ensures that both daughter cells are viable upon separation.  
Depletion of Diaph1, NCKIPSD and ACTR2 caused a significantly longer time for 
abscission, whilst IQGAP1 also significantly increased abscission time, albeit to a 
lower significance (p=0.01). Interestingly, Nap1 and Sra1 depletion did not result in 
significant changes to abscission timing (Figure 7-10), again not an expected result 
based on the comparison with Arp2/3 subunit depletion. The greatest change I 
noticed was in NCKIPSD depleted cells, where most cells took double the amount of 
time for abscission compared to the controls (Figure 7-10). Between anaphase and 
cytokinesis, the actin cortex undergoes a series of shape changes; elongating the cell, 
relaxation of the cortical actomyosin network at cell poles, and the concentration of 
actomyosin at the cell centre to form a contractile ring (Ramkumar & Baum 2016). 
Depletion of an important actin nucleator, such as Diaph1 or Arp2/3, would likely 
have an impact on the progression through these actin cortex dependent processes 
(Evangelista et al. 2002).  
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It was challenging to calculate the time of total separation of daughter cells due to 
the ambiguity of when the cells truly separate, and during times of asymmetric 
division it is difficult to select the point at which the daughter cells cleave. These 
results confirm that nucleators and NPFs are important for active polymerisation 
(and depolymerisation) of actin filaments, to contribute towards the assembly, 
maintenance and closure of the contractile ring. As a follow-up, it would be 
interesting to look at F-actin during these stages, and to further interrogate nuclear 
localisation. It would be informative to study the role of microtubules in the cleavage 
of cells at cytokinesis, and to study the septum, given their role in abscission.  
 
Figure 7-10 Duration of abscission time is perturbed by nucleator and NPF 
silencing. The duration of abscission time was plotted for each nucleator and every 
NPF knockdown. The start of anaphase was identified for each cell and the end of 
cytokinesis was identified. Abscission timing was determined by calculating the 
difference between these two events. Diaph1 siRNA, ACTR2 shRNA, NCKIPSD 
siRNA and IQGAP1 depletion significantly slowed abscission time (**p<0.01, 
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*p<0.05), whilst Sra1 siRNA (p=0.74) and Nap1 siRNA (p=0.46) depletion did not 
significantly change abscission time. Whiskers indicate minimum and maximum 
abscission times. 30 cells were analysed for each siRNA/shRNA HeLa depletion. 
Data was analysed with a Mann-Whitney U-Test.  
7.4 Specific stage of cell cycle failure differs between NPFs 
To further understand the impact that NPF depletion has upon the cell cycle and to 
identify similarities between NPF and nucleator, I identified the exact stage at which 
death occurred. Determining the exact stage of mitotic failure can allow for a greater 
insight into the differential roles that the nucleators and NPFs play within each stage.  
As I have shown previously, Diaph1 knockdown cells predominantly die during 
interphase (71% of death in interphase of total cell death), apparently because they 
are unable to round into mitosis. Those cells that make it through to mitosis appear to 
die in early mitosis during prophase, or late mitosis during telophase (Figure 7-11). 
This observation is not mimicked by depletion of IQGAP1 (15% of death in 
interphase of total cell death), or NCKIPSD (40% of death in interphase of total cell 
death). Cells with an IQGAP1 knockdown predominantly died in mitosis, 
particularly in the first two stages, prophase (45% of death in prophase of total cell 
death) and metaphase (28% of death in metaphase of total cell death). I observed 
cells round up quicker than expected (Figure 7-9), but then begin blebbing profusely 
once they entered into mitosis, often resulting in cell death. Around 10% of cells died 
after furrowing, due to being unable to spread; this is categorised as ‘death after 
dividing’. Interestingly, IQGAP1 depleted cells do not copy Diaph1 depleted cells in 
the pattern and stage of cell death, suggesting that it may have other roles in the cell 
cycle or because of a weaker impact on Diaph1 activity.  
NCKIPSD depleted cells showed similar patterns of cell death with siRNA and 
shRNA gene silencing (Figure 7-11). Of the cells that die, there is an equal 
proportion that die in interphase and in mitosis. Surprisingly, some cells progress 
through most of mitosis, divide and then regress, a process where the daughter cells 
combine post-cytokinesis. These cells likely die due to abscission failure, and do not 
represent a healthy cell population. Cells that regress are unable to spread, and may 
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suggest issues with previous chromosome segregation meaning that they require 
recombination of daughter cells to possibly regain chromosome stability. Again, the 
pattern of death seen in NCKIPSD depleted cells is not similar to that seen in Diaph1 
knockdown cells, adding another layer of uncertainty to the potential NCKIPSD 
interaction. This observation could be because of more extensive perturbation to 
Diaph1 activity or because the nucleators participate in a particular stage of mitosis. 
The role of NCKIPSD in the cell cycle has not been studied in the literature, however 
both the Arp2/3 complex and Diaph1 have been identified as being important for 
regulating actin cortex stability during mitosis (Bovellan et al. 2014). Thus, 
NCKIPSD could be playing a role in regulating both Arp2/3 and Diaph1 at different 
stages of the cell cycle. Further investigations are required to understand its role.  
 
Figure 7-11 Nucleator depletion affects progression through mitosis and 
interrupts it at different stages. Distribution of cell deaths as a function of cell 
cycle stage. Cells that died during interphase are represented in grey, cells that died 
in prophase in green, metaphase in blue, anaphase in purple, telophase in yellow and 
after dividing in orange, are shown. Cells that died after dividing includes those that 
divide and regress, those that divide and could not spread, and cells that oscillated. 
All knockdown lines show a high proportion of cell death occurring in mitosis, 
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however, cells depleted of Diaph1 typically die during interphase. Results were 
gathered from 4 independent experiments examining: non-silencing shRNA (n=936 
cells), non-silencing siRNA (n=178 cells), Diaph1 siRNA (n=200 cells), IQGAP1 
shRNA (n=528), NCKIPSD shRNA (n=462), and NCKIPSD siRNA (n=515).  
As I have shown previously, Arp2/3-subunit depleted cells predominantly die during 
mitosis, an observation opposite of that seen with Diaph1 depleted cells. More 
specifically, of those cells that died, ArpC2 and ACTR2 knockdown cells die in early 
mitosis, namely prophase (55% of death in prophase of total cell death) and 
metaphase (27% of death in metaphase of total cell death) (Figure 7-12). It is also 
important to note that ACTR2 depletion with siRNA yields a different pattern of 
death, despite resulting in the same amount of total death. The results suggest that 
cells were able to successfully round but were unable to organise the chromosomes 
as necessary to allow for continuation of the cell cycle cytokinesis. During these 
stages we know that the Arp2/3 complex and formins are important for generating 
newly polymerised actin filaments and pre-existing actin cables to contribute to 
initial assembly of the contractile ring. This ring remains a dynamic structure in 
which actin and other ring components continuously assemble and disassemble from 
the ring every minute. The rate of actin polymerisation can influence the rate of 
cleavage. Thus, actin polymerisation driven by the Arp2/3 complex and formins is a 
central process in cytokinesis, and could explain the interruption during the cell cycle 
with the depletion of the various nucleators/NPFs. Knockdown of the WAVE 
complex subunits, Sra1 and Nap1, also resulted in an interesting pattern of death, 
with most cells dying during anaphase (44% of death in anaphase of total cell death) 
and during prophase (26% of death in prophase of total cell death), respectively.  
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Figure 7-12 Nucleator depletion affects progression through mitosis and 
interrupts it at different stages. Distribution of cell deaths as a function of cell 
cycle stage. Cells that died during interphase are represented in grey, cells that died 
in prophase in green, metaphase in blue, anaphase in purple, telophase in yellow and 
after dividing in orange, are shown. Cells that died after dividing includes those that 
divide and regress, those that divide and could not spread, and cells that oscillated. 
All knockdown lines show a high proportion of cell death occurring in mitosis. 
Results were gathered from 4 independent experiments examining: non-silencing 
shRNA (n=936 cells), non-silencing siRNA (n=178 cells), ArpC2 shRNA (n=423 
cells), ACTR2 shRNA (n=611 cells), Sra1 siRNA (n=629 cells), and Nap1 siRNA 
(n=542 cells). 
From the results, it appears that Diaph1 has a crucial importance during interphase, 
whilst the other actin-binding proteins, ACTR2, NCKIPSD and IQGAP1, seem to be 
more critical during mitosis. Mitosis is the most sensitive part of the cell cycle, 
requiring a multitude of signalling pathways and shape changes supported by actin 
cortex rearrangements, most likely dictated by the nucleators explored in this thesis. 
The patterns of cell death comparing death in mitosis and interphase reported in the 
graphs above do not follow a specific pattern based on the phenotypes groups 
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(Diaph1-interacting and Arp2/3-interacting) that have been observed in the other 
experiments. To be able to entirely understand the results, further investigations are 
required whereby depleted cells with particular markers (i.e. actin, myosin, tubulin) 
are followed during the cell cycle. This may give an advanced insight into the 
particular aberrations that are occurring to result in death at the stages identified.  
7.5 Combined silencing of NPF and nucleators to determine the signalling 
pathway 
Next, I attempted to determine which nucleator each NPF mainly interacted with by 
combining NPF and nucleator knockdown. My hypothesis is that if I deplete a 
nucleator and an NPF that controls its activity, then the proportion of cells 
successfully making it through the cell cycle will not change compare to nucleator 
depletion alone. Conversely, if the NPF controls the other nucleator, then I should 
see an increase in cell death because I would be affecting two independent pathways. 
Indeed, when Bovellan et al perturbed the activity of both nucleators, they found a 
significant increase in failure to progress through the cell cycle. 
For all experiments, I combined an shRNA stable cell line with siRNA to achieve a 
double knockdown. As a control, I used the nucleator shRNA stable line and 
transfected this with a non-silencing siRNA. All experiments were analysed between 
the controls and the single knockdown, and considered statistically significant if 
**p<0.01/*p<0.05.  
7.5.1 Total cell death in NPF and nucleator knockdown in HeLa cells 
I first began with combining Diaph1 knockdown with NPFs IQGAP1 and 
NCKIPSD. As I did not manage to generate a viable Diaph1 knockdown line with 
shRNA, I combined Diaph1 siRNA with stable lines showing IQGAP1 and 
NCKIPSD knockdown. Given my other experimental results, I expected to see no 
change in cell death when combining IQGAP1 depletion with Diaph1 knockdown, 
and an increase in death when combining IQGAP1 depletion with Arp2/3 knock 
down. Depletion of NCKIPSD has shown to phenocopy Diaph1 in the initial bleb 
size studies, however in many other experiments, NCKIPSD copied neither Diaph1 
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nor Arp2/3. Hence, for the combined depletion of NCKIPSD and Diaph1, I was 
unsure of what to expect.  
In fact, depletion of Diaph1 and IQGAP1 significantly increased the amount of death 
when compared to Diaph1 siRNA alone (Figure 7-13). It could be that depleting 
IQGAP1 completely shuts down all Diaph1 nucleated actin, resulting in the increase 
in death seen. However, qPCR analysis and Western blot analysis revealed that 
Diaph siRNA gave ~94% knockdown in Diaph1 transcript and 95% knockdown in 
protein (Figure 7.1). Therefore, this hypothesis is unlikely. This therefore suggests 
that IQGAP1 may also play a role in regulation of Arp2/3 complex activity or in 
other important process in cell division.  
If NCKIPSD played a role as a Diaph1 inhibitor as reported in the literature 
(Eisenmann et al. 2007), then I would expect depletion of NCKIPSD should rescue 
Diaph1 depleted lines by relieving inhibition on the remaining Diaph1. Interestingly, 
the combination of NCKIPSD and Diaph1 did not significantly change in the total 
cell death when compared to Diaph1 alone (p=0.25). This further supported the role 
of NCKIPSD as a Diaph1 activator rather than an inhibitor. I did not co-deplete 
WAVE and Diaph1, because WAVE is well-known Arp2/3 activator and has not 
been reported to interact with Diaph1.  
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Figure 7-13 Diaph1 and NPF combined depletion affects progression through 
mitosis. When compared to cells transfected with IQGAP1 shRNA + NS siRNA, 
cells depleted in IQGAP1 and Diaph1 showed significantly increased rates of total 
cell death (**p<0.01). When compared to cells transfected with Diaph1 siRNA, cells 
depleted in IQGAP1 and Diaph1 showed significantly increased rates of total cell 
death (**p<0.01). When compared to cells transfected with NCKIPSD shRNA + NS 
siRNA, cells depleted in NCKIPSD and Diaph1 showed significantly increased rates 
of total cell death (**p<0.01). When compared to cells transfected with Diaph1 
siRNA, cells depleted in NCKIPSD and Diaph1 showed no significant difference in 
total cell death (p=0.25). Results were gathered from 3 independent experiments 
examining: non-silencing shRNA (n=399 cells), non-silencing shRNA + siRNA 
(n=256 cells), Diaph1 siRNA (n=185 cells), NCKIPSD shRNA (n=462), 
NCKIPSDsh + NSsi (n=402), IQGAP1 shRNA (n=528), IQGAP1sh + NSsi (n=385), 
Diaph1si + IQGAP1sh (n=200 cells), Diaph1si + NCKIPSDsh (n=742 cells). 
I then carried out double depletions with the Arp2/3 complex and NPFs. WAVE is a 
well-known Arp2/3 activator, thus I expected to see no change when combining 
ACTR2 and WAVE knockdowns. Co-depletion of ACTR2 and Nap1 showed no 
significant change in total cell death (Figure 7-14) when compared to ACTR2 
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depletion alone (p=0.33). This result confirms WAVE as a major interactor and 
activator of the Arp2/3 complex, and further adds to the data supporting this 
interaction in controlling Arp2/3 activity in the cortex.  
The double depletion of ACTR2 + NCKIPSD significantly increases total cell death 
when compared to the ACTR2 depletion alone (Figure 7-1). This is consistent with a 
role an activator of the Arp2/3 complex, and supports data from the other 
experiments suggesting that NCKIPSD acts via a different pathway. ACTR2 + 
NCKIPSD depletion is comparable to NCKIPSD alone; the additional depletion of 
ACTR2 does not potentiate the NCKIPSD phenotype. This again, supports the role 
of NCKIPSD acting via a pathway different to Arp2/3. The double depletion of 
IQGAP1 + ACTR2 appeared to significantly decrease overall cell death when 
compared to ACTR2 alone and IQGAP1 alone (*p<0.05). This suggests that a 
rescuing effect on the depletion of ACTR2. This does not support a role of IQGAP1 
in Arp2/3 activation, as its depletion has resulted in a decrease in cell death, rather 
than an increase. This suggests that IQGAP1, similar to NCKIPSD, acts via a 
different pathway to Arp2/3. Further work will be necessary to confirm this.  
From the NPF combinations with the Arp2/3 complex, it appears that NCKIPSD 
may be activating Diaph1 promoting actin nucleation and confirms that Nap1 acts as 
an NPF for Arp2/3. On the contrary, the combination depletions suggest that 
IQGAP1 does not play a role in Arp2/3 activation and its rescue effect on Arp2/3 
depletion warrants further study.  
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Figure 7-14 ACTR2 and NPF combined depletion affects progression through 
mitosis. When compared to cells transfected with siRNA, cells depleted in ACTR2 
siRNA + IQGAP1 shRNA showed significantly reduced rates of total cell death 
(**p<0.01). When compared to cells transfected with IQGAP1 shRNA + NS siRNA, 
cells depleted in ACTR2 siRNA + IQGAP1 shRNA showed significantly reduced 
rates of total cell death (*p<0.05). When compared to cells transfected with ACTR2 
shRNA + NS siRNA, cells depleted in ACTR2 shRNA + NCKIPSD siRNA showed 
increased reduced rates of total cell death (*p<0.05). When compared to cells 
transfected with NCKIPSD siRNA, cells depleted in ACTR2 shRNA + NCKIPSD 
siRNA showed no significant difference in total cell death (p=0.76). When compared 
to cells transfected with ACTR2 shRNA + NS siRNA, cells depleted in ACTR2 
shRNA + Nap1 siRNA showed no significant difference in total cell death (p=0.33). 
When compared to cells transfected with Nap1 siRNA, cells depleted in ACTR2 
shRNA + Nap1 siRNA showed significantly increased rates of total cell death 
(**p<0.01). Results were gathered from 3 independent experiments examining: non-
silencing shRNA (n=399 cells), non-silencing shRNA + siRNA (n=256 cells), 
ACTR2 shRNA (n=383 cells), ACTR2 siRNA (n=595), NCKIPSD siRNA (n=515), 
Nap1 siRNA (n=542), ACTR2sh + NSsi (n=507 cells), IQGAP1sh + NSsi (n=385), 
ACTR2si + IQGAP1sh (n=498 cells), ACTR2sh + NCKIPSDsi (n=325 cells), 
ACTR2sh + Nap1si (n=831 cells). 
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7.5.2 Total cell death in double NPF knockdown in HeLa cells 
In addition to co-depleting nucleator and NPF, I co-depleted two NPFs 
simultaneously. This could give some indication of the crosstalk that the NPFs may 
be involved in, especially with NCKIPSD and possibly with IQGAP1. Similar to the 
previous experiments, I used a stable shRNA line for silencing one NPF and silenced 
the other with the appropriate siRNA.  
I began with studying IQGAP1 in combination with NCKIPSD and Nap1. Based on 
the previous results, I expected to see no change in cell death when co-depleting 
NCKIPSD and IQGAP1 because they appear to act as NPFs for Diaph1, and possibly 
an increase in death when co-depleting Nap1 and IQGAP1. IQGAP1 + NCKIPSD is 
comparable to IQGAP1 alone but less death compared to NCKIPSD alone. It is 
possible that there is some rescue in this case, but it the combined depletion is not 
significantly different to IQGAP1 alone (Figure 7-15). This could indicate that 
NCKIPSD: 1) is working through Arp2/3 as an activator, albeit not a crucial NPF, or 
2) is working through Diaph1 as an inhibitor. If NCKIPSD is indeed acting as a 
Diaph1 inhibitor, when depleted Diaph1 returns to its active state and thus, no 
change is apparent from IQGAP1 depletion alone. Together, this certainly warrants 
further investigation of the role of NCKIPSD, and supports the strong possibility that 
NCKIPSD acts via both Arp2/3 and Diaph1 in a way not yet understood through 
these experiments. 
Next, the combination of IQGAP1 + Nap1 is comparable to IQGAP1 depletion 
alone, but significantly more death compared to Nap1 alone. This suggests that the 
combined NPF depletion has potentiated the Arp2/3 pathway, leading to a greater 
proportion of cell death.  
From the double NPF depletions, it appears that NCKIPSD may indeed be activating 
Arp2/3 promoting actin nucleation or even inhibiting Diaph1 as suggested in the 
literature. On the contrary, the NPF combinations further support WAVE as acting as 
an Arp2/3 complex activator.  
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Figure 7-15 Double NPF depletion with IQGAP1 affects progression through 
mitosis. When compared to cells transfected with NCKIPSD siRNA, cells depleted 
in IQGAP1 shRNA + NCKIPSD siRNA showed significantly reduced rates of total 
cell death (**p<0.01). When compared to cells transfected with IQGAP1 shRNA + 
NS siRNA, cells depleted in IQGAP1 shRNA + NCKIPSD siRNA showed no 
significant difference in total cell death (p=0.05). When compared to cells 
transfected with Nap1 siRNA, cells depleted in IQGAP1 shRNA + Nap1 siRNA 
showed significantly increased rates of total cell death (**p<0.01). When compared 
to cells transfected with IQGAP1 shRNA + NS siRNA, cells depleted in IQGAP1 
shRNA + Nap1 siRNA showed no significant difference in total cell death (p=0.23). 
Results were gathered from 3 independent experiments examining: non-silencing 
shRNA + siRNA (n=256 cells), IQGAP1 shRNA (n=528 cells), IQGAP1sh + NSsi 
(n=385 cells), NCKIPSD siRNA (n=515), Nap1 siRNA (n=542), IQGAP1sh + 
NCKIPSDsi (n=412 cells), IQGAP1sh + Nap1si (n=433 cells). 
Next, I combined NCKIPSD depletion with IQGAP1 and Nap1 knockdown to 
attempt further exploration of potential NCKIPSD crosstalk (Figure 7-16). Of the 
NPFs studied in this project, NCKIPSD has yielded the least consistent results, at 
times suggesting that it interacts with Diaph1 (possibly as an inhibitory interactor) 
and other times suggesting that it activates Arp2/3.  
In the previous graph, I discussed the combination of IQGAP1 and NCKIPSD 
depletion. NCKIPSD + Nap1 depletion results in an increase in cell death compared 
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to NCKIPSD alone and Nap1 alone. The combination of NCKIPSD + Nap1 led to a 
low significant increase (*p<0.05) in total cell death when compared to NCKIPSD 
knockdown alone, and this trend is worth looking at in more detail. From this NPF 
combination, it appears that NCKIPSD and Nap1 potentiate each other, and it is 
possible that the combination of both could completely shut down nucleation via 
Arp2/3. The total cell death with the depletion of both NCKIPSD + Nap1 is 
comparable to the death seen with ACTR2 alone; this could support NCKIPSD as an 
Arp2/3 activator. It is also important to consider that NCKIPSD may be working in a 
pathway different to that of Nap1, suggesting that in this instance, the increase in 
total cell death is a result of inhibition of the Diaph1 pathway. At this stage, the role 
of NCKIPSD is not understood.  
 
Figure 7-16 Double NPF depletion with NCKIPSD affects progression through 
mitosis. When compared to cells transfected with IQGAP1 shRNA + NS siRNA, 
cells depleted in NCKIPSD siRNA + IQGAP1 siRNA showed no significant 
difference in total cell death (p=0.05). When compared to cells transfected with 
NCKIPSD siRNA, cells depleted in NCKIPSD siRNA + IQGAP1 siRNA showed 
significantly reduced rates of total cell death (**p<0.01). When compared to cells 
transfected with Nap1 siRNA, cells depleted in NCKIPSD shRNA + Nap1 siRNA 
showed significantly increased rates of total cell death (**p<0.01). When compared 
to cells transfected with NCKIPSD shRNA + NS siRNA, cells depleted in NCKIPSD 
shRNA + Nap1 siRNA showed significantly increased rates of total cell death 
(*p<0.05). Results were gathered from 3 independent experiments examining: non-
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silencing shRNA + siRNA (n=256 cells), NCKIPSD shRNA (n=462 cells), 
NCKIPSD siRNA (n=515), IQGAP1 shRNA (n=528), Nap1 siRNA (n=542), 
IQGAP1sh + NSsi (n=385), NCKIPSDsh + NSsi (n=402 cells), NCKIPSDsi + 
IQGAP1sh (n=412 cells), NCKIPSDsh + Nap1si (n=402 cells). 
7.5.3 Cell cycle progression failure associated with IQGAP1 depletion is 
rescued by expression of the IQGAP1 Diaph1 binding domain 
The rescue construct discussed in this section, IQGAP1-DBR, was cloned and 
provided to me for cell line production by Dr. Guillaume Charras.  
To rescue cell deaths due to IQGAP1 depletion, I stably transfected shRNA resistant 
IQGAP1 constructs cloned from mouse IQGAP1 into my knockdown line. First, I 
attempted to make a rescue line using the full-length mouse IQGAP1 sequence. 
Unfortunately, I was unable to make a stable line with this construct. I then tried to 
make a rescue line with IQGAP1’s Diaph1 binding region (DBR) domain fused to 
GFP because much of my data suggested an interaction between IQGAP1 and 
Diaph1. I successfully made stable lines with the DBR rescue and imaged the cells 
overnight to study their progression through the cell cycle. The DBR was able to 
rescue the cell death observed in IQGAP1 depleted lines, with no significant 
difference in the rescue line when compared to the non-silencing control (Figure 
7-17). However, it must be noted that the appropriate control would be a cell line 
expressing IQGAP1shRNA and an empty rescue GFP-vector. For lack of time, this 
was not made. Nevertheless, the decrease in total cell death is evident, supporting the 
role of IQGAP1 as a Diaph1 activator in the actin cortex.  
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Figure 7-17 The Diaph1 binding region (DBR) domain rescues total cell death in 
IQGAP1 knockdown cells. When compared to IQGAP1 shRNA cells, cells rescued 
with the DBR showed a significant decrease in cell death (**p<0.01). There is no 
significant difference between non-silencing control cells and DBR rescue IQGAP1 
cells  (p=0.17), suggesting the DBR rescued the high death phenotype. Results were 
gathered from 3 independent experiments examining: non-silencing shRNA (n=399 
cells), IQGAP1sh (n=528 cells), IQGAP1sh + DBR rescue (n=377 cells). Data was 
analysed with a chi-squared test.  
7.6 Conclusion 
It is known that Arp2/3 and Diaph1 form different types of filaments that are 
required in different processes during cell division. The Arp2/3 complex forms 
branched filaments, whilst formins such as Diaph1 makes filaments well suited for 
contractility, giving the two nucleators independent roles suited to their function. 
Given the importance of Arp2/3 and Diaph1 in regulating cell cycle progression, I 
investigated the role of each candidate NPF in modulating nucleator activity during 
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the cell cycle. I hypothesised that depletion of NPFs would present results similar to 
the depletion of the corresponding nucleator. This investigation also aimed to 
understand the crosstalk between Arp2/3 and Diaph1 that NCKIPSD may be 
involved in.  
In my experiments, Flightless-I displayed no significant increase in death, consistent 
with its lack of effect on bleb size. Diaph1, IQGAP1 and NCKIPSD depletion 
increased the total percentage of cell deaths significantly. Sra1 and Nap1 depleted 
cells surprisingly did not phenocopy ACTR2 depletion with regards to total cell 
death in this experiment, however the cells exhibited other changes with regards to 
decreasing mitotic rounding time. It was also interesting to observe differences with 
regards to effect of depletion for different Arp2/3 subunits; ACTR2 depletion 
significantly increased total cell death, whilst depletion of ArpC2 did not have an 
effect on progression through the cell cycle. Importantly, the decrease in total cell 
death with the rescue of IQGAP1 with the Diaph1 binding region strongly supports 
IQGAP1 as a Diaph1 activator in the actin cortex.  
The investigation into rounding timing in knockdown cells showed that IQGAP1, 
Diaph1 and WAVE depletions caused cells to round significantly quicker than 
controls. On the other hand, NCKIPSD and ACTR2 depleted cells took significantly 
longer for the completion of rounding. Rounding requires the rapid disassembly and 
reorganisation of the actin cytoskeleton network, highlighting the importance of actin 
nucleators such as Diaph1 and the Arp2/3 complex. A decrease of such nucleators 
could have an impact on actin filament turnover, directly impacting the process of 
cell rounding during the cell cycle. To further investigate how the change in physical 
properties of the cortical network impacts actin nucleation, Malti Vaghela, a PhD 
student in the lab, has been interrogating the contribution of actin nucleation kinetics 
and myosin recruitment as a result of nucleator/NPF depletion. The results for this 
are discussed in detail later in the discussion. Together, these results help to support 
the role of IQGAP1 as a Diaph1 activator, WAVE as an Arp2/3 activator, and leaves 
NCKIPSD as an NPF still not completely understood.  
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Chapter 8 NPF depletion impacts cortical architecture of 
interphase HeLa cells 
I further probed the role of NPFs and nucleators in cortex architecture by 
investigating the impact of depletion or inhibition on cortex density and organisation 
in interphase HeLa cells. Identifying changes within the actin cortex organisation can 
potentially help determine how depletion of NPFs impacts processes such as cell 
division. The cortex is organised in a way that allows for cortical contractions, 
required densities, and thickness. The cortex organisation also dictates properties that 
affect the mechanics of the cortex, thus organisation has a great impact on its 
function. As the depletion of NPFs perturbs this tightly regulated process, I would 
expect to see a clear change in cortex organisation using electron microscopy.  
For this investigation, I prepared stable HeLa cells lines (control, ACTR2, ArpC2 
and IQGAP1) and drug treated cells (DMSO, CK666, SMIFH2, SMIFH2 + CK666, 
and LatrunculinB) for electron microscopy and imaged them. This allowed me to 
probe the molecular organisation of the cortex in these cells. The cortex of HeLa 
cells is heterogeneous, with long structures of well-aligned actin filaments, extending 
close to the periphery of spread interphase cells (Figure 8-1A, arrows). In between 
these long fibres are less organised and less dense filaments with no marked 
orientation (Figure 8-1A, asterisk). DMSO treated lines were imaged as a control and 
did not appear to have an impact on actin filament organisation. The long directional 
filaments are very clear (Figure 8-1B, arrows), and the lower density structures in 
between are still present (Figure 8-1A, asterisk). To observe the impact of actin 
depolymerisation, I treated the cells with latrunculin B, a drug that sequesters 
monomeric G-actin, stopping F-actin assembly. This drug disrupted the long aligned 
filament organisation of the actin cytoskeleton and caused aberrations to the usual 
spread interphase cell shape. Only single actin filaments were distinguishable (Figure 
8-1C, arrowheads). From the electron micrographs, it is evident that latrunculin B is 
a powerful disruptor of microfilament organisation, impacting all normal 
characteristics of the organisation of HeLa cells.  
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Figure 8-1 Scanning electron micrographs of the cortex of HeLa cells in 
interphase. A, The actin cortex of wild-type control cells features long bundles of 
directional actin filaments that can be followed along the spread cell (arrows), and in 
between connections of lower density (asterisk). B, The actin cortex of cells treated 
with 100uM DMSO appears to have no change compared to untreated wild-type 
cells. C, The actin cortex of cells treated with 750nM latrunculin B appears distorted, 
and all structures seen in the controls are lost. Single filaments are distinguishable 
(arrowheads). Scale bars: first column (10µm), second column (1µm), and third 
column (200nm). 
I then wanted to investigate the impact of nucleator inhibition upon actin filament 
organisation. Cells treated with CK666 appeared to have less long directional actin 
filament bundles compared to controls, however these were still clearly visible  
(Figure 8-2B, arrows). On the hand, SMIFH2 treated cells appeared to have a more 
dense and homogenous cortex without as the long aligned structures seen in the 
controls. The aligned regions are very short (Figure 8-2C, arrows), however there are 
some small interconnecting filaments visible in between the more structured regions 
(Figure 8-2C, asterisk). Possibly, the inhibition of formins, a linear actin filament 
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nucleator, results in more nucleation via the branched actin nucleator, Arp2/3. It is 
also important to remember that there are other actin nucleators that may also play a 
role in actin nucleation. The apparent increase in density may result from increased 
branching of actin filaments due to increased activity of the Arp2/3 complex. 
SMIFH2 treated HeLa cells also appeared to have lost the spread interphase cell 
shape integrity visible in the low magnification micrograph.  
Drug treatment with both CK666 and SMIFH2 resulted in a severe loss of the overall 
spread morphology, as seen in the low magnification image (Figure 8-2D). Cells 
appear shrunken with apparent changes in their shape. The organisation of the actin 
filaments appears to be patchy and single filaments can be identified within the 
loosely interconnected cortex. There are no long aligned regions as seen in the 
controls, and less so with single drug treatment. Single filaments can be identified 
(Figure 8-2D, arrowheads). Evidently, inhibition of CK666 and SMIFH2 had an 
impact upon the structure of the actin cortex, and thus explains the malfunctions in 
processes requiring proper cortex assembly such as cell division. Interestingly, 
previous work has shown that simultaneous inhibition of formins and Arp2/3 
resulted in high cell death (Bovellan, 2014).   
Based on the actin cortex aberrations observed in cells treated with CK666 and 
SMIFH2, I expected to see similar disorganisation in cells depleted of ACTR2, 
ArpC2 or IQGAP1. Depletion of ACTR2 (Figure 8-3B) or ArpC2 (Figure 8-3C) did 
not have a strong impact upon the organisation of the actin cortex. There were some 
changes in cell spreading in interphase as seen with CK666 treated cells. ArpC2 
depleted cells still displayed the long regions of highly aligned and bundled 
filaments, however ACTR2 depletion appeared to have slightly disjointed filaments. 
This is consistent with the notion that this highly aligned F-actin is nucleated by 
formins. In contrast to Arp2/3 subunit depletion, IQGAP1 knockdown cells appeared 
to have lost the regions of high filament alignment, and actin filaments were less 
organised, similar to SMIFH2 treatment (Figure 8-3D). This further supports 
IQGAP1 as an important NPF controlling the activation of Diaph1 and thereby the 
organisation of the cortex.  
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Figure 8-2 Scanning electron micrographs of membrane extracted HeLa cells in 
interphase. A, The actin cortex of 100µM DMSO treated cells, with well-aligned 
actin filaments bundles (arrows), and interconnecting regions with a lower density 
(asterisk). B, The actin cortex of 100µM CK666 treated cells appears to have lost 
filament directionality, with some remaining areas of directionality (arrows) and 
more areas of lower density (asterisk). C, The actin cortex of 10µM SMIFH2 treated 
cells appears more homogenous and regions of strong alignment (arrows) and high 
density seem to have disappeared (asterisk). D, The actin cortex of SMIFH2 + 
CK666 treated cells appears very patchy and cells have rounded. Very rarely are 
areas evidencing alignment visible (arrows); single filaments can be identified 
(arrowheads). Scale; first column (10µm), second column (1µm), third column 
(200nm). 
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Figure 8-3 Scanning electron micrographs of membrane extracted HeLa cells in 
interphase. A, The actin cortex of wild-type control cells features long aligned actin 
filament bundles that can be followed along the spread cell (arrows). B, The actin 
cortex of ACTR2 shRNA cells appears to have no changes in the organisation of the 
aligned bundles of filaments. C, The actin cortex of ArpC2 shRNA cells appears 
similar to the control cells, with some change in the spread morphology, but little 
change in the organisation of the cortex. D, The actin cortex of IQGAP1 shRNA 
cells appears to have lost the long aligned actin filament bundles. Scale; first column 
(10µm), second column (1µm), and third column (200nm). 
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Chapter 9 Identifying Diaph1 interactors using biotin 
identification (BioID) 
In July 2015, I was awarded a three-month Bogue Fellowship by the Department of 
Cell and Developmental Biology, funding a visit to the laboratory of Prof. Phillippe 
Roux at the IRIC of the University of Montréal. During my time in Montréal, biotin 
identification (BioID), a new and powerful proximity-dependent labelling approach 
was used to map novel interactions. Dr. Geneviève Lavoie carried out cloning of all 
BirA constructs. Antoine Meant generated all stable cell HeLa lines prior to the start 
of the project, and analysed the mass spectrometry data with SAINTexpress as 
detailed below. 
9.1 Validation of the BirA*-fusion protein in HeLa cells 
The wild type 35 kDa Escherichia coli (E. coli) bacterial protein, BirA, functions as a 
biotin protein ligase to regulate the biotinylation of an acetyl-CoA carboxylase 
subunit, as well as a DNA-binding transcriptional repressor for biotin biosynthesis 
(Roux et al. 2012). BirA recognises a stretch of 15 amino acids 
(GLNDIFEAQKIEWHE), known as the AviTag, with high specificity and catalyses 
the attachment of the cofactor, biotin, to the lysine residue (K) in this recognition 
site. However, a mutation of the arginine residue at position 118 to glycine (R118G) 
in BirA causes premature release of activated biotin (biotinoyl-AMP) that can readily 
react with primary amines from the mutated biotin ligase, BirA (R118G), resulting in 
the promiscuous biotinylation of proximal proteins (Choi-Rhee et al. 2004; Roux et 
al. 2012; Kwon & Beckett 2000). The BioID method uses this mutated BirA 
(R118G) and expresses it as a fusion to a bait protein of interest in live mammalian 
cells supplemented with biotin. Expression of this BirA (R118G)/bait fusion protein 
allows for the biotinylation of proteins that interact or come into close proximity 
with the bait in their natural environment. The practical labelling radius of 
promiscuous biotin ligases is an important experimental consideration since a large 
radius would predictably detect more proteins that may not be direct interactors of 
the bait; whereas conversely, a smaller radius would potentially limit detection of 
relevant protein interactors for a larger protein or a protein complex. Studies 
indicated the practical labelling radius of BioID is ~10 nm (D. I. Kim et al. 2014). 
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Cells can then be stringently lysed, and protein interactants can be denatured, 
captured via their biotin labels with high affinity on streptavidin-beads, and 
identified by MS or immunoblot analysis (Roux et al. 2012). 
HeLa cells were selected to stably express the BioID fusion constructs. The 
following HeLa cell lines were used for the BioID experiments: FLAG φ (no BirA*) 
control, BirA* control, BirA*-GFP control, Diaph1-BirA*, Diaph1ΔDAD-BirA*, 
Arp3-BirA* and ArpC4-BirA*. The baits were chosen to provide a non-biased 
approach that would complement the candidate-based approach I used in previous 
chapters. In the mutated (ΔDAD) Diaph1 construct, Diaph1 activity is constitutively 
activated due to the removal of autoinhibition by the DAD domain. Comparison 
between this construct and full length Diaph1 allows to find interactions that depend 
on activation, as Diaph1 is only activated once the DID-DAD interaction is relieved. 
Arp3 and ArpC4 were chosen as important subunits of the Arp2/3 complex.  
The goal of BioID was to identify proximity interactions in the normal context of a 
target protein, hence it was necessary to validate the biotinylation activity of the 
BirA*-fusion protein. Before carrying out large-scale BioID experiments, the BirA* 
stable cell lines were first characterised by western blotting (using streptavidin-
HRP). I induced BirA expression using tetracycline for 0, 4, 8, 12, and 24 hours to 
determine the best duration for protein induction and to check the plasmid 
expression. I then added the substrate, biotin, for different durations to establish how 
is needed to obtain a sufficiently strong biotinylation signal, and to see the pattern of 
biotinylation. This is essential to the success of the method, so it was investigated 
first.  
As expected, there was no biotinylation in the FLAG φ control line, as this construct 
was devoid of BirA* (Figure 9-1). The other two controls, BirA and BirA-GFP were 
induced as expected, and showed a pattern of biotinylation, most strongly in the 
BirA-GFP line. It is also important to note the expected shift in size of the BirA 
construct with the addition of GFP (27kDa), compared to BirA alone. It seems 
apparent that BirA-GFP interacts with more proteins than BirA. Previous studies 
have shown that the tethering of GFP has no effect on BirA activity; it is possible 
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that the difference here is due to non-specific protein binding to the large GFP 
protein and not related to the cell line.  
 
Figure 9-1 Detection of protein biotinylation by Western blot. HeLa BirA* fusion 
cell lines (FLAG φ, BirA, BirA-GFP, Arp3-BirA, ArpC4-BirA, Diaph1-BirA and 
Diaph1ΔDAD-BirA) were induced with 1µg/mL tetracycline for 24 hours and 
supplemented with 50µM biotin for 24 hours (+tet/+biotin). Induced proteins were 
probed with FLAG, and biotinylated proteins were detected with HRP-streptavidin. 
Tubulin was used as a loading control.  
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Of the baits examined, ArpC4 demonstrated the broadest range of biotinylated 
proteins whilst Arp3 demonstrated the narrowest. It has been shown that ArpC4 is 
critical for Arp2/3 complex activity as it mediates binding to F-actin (Goley et al. 
2010). Mutation of residues within ArpC4 can compromise actin polymerisation 
activity, and reduce F-actin affinity. On the contrary, Arp3 is located within the 
centre of the Arp2/3 complex, and is not required for formation of the daughter 
filament nucleus (Liu et al. 2013). Having said that, both subunits are important for 
the function of the Arp2/3 complex and the results yielded in this initial BioID test 
may present a difference due to experimental issues as opposed to biochemical 
functions.  
9.2  Identifying interacting proteins by mass spectrometry  
Through this initial characterisation, the BirA*-fusion proteins were validated in 
HeLa cells and I was able to upscale the experiment from testing 1 million cells in 6-
well plates to testing 20 million cells pooled from two 10 cm dishes. The BioID 
experiment was repeated three times, and proteins identity determined by SAINT to 
be high confidence interacting partners were analysed to create a list of top 
candidates. 
In the case of ArpC4 and Arp3 (Figure 9-2, Figure 9-3), the entire Arp2/3 complex 
was identified, validating the approach. In addition, some new interactors were 
identified, however the majority of these were chaperones (all the TCP1/cpn60 
chaperonin family proteins - CCT1-8). There were also folding proteins (NOB1), G-
proteins (GNB4), and transcriptional activators (CHURC1) amongst those detected.  
I represented these results graphically using STRING analysis.  
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Figure 9-2 BioID string analysis of ARPC4 interactors. Mass spectrometry 
analysis of endogenous proteins that are in close proximity to ARPC4, determined by 
mass spectrometry isolated with streptavidin-coupled magnetic beads. The entire 
Arp2/3 complex was identified. Lines between proteins represent known interactions 
(determined via curated databases or experimentally) and predicted interactions 
(determined via gene fusions, gene neighbourhoods and gene co-occurrence). Small 
nodes represent proteins of unknown 3D structure and large nodes represent proteins 
with some known 3D structure. All candidates displayed have a SAINT score > 0.75 
and STRING analysis was performed at the high confidence interval.  
Table 9-1 ARPC4 interactors identified by BioID, Avg(P) score and function. 
Avg(P) represents the probability of a true interaction between the two proteins, prey 
and bait. Preys with an Avg(P) >0.85 are conserved and considered as good potential 
interactors. The other prey is discarded, as they are likely the result of non-specific 
interactions. 
Protein Avg(P) 
Score 
Function 
USP8 0.87 Removes conjugated ubiquitin from proteins, preventing 
degradation. Involved in endosomal dynamics, cargo sorting and 
membrane trafficking.  
CHURC1  1 Transcriptional activator with role in regulation of cell movement. 
ZFC3H1 0.84 Involved in RNA binding, protein coding gene. 
ARPC4 bait 
Arp2/3 complex subunits 
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Figure 9-3 BioID string analysis of ACTR3 interactors. Mass spectrometry 
analysis of endogenous proteins that are in close proximity to ACTR3, determined 
by mass spectrometry isolated with streptavidin-coupled magnetic beads. The 
majority of hits were chaperone proteins, and the entire Arp2/3 complex. Lines 
between proteins represent known interactions (determined via curated databases or 
experimentally) and predicted interactions (determined via gene fusions, gene 
neighbourhoods and gene co-occurrence). Small nodes represent proteins of 
unknown 3D structure and large nodes represent proteins with some known 3D 
structure. All candidates displayed have a SAINT score > 0.75 and STRING analysis 
was performed at the high confidence interval.  
ACTR3 bait 
Arp2/3 complex subunits 
chaperone proteins 
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Table 9-2 Arp3 interactors identified by BioID, Avg(P) score and function. 
Avg(P) represents the probability of a true interaction between the two proteins, prey 
and bait. Preys with an Avg(P) >0.85 are conserved and considered as good potential 
interactors. The other prey is discarded, as they are likely the result of non-specific 
interactions. 
Protein Avg(P) 
Score 
Function 
CCT1-8 1 Molecular chaperones, assists in folding of proteins upon ATP 
hydrolysis. Plays a role in the folding of actin and tubulin. 
PDCL3 0.81 Modulator of G-proteins.  
GNB4 0.87 Integrates signals between receptors and effector proteins.  
PFDN1 1 Part of a molecular chaperone complex that binds and stabilises 
newly synthesised polypeptides, allowing them to fold correctly.  
NOB1 0.97 Cofactor required for ribosome assembly, orchestrating modification 
and cleavage of the transcript.  
PPP4R1 0.97 Regulator of PP4, a critical regulator of tumour-necrosis factor 
(TNF).  
 
BioID with Diaph1 and Diaph1ΔDAD led to very different results between the two 
forms. There were only three interactors found for full length Diaph1 (Figure 9-4) 
compared to 71 interactors identified for the ΔDAD mutant (Figure 9-5). From the 
results, it seems that the Diaph1 protein interacts with fewer preys due to being in its 
auto-inhibited closed conformation. As expected, this doesn’t appear to be the case 
for the mutant form, which lacks the ability to auto-inhibit. 
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Figure 9-4 BioID string analysis of Diaph1WT interactors. Mass spectrometry 
analysis of endogenous proteins that are in close proximity to Diaph1WT, 
determined by mass spectrometry isolated with streptavidin-coupled magnetic beads. 
Proteins identified have no known interaction network with Diaph1WT. All 
candidates displayed have a SAINT score > 0.75 and STRING analysis was 
performed at the high confidence interval.   
Table 9-3 Diaph1WT interactors identified by BioID, Avg(P) score and 
function. Avg(P) represents the probability of a true interaction between the two 
proteins, prey and bait. Preys with an Avg(P) >0.85 are conserved and considered as 
good potential interactors. The other prey is discarded, as they are likely the result of 
non-specific interactions. 
Protein Avg(P) 
Score 
Function 
SNX2 0.97 Component of a complex with a role in protein sorting in the 
endocytic pathway.  
CXCL9 0.95 Antimicrobial gene involved in T cell trafficking.  
SOWAHC 1 Protein coding gene.  
 
The ΔDAD mutant, in particular, identified a number of proteins known to interact 
with the cell membrane (EFR3A, KIRREL) and involved in Cdc42-mediated 
reorganisation of the cortex (BAIAP2). BAIAP2, also known as IRSp53, has been 
shown to directly interact with Diaph1 and WAVE2 (Goh et al. 2012; Fujiwara et al. 
2000), and further acts to regulate actin dynamics through signalling via the 
Diaph1WT bait 
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protruding membrane and underlying actin cytoskeleton (Disanza et al. 2006). 
FERMT2, also known as mig-2, kindlin-2, pleckstrin domain protein-2, was another 
top ΔDAD mutant interactor. FERMT2 shares close amino acid homology with 
proteins shown to initiate Rac signalling and actin filament reorganisation. Previous 
research showed that loss of FERMT2 resulted in a defect in the cellular control of 
shape change and cytoskeletal organisation (Tu et al. 2003). Another interesting hit 
was PHACTR4, a well-studied group of proteins that bind actin and protein 
phosphatase 1 (Allen et al. 2004). PHACTR4 is known to regulate the phosphatase 
activity of PP1 under the control of actin (Huet et al. 2013) by eliciting 
mechanistically different responses to maintain cellular actin balance through cofilin 
activity. Overall, the proteins identified were interesting, and expanded the inventory 
of actin-binding proteins for further study. 
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Figure 9-5 BioID string analysis of Diaph1ΔDAD interactors. Mass spectrometry 
analysis of endogenous proteins that are in close proximity to Diaph1ΔDAD, 
determined by mass spectrometry isolated with streptavidin-coupled magnetic beads. 
Lines between proteins represent known interactions (determined via curated 
databases or experimentally) and predicted interactions (determined via gene fusions, 
gene neighbourhoods and gene co-occurrence). Small nodes represent proteins of 
unknown 3D structure and large nodes represent proteins with some known 3D 
structure. Arrowheads point to proteins selected for further study as potential NPFs. 
All candidates displayed have a SAINT score > 0.75 and STRING analysis was 
performed at the high confidence interval.   
 
Diaph1ΔDAD bait 
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Table 9-4 Diaph1ΔDAD interactors identified by BioID, Avg(P) score and 
function. Avg(P) represents the probability of a true interaction between the two 
proteins, prey and bait. Preys with an Avg(P) >0.85 are conserved and considered as 
good potential interactors. The other prey is discarded, as they are likely the result of 
non-specific interactions. 
Protein Avg(P) 
Score 
Function 
KIRREL 0.99 Significant role in the development and function of the 
glomerular permeability.  
BAIAP2 0.97 Involved in signal transduction pathways that link deformation of 
the plasma membrane and remodelling of the actin cytoskeleton.  
PVRL3 1 Involved in the formation of cell-cell junctions, including 
adherens junctions and synapses. 
MARK2 0.94 Important regulator of cell polarity in neuronal cells, and also 
controls the stability of microtubules through phosphorylation. 
IFITM3 0.84 Inhibits the entry of viruses to the host cell cytoplasm by 
preventing viral fusion with cholesterol-depleted endosomes. 
PHACTR4 1 Required for neural tube and optic fissure closure, and enteric 
neural crest cell (ENCCs) migration during development. 
ITGAV  1 Receptors for vitronectin, cytotactin, fibronectin, fibrinogen, 
laminin, osteomodulin, prothrombin, thrombospondin and vWF. 
ROBO1 1 Member of the immunoglobulin gene superfamily and encodes an 
integral membrane protein that functions in axon guidance and 
neuronal precursor cell migration. 
NOTCH2  1 Evolutionarily conserved intercellular signalling pathway, which 
regulates interactions between physically adjacent cells. 
SOWAHC 1 Protein coding gene.  
FERMT2 1 Scaffolding protein that enhances integrin activation. 
JAG1 0.87 Involved in cell-fate decisions during hematopoiesis. Involved in 
early and late stages of mammalian cardiovascular development. 
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The main motivation for carrying out BioID with Diaph1 and Arp2/3 was to explore 
a new unbiased proximity-labelling method to find interactors of the Arp2/3 complex 
and Diaph1 and identify potential new NPFs. Through my research, two regulators 
IQGAP1 and NCKIPSD reported to interact with both Arp2/3 and Diaph1, have 
displayed phenotypes similar to Diaph1 depletion in a number of different 
experiments. Thus, I expected IQGAP1 and/or NCKIPSD to be detected in the BioID 
results. Surprisingly, neither IQGAP1 nor NCKIPSD were detected in the three 
BioID repeats. However, it is important to remember that there are many limitations 
to BioID. Generally, BioID is an applicable method to screen for both interacting and 
neighbouring proteins in their native cellular environment. However, the efficacy of 
BioID is contingent upon the ability to biotinylate neighbouring proteins, which is in 
turn dependent on the number and availability of primary amines in these proteins as 
well as the abundance of the proteins themselves. Consequently, the level of 
biotynalisation of a protein is not a direct indicator of the strength or frequency of an 
association. Similarly, the absence of biotinylation does not rule out interaction or 
proximity (Roux et al. 2012). Furthermore, it is possible that an interacting protein 
may be associated with the target in low concentrations, hence may be overlooked by 
mass spectrometry given the breadth of potential candidates (this is called a false 
negative). Most importantly, BioID-mediated biotinylation cannot be used to validate 
an actual protein interaction, but instead should be used as a screen to identify 
candidates that can be subsequently investigated systematically or in a hypothesis-
based manner. Another methodical issue to consider is that the protein is probed over 
the whole cell for 24 hours. Thus, if the protein is only relevant in one part of the cell 
and one part of the cell cycle, it will likely be less biotynalated than a protein 
necessary throughout the cell cycle. Given the mechanism of BioID, biotinylated 
proteins can be placed into three categories; (i) direct interactions, either transient or 
stable, (ii) indirect interactions, or (iii) vicinal proteins that do not interact directly or 
indirectly.  
A further goal is to explore the importance of the identified proteins in a given stage 
of mitosis. This could be done by synchronising cells with a drug that block cells at a 
given stage for several hours, before adding biotin for two hours, then collecting 
cells to identify interacting proteins during this specific cell cycle stage. It would be 
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interesting to see if known cell-cycle regulating proteins would be recognised, and to 
see if new proteins are revealed.  
9.3 Depletion of BioID NPF candidates, BAIAP2 and MARK2, increase total 
cell death 
To study the role of proteins identified in the Diaph1ΔDAD BioID, I assessed their 
impact of depletion on cell cycle progression in HeLa cells. In previous work, 
Diaph1 depletion led to a significant increase in cell death during the cell cycle 
(Bovellan et al. 2014). Due to time limitations, I was able to generate only two stable 
knockdown shRNA lines in HeLa cells: MARK2 and BAIAP2 (Figure 9-6). These 
proteins were chosen as they presented a high abundance in the BioID screen for 
interacting with Diaph1ΔDAD and there is evidence in the literature to suggest that 
they interact with actin nucleators.  
 
Figure 9-6 Validation of protein depletion in HeLa cells. mRNA transcript 
abundance of BAIAP2 and MARK2 shRNA using qPCR; this revealed high 
depletion in BAIAP2 (83% knockdown) and MARK2 (82% knockdown) in stable 
knockdown HeLa cell lines. 
The SH3 domain of BAIAP2, also known as IRSp53, has been reported to directly 
bind to Diaph1 via its FH1 domain (Fujiwara et al. 2000). It has been suggested that 
BAIAP2 may be a downstream effector of Diaph1, mediating part of the RhoA-
Diaph1 signalling pathway, implicated in stress fiber formation and cytokinesis 
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(Watanabe et al. 1999). Other studies show that BAIAP2 interacts with Eps8, an 
actin capper that is capable of regulating actin-based motility (Disanza et al. 2004), 
triggering a specific pathway required for the expression of cyclin D1, an important 
cell cycle driver during interphase (Liu et al. 2010). Moreover, BAIAP2 knockdown 
reduced cyclin D1 expression and resulted in the impediment of G1-phase cell cycle 
progression. Previous studies have associated MARK2 with changes in aspects of 
cell polarity (Cohen & Müsch 2003), an important feature of eukaryotic cells in 
particular during the final stage of cell division (Hehnly & Doxsey 2012). 
 
Figure 9-7 Live cell imaging of silenced HeLa cells using phase contrast 
microscopy. Control cells progress through the cell cycle as normal, abandoning the 
flat morphology of interphase, then advance through the stages of mitosis before cell 
cleavage and abscission where the daughter cells separate. BAIAP2 shRNA (see 
Vid11, USB) cells appear less spread in interphase with the presentation of large 
blebs during mitosis (arrowhead). MARK2 shRNA (see Vid12, USB) cells were very 
blebby during mitosis, with many cells dying at this stage. 
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Individual shRNA depletion of BAIAP2 and MARK2 had a significant effect on 
normal progression through cytokinesis (Figure 9-7, Figure 9-8, see Vid11/Vid12). 
Cells devoid of BAIAP2 demonstrated a similar proportion of total cell death (50%) 
in comparison to Diaph1 siRNA (58%). MARK2 depleted cells also failed to 
progress through the cell cycle as normal with 35% of cells failing to complete 
cytokinesis, a significant increase compared to NS shRNA but less significant than 
BAIAP2 depletion. These results suggest that BAIAP2 and MARK2 have an 
important role to play in the normal progression of the cell cycle in HeLa cells. Cells 
of both depletions displayed large blebs during telophase (Figure 9-7), with many 
failing before cytokinesis.  
 
Figure 9-8 Actin-binding protein depletion affects progression through the cell 
cycle. When compared to cells transfected with non-silencing shRNA/siRNA, cells 
depleted in Diaph1, BAIAP2 or MARK2 showed significantly increased rates of cell 
death (**p<0.01). When compared to Diaph1 depletion, BAIAP2 depleted cells were 
not significantly different in proportion of total cell death (p=0.07), however, 
MARK2 depleted cells were significantly different in number of cells able to 
progress successfully through the cell cycle (**p<0.01). Results were gathered from 
3 independent experiments examining: non-silencing shRNA (n=936 cells), non-
silencing siRNA (n=178 cells), Diaph1 siRNA (n=200 cells), BAIAP2 shRNA 
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(n=348 cells), and MARK2 shRNA (n=300 cells). Data was analysed with a chi-
squared test.  
For further analysis, I classified my data according to the exact cell cycle stage that 
depleted cells were unable to progress beyond. In control conditions (NS 
shRNA/siRNA), the majority of cells that failed to progress through the cell cycle 
died during mitosis (Figure 9-9). Approximately 80% of cells that died were able to 
pass through interphase but not through mitosis. Interestingly, the majority of Diaph1 
depleted cells ‘snap’ into death from their spread interphase state, whilst other cells 
bleb profusely before death.  
 
Figure 9-9 Actin-binding protein depletion affects progression through the cell 
cycle and interrupts it at different stages. Distribution of cell deaths as a function 
of cell cycle stage. Cells depleted of BAIAP2 show an almost equal death in mitosis 
as interphase, whilst cells depleted in MARK2 show a significant skew towards cells 
dying in mitosis compared to interphase. Results were gathered from 4 independent 
experiments examining: non-silencing shRNA (n=936 cells), non-silencing siRNA 
(n=178 cells), ACTR2 shRNA (n=611 cells), Diaph1 siRNA (n=200 cells), BAIAP2 
shRNA (n=348 cells), MARK2 shRNA (n=300 cells). 
BAIAP2 depleted cells presented an almost equal percentage of cells that died in 
mitosis as in interphase. Of those that died in mitosis, a high proportion (75%) of 
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cells failed at prophase, whilst the rest failed at metaphase (25%). On the other hand, 
the majority of MARK2 depleted cells died in mitosis (70%). Interestingly, there was 
a difference in the exact mitotic stage at which death occurred in MARK2 depleted 
cells: 65% failed at prophase, 25% failed at metaphase, 1% failed at metaphase, 5% 
failed at telophase and the rest died after cytokinesis but before spreading. In both 
knockdowns, most cells that died during mitosis failed to progress past prophase, 
suggesting there may be an important checkpoint that MARK2 and BAIAP2 
participate in during normal cell cycle progression.  
The reported interaction between BAIAP2 and Diaph1 could explain the similar 
pattern of cell death observed in the long-term depletion experiments. Overall, the 
literature suggests that BAIAP2 is an important protein required for actin-myosin 
dependent processes, including mitosis, cytokinesis and cytoskeletal reorganisation. 
Thus, the increased failure to progress through the cell cycle in HeLa cells is 
somewhat understandable. Unpublished data has also shown that BAIAP2 is 
upregulated 2-fold during the M-phase, further supporting its role in maintaining the 
cell cycle. Although not much is known about MARK2 and its direct role in actin 
nucleation or cytokinesis, it could be a component of the orderly establishment of 
cell polarity (Ducharme et al. 2006). This role may explain why my results show an 
increase in cell death with MARK2 protein depletion.  
9.4 Conclusion 
BioID is an alternative to more established protein-protein interaction assays such as 
affinity purification. Although extremely useful, such conventional techniques carry 
significant barriers that can result in erroneous and incomplete datasets (Roux et al. 
2012). These limitations include the loss of protein due to protein insolubility or the 
lack of studying an interaction in its proper cellular environment. To help identify 
interacting proteins of Diaph1 and/or Arp2/3, I carried out BioID. BioID labels 
proteins within living cells, and has thus proved effective when applied to insoluble 
proteins (Mehus et al. 2016; Firat-Karalar & Stearnsx 2015; D. I. Kim et al. 2014).  
Although in my BioID experiment, the expected IQGAP1-Diaph1 interaction was 
not observed as it narrowly missed significance, there have been recent 
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improvements to the BioID methods, centred on BioID2, a substantially smaller 
promiscuous biotin ligase. BioID2 enables more-selective targeting of fusion 
proteins, requires less biotin supplementation, and exhibits enhanced labelling of 
proximate proteins (Kim et al. 2016). BioID2 also improves localisation of its fusion 
protein, and even permits the modification of biotinylation range through a flexible 
linker. Possibly, with this new improved BioID2 system, the IQGAP1-Diaph1 
interaction will be revealed. 
A few new and promising candidate proteins NPFs that were highly abundant close 
to the Diaph1 mutant were identified: PHACTR4, MARK2, KIRREL3, BAIAP2 and 
FERMT2. Both MARK2 and BAIAP2 depletion interrupted the normal cell cycle 
progression. Interestingly, the crystal structure of BAIAP2 reveals a helical coiled-
coil domain, shown to possess actin filament bundling ability (Millard et al. 2005). It 
is also thought to have a further role in binding to WAVE2 through its SH3 domain 
(Liu et al. 2010). Taken together, these findings suggest that the BAIAP2-Diaph1 
system plays an important role in cytokinesis through mediating crosstalk between 
the formin cortical actin and the Arp2/3-nucleated cortical actin; however further 
study will be required to certify the interaction and localisation in the cortex. It will 
be necessary to repeat these experiments with siRNA depletion to validate the 
results, and to carry out some combination depletion experiments to see if the effect 
could be potentiated. Given more time, it would also be interesting to study the 
cortical architecture of M2 cells depleted of these BioID hits to determine if they lie 
upstream or downstream of Diaph1.   
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Chapter 10 Discussion 
Malti B. Vaghela, a PhD student from my group, carried out all actin accumulation 
and myosin localisation experiments discussed in this chapter using cell lines that I 
generated and validated using Western blotting and qPCR.  
10.1 Outline 
Cells need to change their mechanical properties and cortical organisation to change 
shape during the cell cycle and for migration. Recent work has shown that as cells 
enter mitosis their cortical tension increases (Chugh et al. 2017). Concomitantly, 
their cortical thickness decreases. Computational simulations have indicated that this 
surprising result may stem from overall changes in cortical actin filament lengths 
between interphase and metaphase. These models further indicate that tension shows 
an optimum for a given filament length and that any variation from this leads to a 
decrease in tension. In support of this interpretation, proteins involved in actin 
filament nucleation and turnover either increased or decreased cortical thickness but 
all gave rise to a decrease in cortical tension (Chugh et al. 2017) This suggests that 
controlling cortical actin filament length may represent an efficient way for cells to 
change their cortical tension for mitosis or migration. One way in which cells could 
regulate the length of filaments within the cortex is through control of the activity of 
actin nucleators in the cortex. Recent work has identified two main nucleators within 
the cortex: the Arp2/3 complex and the formin Diaph1 (Bovellan et al. 2014). 
Furthermore, depletion of Diaph1 led to a thinner actin cortex and a lower cortical 
tension (Chuch et al., 2017). Previous work examining the regulation of the activity 
of Diaph1 and the Arp2/3 complex has shown that it is controlled by RhoGTPases 
either directly or indirectly (Watanabe et al. 1997; Jaffe & Hall 2005; Symons 1996; 
Aoki et al. 2016; Tominaga et al. 2000). Nucleation promotion factors (NPFs) are 
required for the proper spatial and temporal control of actin assembly in cells (Duleh 
& Welch 2010). It is thought that RhoGTPase-dependent activation is transient and 
other factors are involved in activating and stabilising the active conformation (Seth 
et al. 2006); and may play a crucial role in ensuring a long-lasting nucleation.  
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Proteomic analysis revealed the presence of several NPFs in the actin cortex of 
blebs: Flightless-I, NCKIPSD, IQGAP1 (Biro et al. 2013) and WAVE complex 
subunits (Nap1 and Sra1) (Bovellan et al. 2014). I conducted a literature search to 
investigate their known roles in modulating actin nucleation via either Arp2/3 or 
Diaph1 (Figure 10-1). Once activated by Rac1, the WAVE complex is known to 
nucleate actin filaments via the Arp2/3 complex (Campellone & Welch 2010). 
IQGAP1 has been reported to interact with N-WASp/WAVE (Le Clainche et al. 
2007). IQGAP1 has also been shown to interact with the formin Diaph1 (Brandt et 
al. 2007) to prevent inactivation of its interactor, stabilising its nucleation activity. 
NCKIPSD has been reported to interact with both diaphanous-related formins as a 
negative regulator (Eisenmann et al. 2007) and the Arp2/3 complex as an activator 
(Wagner et al. 2013). Flightless-I is thought to interact with formins to prevent 
autoinhibition following activation by RhoA (Higashi et al. 2010). Thus, these NPFs 
all appeared to be promising candidates for controlling and coordinating the activity 
of cortical actin nucleators and may therefore play a role in controlling the length and 
organisation of actin filament networks as well as cortical tension.  
 
Figure 10-1 Schematic of potential interactions between NPFs and cortical 
nucleators. Based on the literature, the following interactions are grouped into those 
that activate nucleation via the Arp2/3 complex, and those that activate nucleation 
via Diaph1. There is evidence for NCKIPSD and IQGAP1 interacting with both 
 185 
Arp2/3 and Diaph1, although the interaction between NCKIPSD and Diaph1 is 
thought to be inhibitory.   
The goal of my thesis was to understand how NPFs function in modifying cortex 
organisation, dynamics and mechanical properties. Based on previous work, it was 
possible to interrogate the possible pathway that an NPF works through, by 
comparing its depletion to the depletion of Arp2/3 or Diaph1. In this thesis, both M2 
and HeLa cells were used. M2 melanoma blebbing cells provide a snapshot into the 
cortex life cycle whilst cervical cancer HeLa cells present a well-defined cortex 
during mitosis and are an accepted model for cell division studies.  
First, the localisation of the NPFs was determined in M2 and HeLa cells using 
immunostaining and live imaging of full-length GFP-tagged constructs. I confirmed 
that NPFs localised to the cell cortex. Then, to assess the involvement of each NPF 
in generation of cortical actin, the size distribution of blebs generated by stable M2 
lines depleted of each NPF was determined. Previous work has shown that changes 
in bleb size reflect changes in the rate of cortical actin regrowth under the bleb 
membrane with increases in growth rate associated with small blebs and decreases 
associated with large blebs (Bovellan et al. 2014). Arp2/3 subunit depletions result in 
small blebs and fast regrowth, whereas Diaph1 depletion resulted in large blebs and 
slow regrowth. To link cellular scale observations to molecular level mechanisms, I 
then examined how NPFs controlled cortical organisation under the membrane of 
M2 cell blebs and in HeLa cell cortex using scanning electron microscopy. Previous 
work showed that depletion of Diaph1 led to large gaps within the cortex, while 
Arp2/3 depletion led to apparently longer filaments but no clear change in actin 
filament density (Bovellan et al. 2014).  
To examine the role of NPFs in actin polymerisation activity, Malti Vaghela used a 
regrowth assay where blebs were artificially triggered by ablating the cortex or a 
HeLa cell arrested in metaphase. F-actin regrowth was imaged under the bleb 
membrane and the actin regrowth rate was determined (Figure 10-2).  
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Figure 10-2 Laser ablation methods and analysis. A, Cortex regrowth in a bleb 
induced in a rounded HeLa cell. Scale bar: 10µm. Ablation at t = 0s. Addition of 
Alexa Fluor 568 allows for reliable cell body-bleb segmentation. B, HeLa cells 
stably express actin-GFP. Turquoise line: outer cortex boundary; red line: inner 
cortex-cytosol boundary; orange line: bleb neck. C, Temporal evolution of the mean 
fluorescence intensity of cortical actin (marked with actin-GFP) at the bleb cortex, 
normalised to the mean cortical fluorescence intensities in the cell body (pink), and 
temporal evolution of the bleb size, normalised to the cell body (blue).  
After having confirmed the impact of NPF depletion on actin regrowth dynamics, I 
next assessed the impact of NPF depletion on cell cycle progression in HeLa cells. In 
previous work it was shown that Diaph1 depletion led to a significant increase in cell 
death during the cell cycle, whereas Arp2/3 depletion did not (Bovellan et al. 2014). 
Combination of Arp2/3 depletion and Diaph1 depletion led to an increase in cell 
death compared to Diaph1 alone. Lastly, Malti Vaghela also examined the 
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enrichment of cellular phosphomyosin (pMLC) in NPF or nucleator depleted cells. 
The aim of this experiment was to further understand if the changes in cortical 
mechanics induced by NPF depletion was a result of myosin delocalisation away 
from the cortex. It was hypothesises that this change in mechanics could come from 
changes in thickness of the cortex or changes in myosin recruitment, as formins 
make filaments that are better substrates for myosin contractility.  
The approaches detailed above allowed us to examine how Flightless-I, IQGAP1, 
NCKIPSD and the WAVE complex regulate actin filament nucleation in the cortex 
via Diaph1 or Arp2/3, or both. Aside from the WAVE complex, the other NPFs are 
not well characterised in their interactions with Arp2/3 or Diaph1 to promote (or 
inhibit) actin nucleation in the cortex. Considering the importance of the actin cortex 
during processes involving shape change such as cytokinesis, cell locomotion and 
tissue morphogenesis, further study of the control of cortical nucleators is warranted. 
10.2 How is the activity of Diaph1 regulated by NPFs? 
In its autoinhibitory ‘resting’ state, Diaph1 does not possess actin-nucleating activity, 
requiring activation by Rho GTPases. However, it is thought that RhoGTPase-
dependent activation is transient and other factors are involved in activating and 
stabilising the active conformation (Seth et al. 2006). Interactions with NPFs such as 
Flightless-I (Higashi et al. 2010), IQGAP1 (Brandt et al. 2007), and/or recruitment 
by the Abelson interactor 142 (Abl1, a component of the WAVE complex) have been 
suggested as possibly working together with Rho to activate Diaph1 and maintain it 
active by stabilising the relieved open conformation of Diaph1. RhoGTPases are far 
outnumbered by their substrates, thus NPFs may play a crucial role in ensuring a 
long-lasting nucleation activity. NCKIPSD has been shown to negatively regulate 
formins suggesting a novel role for the control of actin dynamics by NCKIPSD 
(Eisenmann et al. 2007). 
Fli-I depletion did not appear to change bleb size in M2 cells or change progression 
through the cell cycle in HeLa cells, as hypothesised based on its proposed 
interaction with Diaph1 (Higashi et al. 2010). It is well known that actin nucleators 
such as the formin family have multiple binding partners that result in their 
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activation. Thus, it is possible that Fli-I has a biologically redundant role in the 
cortex, and its depletion is overcome by the interaction of other activating proteins to 
enable normal activity of Diaph1. Fli-I may also act at a specific stage of the cell 
cycle (e.g. in cell division) such that the appearance of blebs in interphase cells as a 
reporter is not a sufficient to indicate its function. Based on these experimental 
results, I decided not to pursue study of Fli-I further.  
In blebbing assays, I found that IQGAP1 depletion and NCKIPSD depletion both 
had phenotypes associated with large blebs, suggesting that they primarily affect 
Diaph1 activity. Large blebs could either be due to slow regrowth or due to an 
increase in contractility. Arp2/3 depletion gives rise to a small bleb phenotype and an 
increase in contractility (unpublished research by Malti Vaghela), indicating that 
changes in bleb size correlate with slower cortical actin regrowth rate rather than a 
change in contractility. Malti Vaghela carried out a regrowth assay where bleb 
formation was induced in a controlled manner by laser ablation of the cortex in HeLa 
cells. The assay follows progression of bleb growth, arrest, and retraction and 
linescans are acquired around the bleb periphery from the first sign of cortex 
regrowth. In control conditions, the actin accumulation rate reports on the average of 
the accumulation rates of all participating nucleators. Thus, if a slower-than-average 
nucleator is depleted, accumulation rate will increase, and conversely, if a faster-
than-average nucleator is depleted, assembly speed will decrease. IQGAP1 depletion 
led to a significant decrease in actin accumulation rate, consistent with its potential 
role in keeping Diaph1 active (Figure 10-3). NCKIPSD depletion also led to a 
significant decrease in actin regrowth rate, consistent with the large bleb phenotype 
and a potential role as an activator of Diaph1 rather than an inhibitor as suggested by 
a previous study (Eisenmann, 2007) (Figure 10-3).  
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Figure 10-3 Actin accumulation rates of NPFs thought to interact with Diaph1. 
Regrowth rates follow bleb size data. Actin accumulation rates corrected for the 
relative cortical actin between cell lines for cells transfected with non-silencing 
siRNA, non-silencing shRNA, Diaph1 siRNA, IQGAP1 shRNA and NCKIPSD 
siRNA (n=76, 86, 11, 32, 16 p=4E-4, 4E-10 and 5E-4), (*p < 0.05, ** p< 0.01 and 
***p<0.001). 
Consistent with a role in maintaining Diaph1 active suggested by the blebbing 
phenotype, IQGAP1 depletion led to cortical actin networks with large gaps, 
although the effect was less pronounced than with Diaph1 depletion. It is possible 
that Diaph1 retains some nucleating activity without the requirement of further 
stabilising activity by IQGAP1, suggesting that IQGAP1 is not the only NPF 
regulating Diaph1 in the cortex. NCKIPSD depletion led to a clear increase in 
cortical density compared to control cortices. This was surprising because the large 
bleb phenotype observed in live imaging experiments is consistent with a reduction 
in Diaph1 activity and thus we would expect to observe cortices with gaps. The tight 
cortex mesh observed in NCKIPSD depleted cells was also different from what is 
observed in Arp2/3 knockdowns, suggesting a unique role for NCKIPSD in 
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modulating cortical actin nucleation. The increase in cortical actin density observed 
upon depletion suggests that NCKIPSD represses an actin nucleation pathway in 
addition to activating Diaph1. One potential candidate is the Wave pathway as 
NCKIPSD and Wave might compete for Arp2/3 complexes. The potential role of 
NCKIPSD will be discussed further in the following sections.  
In previous work, Diaph1 depletion led to a thinning of the actin cortex (Chugh et al. 
2017) and an increase in cell death as the cells progressed through the cell cycle 
(Bovellan et al. 2014). Thus, I examined how depletion of each NPF affected cell 
cycle progression and actin cortex morphology during cell division. Experiments 
examining the effects of NPF depletion on cortical thickness are ongoing in 
collaboration with Dr. Priyamvada Chugh in Prof. Ewa Paluch’s lab. IQGAP1 
depletion led to a large increase in cell death, similar to Diaph1. This high proportion 
of cell death was also recorded in cells following NCKIPSD depletion. In both cases, 
cell death was not as high as observed with Diaph1 depletion. This again supports 
the role of these NPFs as stabilising the Rho-activated open conformation of Diaph1. 
The high death rate observed in IQGAP1 depleted cells was able to be completely 
rescued by the Diaph1 binding region of IQGAP1, indicating that IQGAP1-mediated 
stabilisation of Diaph1 activity is key during the cell cycle. The combined depletion 
of Diaph1 and IQGAP1 caused a significant increase in cell death compared to 
Diaph1 depletion alone. This was similar to what was observed when Diaph1 and 
Arp2/3 complex were co-depleted, suggesting that IQGAP1 may also play a role in 
Arp2/3 activation or that Diaph1 activity is completely abrogated. I also found that 
combined depletion of NCKIPSD and IQGAP1 did not increase overall cell death in 
HeLa cells compared to IQGAP1 depletion alone, suggesting that they either act in 
concert or that IQGAP1 is the dominant NPF.  
Further work is required to understand the exact role of IQGAP1 and NCKIPSD in 
modulating Diaph1 activity during cell cycle progression in HeLa cells. In particular, 
the exact mechanism and stage of the cell cycle in which Diaph1 depletion provokes 
cell death remains unclear. Depletion of IQGAP1 and NCKIPSD would perturb actin 
turnover in the cortex, which is necessary to enable cell shape change during 
rounding, resulting in a possibly unorganised rounded morphology. Alternatively, it 
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has been shown that formin-nucleated bundled F-actin networks tend to be more 
conducive to host myosin II contractility as opposed to Arp2/3-mediated branched F-
actin (Ramanathan et al. 2015; Michelot & Drubin 2011). Depletion of IQGAP1 or 
Diaph1 might therefore perturb myosin contractility, resulting in failure of proper 
cortical contractions. To probe the effect of nucleator inhibition upon contractility, 
Malti Vaghela carried out immunostaining experiments on SMIFH2 and CK666 
treated HeLa cells. Here, the aim was to observe a change of cortical localisation of 
myosin as a result of the change in nucleation of the actin cortex. In fact, loss of 
cortical myosin was observed as a result of SMIFH2 treatment, a broad spectrum 
formin inhibitor (Figure 10-4) and in addition, this led to a decrease in cell stiffness. 
This change was not observed in CK666 treated cells. This result is interesting as it 
could help understand the high proportion of cell death seen in Diaph1 or IQGAP1 
depleted HeLa cells, as being due to a loss of cortical myosin and concomitant shape 
change problems. Thus, formin-mediated actin nucleation appears important for 
cortical myosin recruitment. Further experiments probing myosin localisation in NPF 
depleted lines with live imaging are ongoing and they may also aid in understanding 
reasons for the high cell death observed in IQGAP1 and NCKIPSD depleted lines.  
 
Figure 10-4 Formin inhibition leads to loss of cortical myosin. Live HeLa cells 
blocked in metaphase with MG132 expressing MRLC-GFP and LifeAct-Ruby 
imaged before and 1hr after being treated with DMSO (100µM), CK666 (100µM) or 
SMIFH2 (40µM). The MRCL-GFP (green) and LifeAct-Ruby (purple) for each cell 
are overlaid in the third row. Scale bar: 10µm. 
myosin
lifeact
myosin 
lifeact
No tr. +DMSO No tr. +CK666 No tr. +SMIFH2
 192 
The role of NCKIPSD remains puzzling. Although it was described as an inhibitor of 
formins in previous work, our experiments suggest it acts as an activator. Therefore, 
we have started collaborating with the group of Dr Guillaume Romet-Lemonne in 
Paris to explore how NCKIPSD affects Diaph1 mediate actin polymerisation at the 
single filament level. Preliminary data obtained by Dr Yan Cao-Lu suggests that 
NCKIPSD accelerates nucleation via Diaph1 (correspondence from Yan Cao-Lu). 
Experiments examining the interplay with Arp2/3 and Diaph1 are ongoing.  
Overall, my data strongly supports IQGAP1 as an important class II Diaph1 
activator, working to stabilise and maintain its active conformation. NCKIPSD 
appears to phenocopy Diaph1 in a number of assays, appears to inhibit Diaph1 in 
combination experiments, and possibly activate Arp2/3 in others, suggesting it may 
have a role in crosstalk between Diaph1 and Arp2/3, allowing the cell to fine tune its 
cortex.  
10.3 How is the activity of Arp2/3 regulated by NPFs? 
NPFs known to interact with the Arp2/3 complex, fall into two classes, depending on 
their activity. Class I NPFs activate nucleation, whilst class II NPFs maintain 
activation. The Wave regulatory complex (WRC) is a well-studied class I activator 
for the Arp2/3 complex (Goley & Welch 2006). I expected the depletion of Wave 
complex subunits to phenocopy Arp2/3 subunit depletion in blebbing assays and in 
long term imaging experiments. In my experiments, I focused on the subunits Sra1 
and Nap1, as they were detected in the proteomics. Depletion of both subunits gave 
rise to small blebs, and a cortex with longer filaments, consistent with the 
phenotypes observed for Arp2/3 depletion. Furthermore, Nap1 depletion 
significantly increased actin regrowth rate, similar to depletion of ACTR2 (Figure 
10-5). Cortical stiffness measurements also carried out by Malti Vaghela with AFM 
also mirrors bleb size results. Arp2/3 subunit depletion, Nap1 depletion and 
treatment with CK666 led to an increase in stiffness. Through all of my assays and 
those used by Malti Vaghela, WAVE complex depletion always phenocopied Arp2/3 
depletion indicating that WRC plays a central role in the regulation of Arp2/3 in the 
cortex. 
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Figure 10-5 Actin accumulation rates of NPFs thought to interact with Diaph1. 
Regrowth rates follow bleb size data. Actin accumulation rates corrected for the 
relative cortical actin between cell lines for cells transfected with (e) non-silencing 
siRNA, ACTR2 siRNA and Nap1 siRNA (n=76, 30, 29, p=2E-13 and 0.008) (* p < 
0.05, ** p < 0.01 and *** p<0.001). 
Interestingly, my experiments also showed that depletion of ACTR2 and ArpC2 did 
not affect cell cycle progression to the same extent. Cells depleted of ArpC2 did not 
have any significant change in cell death, similar to depletion of Nap1/Sra1, whereas 
cells depleted of ACTR2 had a high incidence of cells failing to progress through the 
cell cycle. This observation is interesting, as it raises the question of whether 
different Arp2/3 subunits play different roles in the activity of the complex. 
Structurally, it has been documented that the ArpC2 and ArpC4 subunits are located 
at the interface between the Arp2/3 complex and mother filaments during branching 
(Gournier et al. 2001; Goley et al. 2004). It was previously thought that Arp2/3 actin 
nucleation required the presence of the mother filament, however recent work has 
shown that nucleation can occur without the requirement for a mother filament 
(Wagner et al. 2013). In this case, interfacing with the mother filament may be 
dispensable, and this may explain why the depletion of the ArpC2 subunit did not 
reflect any abnormalities in the progression through cell division. 
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In contrast to ARPC2, ACTR2 is central to the function of the Arp2/3 complex. It is 
one of the two subunits that template the new filament. ACTR2 must be 
phosphorylated (by Nck-interacting kinase) for the Arp2/3 complex to be activated 
by NPFs (Choi et al. 2013). It has been further suggested that the Arp2/3 complex 
acts as a coincidence detector, requiring both the binding to NPFs and the 
phosphorylation of ACTR2 for increased activity (LeClaire et al. 2015). Therefore, 
the depletion of ACTR2 would clearly diminish nucleating activity of the Arp2/3 
complex, and thus, this may be one explanation for the observed difference between 
the impact of ACTR2 and ARPC2 depletion. To test this prediction, a construct 
mutated for the ACTR2 phosphorylation sites could be generated and expressed into 
HeLa cells to examine effects of this mutation in cell division. This differential role 
for different Arp2/3 subunits has recently been reported more in literature (Abella et 
al. 2015), and is an important aspect of the Arp2/3 complex to consider when 
studying its activity.   
Unlike other Arp2/3 complex activators, it has been reported that NCKIPSD does not 
bind actin monomers or filaments, and interacts with the complex using a non-
WASP-like binding mode (Wagner et al. 2013). In addition, it has been suggested 
that NCKIPSD-activated Arp2/3 complex creates linear instead of branched actin 
filament networks. In my experiments and in those of Malti Vaghela, NCKIPSD 
sometimes phenocopied Arp2/3 depletion, sometimes Diaph1 depletion, and 
sometimes neither, hinting at a complex role. In particular, in blebbing cells, it led to 
large blebs, something observed with Diaph1 depletion, but also led to a dense 
cortex. In the framework I proposed for NCKIPSD’s role in coordinating Diaph1 and 
Arp2/3 nucleation, its depletion would lead to reduction of Diaph1 activity and 
would lead to less nucleation of unbranched F-actin via Arp2/3, leaving on 
nucleation of branched actin via WRC mediated Arp2/3 activation. Thus the high 
density of F-actin present in NCKIPSD depleted cortices might reflect enhanced 
WRC Arp2/3 nucleation and enhanced branching leading to the tighter actin meshed 
observed. Finally, as previously mentioned, it appears that IQGAP1 may have a 
lesser role in regulating nucleation via the Arp2/3 complex, although in our (my own 
and Malti Vaghela’s) experiments, this only appeared when we co-depleted Diaph1 
and IQGAP1 in long term imaging assays.  
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It is possible that WAVE and NCKIPSD may compete for the Arp2/3 complex. It is 
possible that NCKIPSD generates an actin seed via Arp2/3 nucleation, and then 
brings a Diaph1 dimer into contact with the newly created barbed end. Here, 
NCKIPSD regulates nucleation through both Diaph1 and the Arp2/3 complex, rather 
than predominantly through one nucleator. This may explain the discrepancy in 
results observed in the different assays.  
The role of NCKIPSD remains unclear; further work is required to understand the 
role of NCKIPSD in controlling actin nucleation in the actin cortex. Confirmation of 
this data in single filament assays would be worthwhile for continuing this 
investigation.  
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Chapter 11 Appendix 
11.1 BioID bait cloning sequences 
Dr. Geneviève Lavoie carried out cloning of all BirA constructs (sequences below). 
>Arp3 
NNNNNNNNNNNNNNNNNNNNNNNNNNCNANNNNGGGNNNNNGGCCCCGGCGGCGGCGCGCCTGT
ACNNNNNTNTGCGGCCGCAATGGCGGGACGGCTGCCGGCCTGTGTGGTGGACTGTGGCACGGGGTA
TACAAAACTAGGATATGCTGGAAATACAGAACCACAGTTTATCATCCCTTCCTGTATTGCTATTAAG
GAGTCAGCAAAAGTGGGTGATCAAGCTCAAAGGAGGGTGATGAAAGGTGTTGATGACCTAGACTTC
TTCATTGGTGATGAAGCAATAGAAAAACCTACATATGCAACAAAGTGGCCAATCCGCCATGGTATA
GTTGAAGATTGGGACTTAATGGAAAGGTTTATGGAGCAAGTGATCTTTAAATATTTAAGGGCAGAA
CCTGAAGACCATTATTTTCTTTTGACTGAACCTCCATTGAATACTCCAGAAAACAGGGAATATACTG
CTGAAATAATGTTTGAGTCCTTCAATGTTCCAGGCTTGTACATTGCTGTGCAGGCTGTTCTTGCCTTA
GCTGCATCTTGGACCTCAAGACAAGTAGGAGAACGGACGTTGACCGGTACGGTAATAGACNNNGG
AGATGGTGTCACTCATGTCATTCCTGTGGCTGAAGGGTATGTGATTGGCAGCTGTATTAAACACATT
CCAATCGCAGGACGAGATATAACATATTTTATTCAGCAACTGCTGANAGACCGAGAAGTAGGAATC
CCTCCAGAACAATCCTTGGAAACTGCTAAGGCAGTAAAGGANCGCTATAGTTATGTCTGNCCAGAN
TTAGTAAAAGAANTTAACANTATGATACAGATGGGTCAAAATGGATTAAACAGTATACTGGAATCA
ATGCTATCTCNAAGAAAGAGTTTTCTATCNNTGTTNGNNNTGAGAGANTTTTGGGACCTGAANTCTT
TTTCATCCNGNNNTTTGCTAATCCAGANNTTACNCANCNATCTCNNANTTGTANATGAAGNAATTN
NNANTTGTCCNNNGATGTNNNNANGTCNTNNNNNACNANANTNTGNCCTNTCNGGANGNTCANCC
NTGNNCNGGNNTTTNGNANNTC 
>Arpc4 
NNNNNNNNNNNNNNNNGCGGNNCGCGNNNGGGGGGNNCTGGCCCCGGCGGCGGCGCGCCTGTAC
AGATATCTGCGGCCGCAATGACTGCCACTCTCCGCCCCTACCTGAGTGCCGTGCGGGCCACATTGCA
GGCTGCCCTCTGCCTGGAGAACTTCTCCTCCCAGGTTGTGGAACGACACAACAAGCCGGAAGTGGA
AGTCAGGAGTAGCAAAGAGCTCCTGTTACAACCTGTGACCATCAGCAGGAATGAGAAGGAAAAGG
TTCTGATTGAGGGCTCCATCAACTCTGTCCGGGTCAGCATTGCTGTGAAACAGGCTGATGAGATCGA
GAAGATTTTGTGCCACAAGTTCATGCGCTTCATGATGATGCGAGCAGAGAACTTCTTTATCCTTCGA
AGGAAGCCTGTGGAGGGGTATGATATCAGCTTTCTGATCACCAACTTCCACACAGAGCAGATGTAC
AAACACAAGTTGGTGGACTTTGTGATCCACTTCATGGAGGAGATTGACAAGGAGATCAGTGAGATG
AAGCTGTCAGTCAATGCCCGTGCCCGCATTGTGGCTGAAGAGTTCCTTAAGAATTTTTAACTCGAGT
CTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGT
TTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATG
AGGAAATTGCATCGCATTGTCTGAGTAGGTGNNNTTCTATTCTGGGGGGTGNNNNNNNNN 
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>Diaph1deltaDAD 
NNNNNNNNNNNNNNNNNNNNNNNNCGCCGNNNNGGGGGNNCTGGCCCCGGCGGCGGCGCGCCTG
TACAGATATCTGCNGNCGCNATGGAGCCGCCCGGCGGGAGCCTGGGGCCCGGCCGCGGGACCCGG
GACAAGAAGAAGGGCCGGAGCCCAGATGAGCTGCCCTCGGCGGGCGGCGACGGCGGCAAATCTAA
GAAATTTCTGGAGAGATTTACCAGCATGAGAATTAAGAAGGAGAAGGAAAAGCCCAATTCTGCTCA
TAGAAATTCTTCTGCATCATATGGGGATGATCCCACAGCACAGTCATTGCAAGATGTTTCAGATGAA
CAAGTGCTGGTTCTCTTTGAACAGATGCTGCTGGATATGAACCTGAATGAGGAGAAACAGCAACCT
TTGAGGGAGAAGGACATCATCATCAAGAGGGAGATGGTGTCCCAATACTTGTACACCTCCAAGGCT
GGCATGAGCCAGAAGGAGAGCTCTAAGTCTGCCATGATGTATATTCAGGAGTTGAGGTCAGGCTTG
CGGGATATGCCTCTGCTCAGCTGCCTGGAGTCCCTTCGTGTGTCTCTCAACAACAACCCTGTCAGTT
GGGTGCAAACATTTGGTGCTGAAGGCTTGGCCTCCTTATTGGACATTCTTAAACGACTTCNTGATGA
GAAAGAAGAGACTGCTGGGAGTTACGATAGCCGGAACAAGCATGAGATCATTCGCTGCTTGAAAG
CTTTTATGAACAACAAGTTTGGAATCNAGACCATGTTGGAGACAGAAGAAAGAATCCTACTGCTGG
TCANAGCCATGGATCCTGCTGTTCCCAACATGATGANTGATGCAGCTAANCTGCTTTCTGCTCTTTG
TATTCTACCGCANCCAGAGGACATGAATGAAAGGGTTTTGGANGNNATGACNGAAANAGCTGANA
NGGATGANTGGANNNTTTCCNGCCGCTGCTGGANNGATTAAAAGNGANCNCTATTGNNNNGNNGN
TGGATGCCTANNGCTGATCAATGCTCTCATCNCNCCNGCGGAGNNCNTGNNNTNCNANNNCNNNNN
NANNNACTGATNCNTTNGGGNTANNNN 
>Diaph1WT 
GNNNNNNNNNNNNNNNNCNNNNNNCNNNNNGNGGGNNCTGGCCCCGGCGGCGGCGCGCCTGTAC
AGATATCTGCGGCCGCAATGGAGCCGCCCGGCGGGAGCCTGGGGCCCGGCCGCGGGACCCGGGAC
AAGAAGAAGGGCCGGAGCCCAGATGAGCTGCCCTCGGCGGGCGGCGACGGCGGCAAATCTAAGAA
ATTTCTGGAGAGATTTACCAGCATGAGAATTAAGAAGGAGAAGGAAAAGCCCAATTCTGCTCATAG
AAATTCTTCTGCATCATATGGGGATGATCCCACAGCACAGTCATTGCAAGATGTTTCAGATGAACAA
GTGCTGGTTCTCTTTGAACAGATGCTGCTGGATATGAACCTGAATGAGGAGAAACAGCAACCTTTG
AGGGAGAAGGACATCATCATCAAGAGGGAGATGGTGTCCCAATACTTGTACACCTCCAAGGCTGGC
ATGAGCCAGAAGGAGAGCTCTAAGTCTGCCATGATGTATATTCAGGAGTTGAGGTCAGGCTTGCGG
GATATGCCTCTGCTCAGCTGCCTGGAGTCCCTTCGTGTGTCTCTCAACAACAACCCTGTCAGTTGGG
TGCAAACATTTGGTGCTGAAGGCTTGGCCTCCTTATTGGACATTCTTAAACGACTTCATGATGAGAA
AGAAGAGACTGCTGGGAGTTACGATAGCCGGAACAAGCATGAGATCATTCGCTGCTTGAAAGCTTT
TATGAACAACAAGTTTGGAATCAAGACCATGTTGGAGACAGAAGAAGGAATCCTACTGCTGGTCAG
AGCCATGGATCCTGCTGTTCCCAACATGATGATTGATGCAGCTAAGCTGCTTTCTGCTCTTTGNATTC
TACCGCAGCCAGAGGACATGAATGAAAGGGTTTTNGNAGGCAATGACAGAAAGAGCTGAGATGGA
TGAAGTGGNACGTTTCCAGCCGCTGCTGGNTGGATTAAAANTGGNNCNNCNNNNGCNCTGNNNNN
NNTGNCTANNNCTGATCNATGCTCNCATCNN 
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